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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Clinical Implications of Bacterial Glycocalyx
The bacterial glycocalyx is increasingly 
being recognized as a major factor con­
tributing to the host-parasite relationship 
in both health and disease. Costerton and 
colleagues at the University of Calgary 
have performed much of the pioneering 
work in this area. They have defined the 
bacterial glycocalyx as an anionic poly­
saccharide matrix of bacterial origin out­
side the peptidoglycan of gram-positive 
bacteria and the outer cell membrane of 
gram-negative bacteria. The term, 
glycocalyx, encompasses the well-known 
bacterial capsule, which has been recog­
nized for many years because of its 
visualization by negative staining and 
because of the mucoid appearance of 
freshly isolated colonies in vitro. 
However, the ubiquity of the glycocalyx 
and its presence in nonencapsulated bac­
teria have only recently been recognized. 
This has been due to the failure to visual­
ize the glycocalyx by ordinary light and 
electron microscopy and its tendency to 
be lost during in-vitro bacterial culti­
vation.1
The production of the glycocalyx con­
fers certain ecologic advantages on bac­
teria, allowing them to attach to each 
other as well as to various surfaces to 
form microcolonies. This exopolysaccha­
ride functions consequently as a protec­
tive “ slime” . The process by which bac­
teria are able to bind to surfaces of either 
biologic or nonbiologic origin is known 
as adherence. This ability is essential for 
bacteria to colonize and ultimately to 
establish infection. The available mechan­
isms by which most bacteria adhere are 
either the production of glycocalyx or the 
formation of pili (hair-like external 
appendages), or both. The formation of 
glycocalyx has been shown also to retard 
host macrophage phagocytosis and limit 
the availability of antibiotics to their tar­
get site by acting as an ion-exchange bar­
rier. This effect may be another factor 
that accounts for the frequently observed 
discrepancy between in-vitro susceptibil­
ity and clinical unresponsiveness to a 
given pathogen.
Foreign bodies offer sites where bac­
teria may adhere without being subject to 
local host-defence mechanisms, including 
competition with normal flora. The in­
dwelling urinary catheter is an example 
in which intra- or extraluminal coloniza­
tion by bacteria is established quickly and 
eventually leads to direct bladder mucosal 
attachment and invasion.2 The article by 
Nickel and associates in this issue (pages 
50 to 54) reports a patient with an in­
dwelling Foley catheter in whom a urinary 
tract infection developed 3 days after 
insertion. The infection was not eradi­
cated by antibiotics to which the organ­
ism was susceptible in vitro, but was 
treated successfully after the catheter was 
removed. Electron microscopic studies 
showed that the bacteria were embedded 
in glycocalyx on the catheter wall both 
intra- and extraluminally. This report 
demonstrates the frequent difficulty in 
treating infections in the presence of for­
eign bodies that is in part due to bacterial 
glycocalyx formation.
Promising and interesting strategies to 
prevent and treat infections are based on
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the role of the bacterial glycocalyx. Subin- 
hibitory concentrations of certain antibi­
otics have been shown to suppress adher­
ence in vitro and to reduce or inhibit 
glycocalyx production. This approach 
also has been demonstrated by Ofek and 
associates3 to reduce colonization in vivo 
by susceptible bacteria.
Mucin and its analogues such as 
heparin and sodium pentosanpolysulfate 
can retard adherence on biologic and inert 
surfaces by making them “ wet” , due to 
their avidity to bind water. Sodium pen­
tosanpolysulfate has the added advan­
tages that it is available orally, is excreted 
in urine and possesses little anticoagulant 
activity. Such agents have been shown to
decrease bacterial adherence in animal 
models.4 The advantages of the mucin 
analogues are their broad nonspecific 
spectrum and the consequent reduction in 
antibiotic utilization that could lead to 
less-frequent development of resistance. 
Whether these analogues would work 
clinically and whether bacteria would 
emerge unaffected by them is unknown. 
Based on our increasing understanding of 
the bacterial glycocalyx, the possibility of 
precoating catheters with these substances 
may lead to a useful new approach to 
such infections.
A nton Maki, J r ., md, frcpc 
O le Hammerberg, md, frcpc
Department of Pathology and Department of Pediatrics,McMaster University,Health Sciences Centre, Rm. 2N29,Hamilton, Ont.L8N 3Z5
References
1. COSTERTON JW, IRVIN RT, CHENG KJ: The bacterial 
glucocalyx in nature and disease. Annu Rev Microbiol 
1981; 35: 299-324
2. Garibaldi RA, Burke JP , Britt MR, Miller m a , 
Sm ith  CB; Meatal colonization and catheter-associated 
bacteriuria. N  Engl J  Med 1980; 303: 316-8
3. Ofek 1, Beachey  EH, E isenstein b i , alkan  ML, 
Sharon  N: Suppression of bacterial adherence by sub- 
minimal inhibitory concentrations of beta-lactam and 
aminoglycoside antibiotics. Rev Infect Dis 1979; 1: 832-7
4. Parsons CL, P ollen  J J , Anwar H, Stauffer C, 
Schm idt  JD: Anti-bacterial activity of bladder surface 
mucin duplicated in the rabbit bladder by exogenous 
glycosaminoglycan (sodium pentosanpolysulfate). Infect 
Immun 1980; 27: 876-81
Ultrasonography and the Surgeon
Major advances in medicine made before 
we ourselves entered clinical practice we 
take largely for granted. Those advances 
that occur during our careers allow us to 
witness medicine in evolution and excite 
our imagination as we strive to apply the 
new discovery or technology. Diagnostic 
ultrasonography is one such advance. 
Based on sonar, developed during World 
War I, it was introduced into medicine in 
the late 1950s. As a house officer in a neu­
rosurgical unit in 1964, I struggled to 
detect intracranial midline shifts with a 
crude self-operated A-mode machine 
while across the city Professor Ian Donald 
was conducting his pioneer studies of B- 
mode and then B-scanning of the female 
pelvic organs.1 His two-dimension cross- 
sectional pictures of the abdomen failed, 
however, to excite much enthusiasm 
except among obstetricians who were glad 
to have any nonradiologic method of 
visualizing the pregnant uterus. The real 
breakthrough came in the last decade 
when grey-scale ultrasonography was 
introduced; this added gradations of grey 
to the pure white and pure black of the 
older pictures. Suddenly, even a surgeon 
could recognize the kidney.2 The simul­
taneous development of much more sophisticated transducers dramatically 
improved resolution so that tubular struc­
tures as small as 2 mm in diameter could 
be identified. Most recent is the introduc­
tion of real-time scanning that allows the 
detection and displaying of movements so 
that vessel pulsation can be seen; it allows 
organs to be viewed in cross-section in any plane.
Ultrasonography has had a major 
impact on every surgical discipline from 
cardiovascular surgery with its use of 
echocardiography and doppler of the
carotid arteries to neurosurgery with its 
intraoperative use of ultrasonographic 
probes. Perhaps the general surgeon has 
benefited most. Ultrasonography now 
provides reliable, accurate diagnosis of 
neck and breast masses, pleural effusions, 
abdominal aortic aneurysms, gallstones, 
liver metastases, pancreatic tumours and 
intra-abdominal abscesses. The major 
advantages of ultrasonography are that it 
is totally noninvasive and rapidly per­
formed. Its major disadvantages are that 
it is unusually dependent on the skill of 
the operator and it provides an anatomi­
cal picture but tells us nothing about func­
tion. Even the latter drawback, however, 
is being overcome. With the new doppler 
techniques it is now possible to determine 
something about the function or organs 
such as liver, kidney and ovary. While the 
arguments about computerized tomogra­
phy still rage,3 nobody now doubts the 
cost-effectiveness and genuine need for 
diagnostic ultrasonography. A couple of 
simple examples illustrate this. It is now 
possible to make a cytologic diagnosis of 
pancreatic cancer on the basis of the 
patient’s first visit to the out-patient 
department of some centres.4 Invasive 
techniques carried out under ultrasono­
graphic control are now replacing 
laparotomy for drainage of some intra­
abdominal abscesses.5 Few technologies 
have had such a marked impact on the 
everyday activity of surgeons.
Many more applications for ultrasono­graphy will be found. The era of discov­
ery is not yet over. The paper by Rankin 
and his colleagues in this issue (pages 84 
and 85) illustrates how collaboration 
between radiologist and surgeon can 
uncover yet another simple new applica­
tion. Admittedly it is not often difficult
to distinguish clinically between an inci­
sional hernia and a hematoma but the 
important contribution of this paper is 
that it describes clearly the characteristic 
ultrasonographic appearance of the 
postoperative abdominal wall hematoma. 
Despite the fact that Rankin and associ­
ates have not provided for comparison 
the ultrasonographic appearance of an 
incisional hernia, their description of the 
hematoma is convincing. Few surgeons 
and certainly no ultrasonographer will 
forget that characteristic radial configu­
ration of the septae within the hematoma. 
There are certainly other diagnostic 
appearances particularly of soft-tissue 
masses waiting to be described. The sur­
geon is in the uniquely privileged position 
of being able to obtain early correlation 
of the ultrasonographic with the gross and 
histologic appearance of the lesion. I 
would have loved to have had real-time 
when I was a houseman!
Max M. Cohen , mb, frcs(Edin), frcsc
Member,Editorial Board
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State of the Art
From time to time, we all find ourselves 
responsible for a patient whose treatment 
is controversial or has recently changed. 
There are two approaches: one can con­
sult widely or one can learn what the 
recent advances have been and apply 
them. The purpose of the new “ State of 
the A rt” section in the journal is to sup­
port the latter policy. Examples are the 
offerings by Mark Boyd on pelvic inflam­
matory disease in this issue (pages 11 to 
13) and by J.S. Dorsey on use of a sub­
cutaneous vein remover to harvest the 
greater saphenous vein for coronary 
artery bypass grafting (pages 13 and 14).
Pelvic Inflammatory Disease
Several important points are made in 
Boyd’s paper. A culture should be 
obtained if possible in pelvic inflam­
m atory disease and this requires 
laparoscopy. The antibiotic treatment 
differs markedly for each organism and 
a broad-spectrum approach is not pos­
sible.
Laparoscopy is most useful in estab­
lishing the diagnosis and should be used 
when laparotomy is not indicated. The 
microbiologic features of pelvic inflam­
matory disease are now known to be
diverse and include mixed aerobic and 
anaerobic flora.
In the case of abscesses found unex­
pectedly at the time of laparotomy, cul­
ture and drainage are all that should be 
done. Until recently, the proper answer 
to the question “ what is the correct treat­
ment of tubo-ovarian abscess?” was total 
hysterectomy with bilateral salpingo- 
oophorectomy; even current textbooks 
offer the same advice. This is not the state 
of the art: early and correct bacteriologic 
diagnosis and appropriate antibiotic ther­
apy with simple drainage of abscesses 
usually achieves complete resolution of 
the infection and restoration of normal 
organ function.
It is important to remember that 
regardless of the laboratory report, gross 
pus is rarely sterile and fetid pus is never 
free of strict anaerobes. One of four 
antibiotic combinations should be chosen 
for pelvic inflammatory disease: clin­
damycin plus an aminoglycoside, cefoxi­
tin plus doxycycline, metronidazole and 
doxycycline, or piperacillin plus an 
aminoglycoside. Piperacillin, a third 
generation semisynthetic penicillin that is 
active against Bacteroides sp, can be sub­
stituted for clindamycin or metronida­
zole. Escherichia coli becomes resistant to 
piperacillin quickly and, therefore, it
should be used with an aminoglycoside. 
Single-agent coverage with cefoxitin, 
cefotaxime and monobactam offers no 
therapeutic advantage over the combina­
tions described.
These antibiotic regimens are used 
because pelvic inflammatory disease is 
usually caused by, or at least associated 
with, multiple organisms. In a recent 
study1 among women with gonorrhea 
proven by culture, 25% also had a posi­
tive culture for Chlamydia trachomatis.
I agree with the recommendations of 
Boyd that most patients with pelvic 
inflammatory disease can be treated effec­
tively with antibiotics alone if the causal 
organisms are identified, most do not 
require operation and when it is per­
formed, resection of fallopian tubes, 
ovaries or uterus is almost never indi­
cated.
Lloyd D. MacLean, md, frcsc 
Coeditor
Reference
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SESAP IV Question
8. In which of the following cases should replantation of a digit amputated at the metacarpalphalangeal joint be 
performed?
(A) Replantation of a thumb adequately refrigerated for eight hours after injury
(B) Replantation of a dominant index finger (single-digit amputation)
(C) Replantation of a digit with a positive “ Chinese red line”
(D) Ring avulsion accident causing amputation
(E) Crushing amputation with multiple comminuted fractures of the digit
To the question above select the one answer that is best of the five given. For the critique of Item 8 see page 90.
(Reproduced by permission from SESAP IV  Syllabus; Surgical Education and Self-Assessment Program No. 4. For 
enrolment in the Surgical Education and Self-Assessment Program No. 4, please apply to the American College of 
Surgeons, 55 East Erie St., Chicago, IL 60611.)
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SURGEO NS ’ UPDATE
*
What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Surgeons in Canada Honoured 
by the American College 
of Surgeons
The contingent from Canada didn’t 
exactly sew it up, but when the annual 
meeting of the American College of Sur­
geons opened this year, the group from 
the north was there in the power struc­
ture in rather impressive numbers, and the 
top office was held by a Canadian.
The ACS, which was holding its 70th 
clinical conference, met in San Francisco 
from Oct. 21 to 26. It has always counted 
a good number of surgeons from Canada 
among its 40 000 or so members, and this 
year the numbers were reflected in the 
hierarchy.
Mueller Receives ACS Distinguished 
Service Award
The highest honour awarded by the 
College went to a surgeon in Canada. Dr. 
C. Barber Mueller of Hamilton, Ont.,
C. Barber Mueller, MD, FACS, FRCSC
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
was presented with the Distinguished 
Service Award, the 28th recipient in the 
history of the College and the first to give 
it a home north of the 49th parallel.
The award recognizes extensive contri­
butions to the field of surgery. Mueller 
is a natural to receive it. Professor Emeri­
tus of Surgery at McMaster University, 
he has helped shape the surgical exami­
nations for the Royal College of Physi­
cians and Surgeons of Canada, serving on 
the Surgical Test Committee and the 
Committee on Examinations for most of 
a decade and chairing the Basic Surgical 
Examination Committee from 1971 to 
1979. Similarly, he has contributed 
actively to the Medical Council of 
Canada’s examinations committee and 
the US National Board of Medical Exam­
iners. He was instrumental in the design 
of the “ Surgical Education and Self- 
Assessment Program” , which is featured 
in each issue of this journal. Little wonder 
that when presented with the award he 
was cited for his work in raising the stand­
ards of examinations and improving con­
tinuing medical education.
The Distinguished Service Award cita­
tion issued to Mueller reads:
“ In acknowledgement of more than 30 
years of devoted service to many commit­
tees of this College, dealing with fun­
damental research, continuing education, 
scientific terminology and clinical classifi­
cations; and
“ In appreciation of substantial achieve­
ment by superb performance of his 
professorial duties at several universities 
in the United States and Canada, where 
he has contributed heavily to basic 
research and clinical practice, with spe­
cial reference to breast carcinoma; and
“ In gratitude for his dedication to the 
broad administrative aspects of his aca­
demic community and the profession of 
surgery by advice and consultation to 
other specialties and to the federal 
government on testing, competence, licen­
sure and the ethics of research, the Board 
of Regents is pleased to award its highest 
honor.”
Besides being coeditor of the Canadian 
Journal o f Surgery, and having almost 
100 scientific articles to his credit, he is 
a former member of the editorial board 
of the Journal o f Surgical Research and 
a current member of the Committee on 
Publications of the Canadian Medical 
Association.
A graduate of Washington University 
School of Medicine, St. Louis, he com­
pleted his internship and residency at 
Barnes Hospital in 1943. He also com­
pleted a fellowship in biochemistry at 
Harvard Medical School, Boston.
During his career, half of which he has 
spent in Canada, he has served a number 
of universities as professor of surgery, 
including Washington University, Upstate 
Medical Center of the State University of 
New York, Syracuse, and McMaster 
University, where he was department 
chairman until 1972.
A member of numerous professional 
associations in Canada and the United 
States, Dr. Mueller has been a fellow of 
the American College of Surgeons since 
1953 and has participated on various ACS 
committees.
In an interview with CJS, Dr. Mueller 
paid tribute to McMaster, which he 
termed a special medical school — one 
that provided a stage on which he could 
play. He recalled being welcomed “ with 
reasonably open arms” not only by the 
faculty but also by the various organiza­
tions that were formulating examinations. 
The most salient day he remembers was 
a Saturday during the first year of Dr. 
Bob Dixon’s tenure as head of the Royal 
College. It was late and the examinations 
committee was meeting — with barely a 
quorum — and as one of the last items 
of business it proposed a task force to re­
structure examinations for fellowship and 
certification. He feels that was the begin­
ning of quality standards for surgeons in 
Canada.
The Distinguished Service Award is not 
a first for Dr. Mueller; he was honoured 
in much the same way by the Association 
for Academic Surgery in 1976.
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Canadian Surgeons Holding ACS Offices
The top job at the American College 
of Surgeons went to Charles G. Drake of 
London, Ont., and four other surgeons 
practising in Canada occupied positions 
on the governing body at the San Fran­
cisco meeting: Lloyd D. MacLean of 
Montreal, the Journal’s other coeditor, 
will continue to serve on the Board of 
Regents and is joined by Tait McPhedran 
of Calgary; Jean G. Couture of Quebec 
City will be a member of the Executive 
Committee of the Board of Governors 
and George P . Konok of Halifax is a new 
governor.
Charles Drake, who is the 65th presi­
dent of the ACS, is accustomed to being 
“ way up there” in everything he does, 
including piloting his own aircraft. Quite 
appropriate that he should be flying the 
flag of Canada at the ACS meeting: he 
is Clinical Professor and ex-chairman of 
the Department of Surgery, University of 
Western Ontario, Surgeon-in-Chief at 
University Hospital and a consulting sur­
geon at Victoria Hospital. An internatio­
nally recognized neurosurgeon, he 
specializes in treatment of cerebral 
aneurysms. He has shared his expertise as 
guest lecturer and professor all over the 
world and has been honoured with fel­
lowships on practically every continent.
A native of Windsor, Ont., Dr. Drake 
received his MD from the University of 
Western Ontario. His postgraduate train­
ing included residencies in general surgery 
and neurosurgery at Toronto General 
Hospital and a fellowship in neurophysi­
ology at the University of Western 
Ontario and at Yale University. He 
studied neurosurgery as the G.A. Rout-
Charles G. Drake, MD, FACS, FRCSC
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ledge Travelling Fellow at various Brit­
ish and European clinics.
He was awarded the Order of Canada 
in 1982 and the Canadian Royal Bank 
Award in 1983. He is a member of 24 
national and international medical soci­
eties, holds honorary memberships in 10 
neurosurgical associations and is an 
honorary fellow of the Royal College of 
Surgeons of Edinburgh, The Royal Aus­
tralasian College of Surgeons, the Royal 
College of Surgeons of South Africa and 
the Royal College of Surgeons of 
England. He has been a fellow of the 
American College of Surgeons since 1954 
and has been a Regent of the College since 
1967.
He has been a member of the council 
o f the Royal College of Physicians and 
Surgeons of Canada, the Canadian Coun­
cil on Hospital Accreditation, the Ameri­
can Academy of Neurological Surgeons 
and is a member of the Canadian Forces 
Medical Council. He has been a member 
and chairman of the editorial board of the 
Journal o f  Neurosurgery and served as 
Vice-president of the James IV Associa­
tion of Surgeons. Drake has been Presi­
dent of the Canadian Neurosurgical Soci­
ety, the Southwestern Ontario Surgical 
Society, the Canadian Association of 
Clinical Surgeons, the American Associ­
ation of Neurological Surgeons, the Soci­
ety of Neurological Surgeons and the 
World Federation of Neurosurgical 
Societies.
So one may ask how he finds time to 
be part of the Audubon Society and the 
Canadian Wildlife Federation.
Dr. Lloyd D. MacLean became a mem­
ber of the ACS Board of Regents in 1983 
and has been active on the policy-making 
body since. He is Surgeon-in-Chief at the 
Royal Victoria Hospital, Montreal, and 
Professor of Surgery at McGill Uni­
versity.
One of the four new regents elected to 
3-year terms, Dr. N. Tait McPhedran is 
Professor of Surgery at the University of 
Calgary and former Director of the 
Department of Surgery at Foothills 
Hospital, Calgary. McPhedran is a past 
president of the Canadian Association of 
General Surgeons (1980) and was a gov­
ernor of ACS from 1976 to 1981.
In addition to his new position on the 
executive of ACS Board of Governors, 
Dr. Jean Couture is currently President 
of the Royal College of Physicians and 
Surgeons of Canada. He is Professor and 
Chairman of the Department of Surgery, 
Laval University and Senior Attending 
Surgeon and Director of the Oncology 
Unit, Hopital du Saint-Sacrement, Ste- 
Foy, PQ.
Amy Chouinard
NOTICES
Stereotactic and 
Functional Neurosurgery
The 9th meeting of the World Society for 
Stereotactic and Functional Neurosurgery 
will be held July 4-7, 1985 at the Chelsea 
Hotel and the University of Toronto, 
Toronto, Ont. It will be immediately fol­
lowed by the International Congress of 
Neurological Surgery.
For further information please write 
Mrs. Rae Ryan, Administrative Coordi­
nator, Division of Neurosurgery, Eaton 
Bldg. North 7-221, Toronto General 
Hospital, 101 College St., Toronto, Ont. 
M5G 1L7 or call (416) 595-3443.
International Congress on 
Craniofacial Anomalies
The fifth international congress on cleft 
palate and related craniofacial anomalies 
will take place in Monte Carlo from Sept. 
2-7, 1985 at the Congress Center. The 
congress chairman is Dr. Rene Malek. 
This important meeting will be of parti­
cular interest to plastic, dental pediatric 
and maxillofacial surgeons, to orthodon­
tists, otorhinolaryngologists and speech 
pathologists, and all others working in 
this field. The deadline for the submis­
sion of abstracts is Nov. 15, 1984. For 
further information contact Dr. Rene 
Malek, 6, rue Erlanger, 75016 Paris, 
France or SOCFI, 14, rue Mandar, 75002 
Paris, France.
Postgraduate Course 
in General Surgery
From May 2-4, 1985 a postgraduate 
course in general surgery will be held at 
the St. Francis Hotel in San Francisco, 
Calif. This program, offered annually by 
the Department of Surgery of the Univer­
sity of California School of Medicine in 
San Francisco, provides the general sur­
geon with a clinically oriented and inten­
sive overview of problems encountered in 
daily practice. Distinguished guests join 
the faculty from the Department of Sur­
gery to present the most authoritative and 
current information.
The symposium is sponsored by Ex­
tended Programs in Medical Education of 
the University of California School of 
Medicine in San Francisco. It will meet 
the criteria for 15 hours of AMA/CMA/ 
ACCME Category 1 credit.
For further information contact: 
Extended Programs in Medical Educa­
tion, Rm. 569-U, University of Califor­
nia, San Francisco, CA 94143; (415) 
666-4251.
continued on page 75
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Pelvic Inflammatory Disease 
and the General Surgeon
New causal agents of pelvic inflamma­
tory disease that have recently been 
determined are Chlamydia trachomatis, 
anaerobic bacteria and penicillinase- 
producing gonococci. It is also recog­
nized that the pelvic infection is normally 
polybacterial. The symptoms produced 
by these organisms are so indefinite that 
diagnosis based on clinical findings alone 
is often difficult. The diagnosis of pelvic 
inflammatory disease should therefore be 
established by laparoscopy in these 
cases. Antibiotics capable of eradicating 
most pelvic infections are now available. 
As a result of their use, the primary ther­
apy has become medical. The indication 
for surgery is, in essence, failed medical 
therapy. Ablative surgery should gener­
ally be delayed until adequate antibiotic 
therapy has been tried and found inade­
quate. Furthermore, the surgery should 
be conservative because the disease is 
often unilateral. Total abdominal hys­
terectomy and bilateral salpingo- 
oophorectomy as a treatment for pelvic 
inflammatory disease should be the 
exception rather than the rule.
De nouveaux agents 6tiologiques de la 
salpingite aigue ont ete identifies; il 
s'agit de Chlamydia trachomatis, de bac- 
teries anafirobies et de gonocoques pro- 
ducteurs de penicillinase. II est aussi 
reconnu que la salpingite aigue est habi- 
tuellement polybacterienne. Les sympto- 
mes causes par ces microorganismes 
sont tellement g6neraux qu'il est souvent 
difficile de diagnostiquer la maladie a 
partir du seul tableau Clinique. Dans ces 
cas, le diagnostic de salpingite aigue doit
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etre etabli a la laparoscopie. II existe 
maintenant des antibiotiques capables de 
supprimer la plupart des infections pel- 
viennes. Avec leur emploi, le traitement 
primaire est devenu medical et seul 
I'echec de celui-ci commande la chirur- 
gie. La resection doit generalement etre 
retardee jusqu'a ce que l'antibioth6rapie 
ait ete essayee et son echec constate.
De plus, la chirurgie se doit d'etre con- 
servatrice puisque la maladie est souvent 
unilateral. Dans le traitement de la sal­
pingite aigue, l'hyst6rectomie abdominale 
totale et la salpingo-ovarectomie bilate- 
rale devraient done etre I'exception plu- 
tot que la regie.
A general surgeon may find pelvic inflam­
matory disease unexpectedly while per­
forming emergency abdominal surgery. 
The immediate impression on seeing the 
grossly infected fallopian tubes covered 
with quantities of purulent material is that 
surgical removal will be required. On the 
contrary, I emphasize that the treatment 
should be medical. The removal of any 
pelvic tissue in these circumstances is sel­
dom indicated; the removal of all the pel­
vic reproductive organs is almost never 
indicated. Conservation of these organs
Table 1-Bacteria Commonly Found 
in Pelvic Inflammatory Disease
Aerobes 
Gram-positive 
Staphylococcus sp 
Streptococcus sp 
Gram-negative 
Bacilli -  Escherichia co/i 
Cocci -  Neisseria gonorrhoeae
Anaerobes 
Gram-positive 
Clostridium  sp 
Peptostreptococcus sp 
Gram-negative 
Bacteroides fragilis 
bivius 
disiens
Chlamydia trachomatis
has become especially important in view 
of successful microsurgical repair of 
injured tubes and the continued success 
of in-vitro fertilization techniques.
The organisms involved in pelvic 
inflammatory disease are, with the excep­
tion of Neisseria gonorrhoeae and 
Chlamydia trachomatis, those that are 
normally found in the vagina and cervix 
(Table I).1 Of the aerobes, the gram­
negative organisms, either cocci (i.e. N. 
gonorrhoeae) or the bacilli (Escherichia 
coli) are of special concern. The 
gonococci may be further divided into 
those that produce penicillinase and those 
that do not. In the Far East, penicillinase- 
producing gonococci are becoming 
increasingly common. Because of the cur­
rent mobility of our population and its 
cosmopolitan nature the presence of these 
particular organisms must also be consi­
dered in Canada.
Gynecologists are aware of the impor­
tance of anaerobic infections in pelvic 
inflammatory disease, particularly in 
tubo-ovarian abscesses; in these cases, 
85% of the cultures yield anaerobes.2 
Bacteroides fragilis is of concern to the 
general surgeon; Bacteroides bivius and 
Bacteroides disiens are also important in 
pelvic infections of gynecologic origin.
Finally, C. trachomatis must be consi­
dered. Until recently, American investi­
gators could not consistently isolate this 
organism and considered it an unusual 
cause of pelvic inflammatory disease.3 
Their experience contrasted with that of 
the Scandinavians,4 who found C. tra­
chomatis in the majority of their patients. 
Recently, however, reports from Ameri­
can centres have confirmed the Scandina­
vian experience.5 The pathogenesis and 
the nature of the organism are equally 
controversial. In tissue culture of tubal 
epithelium, C. trachomatis is markedly 
destructive, but we do not know the 
means by which it effects this change. 
Does it act on its own or synergistically 
with other organisms present in the geni­
tal tract? What is the nature of the organ-
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ism? It has constituents that are common 
to both bacteria and viruses. For clinical 
purposes we only need to know that it is 
susceptible to antibiotics and therefore 
can be considered bacterial.
The natural history of pelvic inflamma­
tory disease is perhaps best described as 
it relates to the infection caused by N. 
gonorrhoeae. The offending organisms 
are thought to be present in the seminal 
fluid of affected men.6 These organisms 
attach themselves to sperm and are thus 
transported to the fallopian tubes. Once 
in the tube an endosalpingitis results. Fur­
ther spread can be in one of two direc­
tions. The first is through the tubal ostia 
and hence into the peritoneal cavity. 
Usually the infected material remains 
localized to the cul de sac, impeded by the 
pelvic structures. After affecting the 
endosalpinx, the organism may also 
migrate through the basement membrane 
of the tube. In the submucosa, microab­
scesses are formed, which cause lasting 
changes in the tubal architecture and have 
an immediate effect on the growth of the 
anaerobes. The result of the N. gonor­
rhoeae growth is to change the oxidation- 
reduction potential of the affected tissue; 
this favours the growth of the anaerobes. 
The development of anaerobic lesions 
further changes the local oxidation- 
reduction potential and thus arrests the 
growth of the fastidious gonococcus. 
Thus, the price of curbing N. gonor­
rhoeae is to allow the growth of 
anaerobes.
The involvement of the ovaries in pel­
vic inflammatory disease appears to be by 
one of two means. It was traditionally 
taught that spread was direct from the 
infected tube. Recent theory suggests, 
however, that ovarian involvement indi­
cates hematogenous spread. Certainly the 
frequent unilateral involvement suggests 
a different mechanism from that usually 
described.
The end of this process, when 
untreated, is rupture of the tubo-ovarian 
complex with release of purulent material 
into the peritoneal cavity. This generally 
does not happen to patients under treat­
ment in hospital. Inappropriate and 
overly aggressive surgery may be carried 
out when there is undue anxiety over this 
rare ocurrence.
The progress of pelvic inflammatory 
disease is predictable and can be staged. 
We can also define the aims of treatment 
for each stage. These have been described 
by M onif7 as follows:
• In acute salpingitis without peritoni­
tis, the aim of treatment is to eradicate 
the pelvic infection and to relieve 
symptoms.
• In acute salpingitis with peritonitis, 
the major additional aim of treatment is 
to preserve fallopian structure and 
function.
• In acute salpingitis with evidence of 
tubal occlusion or involvement of the 
tubo-ovarian complex, a major focus of 
treatment is to preserve ovarian function.
• In ruptured tubo-ovarian complex, 
the major aim is to preserve life.
For many physicians the clinical diag­
nosis of pelvic inflammatory disease can 
be dismissed with such aphorisms as 
“ poor intern’s diagnosis” or “ pretty 
inadequate diagnosis” . That there is some 
truth to such allegations has been demon­
strated by the clinical research of Wes- 
trom .8 As a gynecologist working at 
Lund in Sweden, he perform ed 
laparoscopy over many years on all 
patients entering hospital with a diagno­
sis of pelvic inflammatory disease. He has 
now examined about 3000 patients. He 
was able to demonstrate that the diagno­
sis of pelvic inflammatory disease is inex­
act and that both false-positive and false­
negative diagnoses are frequent. In only 
20% of the cases were the symptoms 
specific enough that he could confidently 
make the diagnosis on clinical and labora­
tory grounds without laparoscopy. Con­
firmation of the diagnosis at present 
depends on the laparoscopic examination. 
Without this the diagnosis must be in 
doubt and treatm ent haphazard. 
Laparoscopy permits us not only to make 
a specific diagnosis, but also to identify 
the stage of the disease and to culture the 
purulent material directly.
Westrom8 has also demonstrated that 
the symptom complex varies with the 
predominant organism (i.e., gonorrheal, 
chlamydial or anaerobic). For example, 
if the disease is found in an older woman 
who is seriously ill and has a pelvic mass, 
an anaerobic infection is likely. Disease 
in a young woman who is not seriously 
ill and is afebrile is most often due to a 
chlamydial infection. Neisseria gonor­
rhoeae is normally found in the young, 
with an acute onset at the time of the 
menses.
What is the antibiotic regimen of 
choice? Because of the polybacterial 
nature of the disease, a combination of 
antibiotics must be used.9 At present, the 
two most frequently used combinations 
are cefoxitin and doxycycline, or clin­
damycin and an aminoglycoside. Both 
have their disadvantages. Cefoxitin and 
doxycycline, while giving good coverage 
for N. gonorrhoeae and C. trachomatis, 
may not be satisfactory for some anaero­
bic infections. On the other hand, clin­
damycin and an aminoglycoside are excel­
lent for anaerobes and the gram-negative 
bacilli but do not provide adequate antibi­
otic therapy for C. trachomatis and 
gonoccocal infections. Flagyl and doxycy­
cline have also been suggested but while 
providing ample coverage for anaerobes 
and C. trachomatis, they are not ideal for 
N. gonorrhoeae and some of the gram­
negative rods. More recent formulations 
include cefotaxime or monobactam (third 
generation cephalosporins) for the 
aminoglycoside and the use of piperacil­
lin for anaerobic coverage.
It is not possible to demonstrate with 
controlled studies that the frequency of 
ectopic pregnancies falls or that fertility 
rates rise as a result of using one or other 
of these regimens. Despite this, the ration­
ale of the therapy is based on careful bac- 
teriologic studies and suggests that the 
antibiotic should be chosen in this way. 
The immediate clinical response is usually 
most gratifying.
Thus, if the diagnosis of pelvic inflam­
matory disease is strongly suspected 
before a general surgical laparotomy, 
laparoscopy, followed by antibiotic ther­
apy, should be done first. The patient 
should show an early response, feeling 
better and having less abdominal pain 
within 24 hours. Fever, leukocyte count 
and erythrocyte sedimentation rate should 
fall within 48 hours and the size of an 
abnormal pelvic mass, if present, should 
stabilize in 72 hours. If improvements of 
this nature are not seen within this time, 
surgical exploration is mandatory to iden­
tify and drain the abscess.
What should be done when the general 
surgeon finds pelvic inflammatory disease 
unexpectedly at laparotomy? It is most 
important to remember that over 75% of 
these patients do not need operation of 
any sort.2 The tube, ovary or uterus 
should not be removed, for in the future 
they may well become functionally nor­
mal. The woman or her legal adviser sub­
sequently may remind you uncomforta­
bly of this fact. In these patients a culture 
should be done (both aerobic and anaero­
bic) and the abdomen closed. You can 
confidently expect a complete resolution 
with medical therapy; often normal 
reproductive function will also return.
On the other hand, if an abscess is 
found it should be removed or drained. 
In over 70% of these cases serious disease 
will be found only unilaterally.2 Such 
abscesses should be removed; disease 
remaining in the other tube and ovary 
would be expected to respond to the 
antibiotics. Generous irrigation of the 
pelvis and secondary closure of the abdo­
men should be carried out. Formerly, sur­
gery for gynecologic infections was 
limited to draining a pelvic mass through 
the cul de sac or removing tubes, ovaries 
and uterus. The latter operation is now 
considered unnecessarily radical.
The indication for hysterectomy should 
be more liberal when pelvic infection fol­
lows immediately after childbirth.10 In 
these cases, however, the responsible phy­
sician will recognize the nature of the sur­
gical emergency. The organisms involved 
in this event are often the gram-positive 
anaerobes (Clostridium sp).
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In summary, then, it is important for 
all physicians to be aware of the nature 
of this disorder and its consequences. The 
clinical features are nonspecific and we, 
as gynecologists, have acknowledged our 
inability to diagnose the disease properly 
by ordinary clinical means. We favour the 
use of the laparoscope to diagnose and 
stage this disorder accurately. For stage 
1 (salpingitis without peritonitis) and 
stage 2 (salpingitis with peritonitis), com­
bination antibiotic therapy should be ade­
quate. If the response is not immediate, 
surgical exploration is indicated. If, on
the other hand, operation is performed 
under the impression that other problems 
are present, great care must be taken not 
to be unnecessarily radical.
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Harvesting the Greater Saphenous Vein With a Subcutaneous
Vein Remover
A subcutaneous vein remover has been 
developed to facilitate harvesting of the 
greater saphenous vein. The technique 
described is applicable only to the seg­
ment of saphenous vein above the knee. 
This technique was used in 19 selected 
patients without complication; however, 
intraoperative and postoperative precau­
tions are necessary to prevent bleeding 
and injury to the vein.
Un extracteur de veines sous-cutanees a 
et6 mis au point dans le but de faciliter 
le prelfevement de la veine saphfcne 
interne. La technique decrite ne s'appli- 
que qu’au segment de veine saph&ne 
situe au dessus du genou. Cette techni­
que fut utilisee sans complications chez 
19 patients choisis; nSanmoins, des pre­
cautions per- et postoperatoires sont 
necessaires si I’on veut eviter l'h6morra- 
gie ou une atteinte de I'int§grit6 de la 
veine.
The technique of harvesting the greater 
saphenous vein has been standardized, 
but it is time-consuming and is often
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delegated to less well-trained members of 
the surgical team. Although complica­
tions at the site of harvesting are report­
edly few, when they do occur they can
FIG. 1—Oblique incisions are made below 
inguinal ligament and over medial aspect of 
knee.
FIG. 2—Vein-guide catheter exits through 
venotomy in groin.
produce serious morbidity and prolong 
hospitalization. Even when there are no 
complications, postoperative discomfort 
along the incision and lower extremity 
edema may be sources of concerns and 
complaints.
A subcutaneous vein remover (Vein- 
Trap; Atrium Medical Corp., Amherst, 
NH) is available to facilitate saphenous- 
vein harvesting. We have used the tech­
nique, which is applicable only to the seg­
ment of vein above the knee, in 19 
selected patients who required a greater 
saphenous vein for coronary artery 
bypass.
Technique
Preoperatively, the status of the 
patient’s lower extremities is assessed for 
saphenous-vein harvesting. The legs are 
prepared in the usual fashion. They are 
rotated so that the medial aspect of the 
thighs is directed anteriorly. Two 3- to 
4-cm oblique incisions are made (Fig. 1), 
one about 5 cm below the inguinal liga­
ment and the other over the medial aspect 
of the knee. The greater saphenous vein 
is isolated at both sites and ligated. 
Through a transverse venotomy at the 
distal incision, a vein-guide catheter is 
inserted and passed proximally in the 
vein; the guide is brought out through 
another venotomy at the proximal inci­
sion (Fig. 2). At the distal end the vein
VOLUME 28, NO. 1, JA N U A R Y 1985 /  THE CANADIAN JOURNAL OF SURGERY 13
is secured to the catheter with a ligature.
The subcutaneous vein remover is a dis­
posable unit, comprising a cylindrical 
plastic tube 55 cm long and 15 mm in 
diameter. One end of the cylinder con­
tains two scalpel blades (5 mm and 4 mm) 
mounted around the circumference of the 
cylinder. The cutting edges of the blade 
are oriented for cutting with clockwise 
rotation.
After the catheter is secured to the vein, 
the vein remover is passed over the vein- 
guide catheter at the knee (Fig. 3). With 
a clockwise rotatory motion, the vein 
remover is advanced subcutaneously to 
the proximal incision (Fig. 4). The dis­
sected vein is then removed along with the
FIG. 3—Vein remover passed over vein- 
guide catheter at knee.
FIG. 4—Vein remover is advanced sub­
cutaneously to proximal incision.
FIG. 5—Vein is removed from catheter and 
prepared by usual methods.
catheter and the vein remover. The vein 
is removed from the catheter (Fig. 5) 
and prepared by standard methods. Har­
vesting time is 3 to 5 minutes per vein. 
The wounds and the subcutaneous tun­
nel are packed with antibiotic-soaked 
gauze until cardiopulmonary bypass is 
completed and the effect o f heparin is 
reversed with protamine sulfate. The 
wounds are closed in layers with absorb­
able sutures and are not drained. The legs 
are wrapped snugly with two elastic band­
ages for 72 hours.
Patients and Results
The described technique o f harvesting 
the greater saphenous vein from the thigh 
has been used in 19 patients. Only one 
had pedal edema postoperatively, and no 
patient has complained of serious discom­
fort along the harvesting tract. Skin dis­
coloration and slight swelling over the 
harvesting area were noted in all patients, 
but these effects usually resolved within 
3 to 4 weeks.
Excessive force and improper angling 
o f the vein remover during advancement 
should be avoided. The vein remover is 
rotated about 10 times for each 1 to 2-cm 
advancement of the device. It is advanced 
parallel to the plane o f the thigh along the 
presumed natural course o f the vein. This 
course is defined by the vein guide 
catheter, which is not held but allowed to 
lie loosely in the operative field. Packing 
of the subcutaneous tunnel is necessary 
since excessive bleeding from the harvest­
ing site might otherwise occur during 
heparinization for the cardiopulmonary 
bypass.
In the initial trials of this device, sig­
nificant wound hematomas occurred in 
patients who were obese, in cardiogenic 
shock, elderly or who had intra-aortic bal­
loon pump assistance before or after 
operation. The device should not be used 
in these patients. Patient selection and 
postoperative compression dressings have 
been effective in preventing wound hema­
tomas even in patients receiving sub­
cutaneous heparin postoperatively.
Comment
The speed o f harvesting the vein is not 
the main advantage o f the device, but it 
does make harvesting easier. Only one 
patient has had lower extremity edema 
postoperatively and none have experi­
enced numbness or pain at the incision 
sites. Patients experience mild tightness 
along the tunnel tract, but this resolves 
within 3 to 4 weeks.
The proximal portion o f  the greater 
saphenous vein can be harvested using a 
subcutaneous vein remover. With precau- 
sions, problems of vein damage and 
bleeding can be avoided.
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Eosinophilic Cystitis: Pleomorphic Manifestations
Because eosinophilic cystitis is rare, the 
authors present two cases of this inflam­
matory condition. In one, eosinophilic 
ureteritis presented as ureteral obstruc­
tion; this is only the second such case to 
be reported. The literature on eosino­
philic cystitis is reviewed. The condition 
affects people of all ages and its cause 
is unknown. The clinical presentation 
varies, but hematuria is a constant fea­
ture with urinary frequency and dysuria 
being common. Management is also vari­
able, ranging from treatment for symp­
toms only to aggressive surgical therapy.
Vu la rarete des cystites eosinophiles, les 
auteurs dEcrivent deux cas de cette 
maladie inflammatoire. Dans un cas, une 
ureterite eosinophile s'est manifestee par 
une obstruction de I'uretEre; il s'agit du 
deuxieme cas de ce genre seulement E 
etre signale. On etudie la littErature sur 
les cystites Eosinophiles. Elle touche des 
gens de tous ages et sa cause est incon- 
nue. Le tableau ciinique varie, mais 
I'hematurie est constante et la pollakiurie 
ou la dysurie sont frEquentes. Le traite- 
ment varie Egalement. II peut etre uni- 
quement symptomatique comme il peut 
nEcessiter une chirurgie agressive.
Eosinophilic cystitis is a rare inflamma­
tory condition of the bladder. It is charac­
terized by eosinophilic infiltration of the
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mucosa, submucosa and muscularis 
mucosae with resulting muscle necrosis, 
fibrosis and scarring.1’2 Brown in I9603 
was the first to describe the pathologic 
features o f this condition. Since then, 40 
cases have been documented in the 
English literature. We report two cases of 
eosinophilic cystitis with different clini­
cal presentations. One of these is the 
second reported case o f ureteral obstruc­
tion secondary to eosinophilic ureteritis.
Case Reports
Case 1
A 72-year-old man presented with pain in the 
right flank associated with intense dysuria and 
frequency. Culture of the urine was sterile and 
an intravenous pyelogram was normal. Cys- 
tourethroscopy revealed some edema and red­
ness around the right ureteric orifice; this was 
thought to be typical of a spontaneously passed 
calculus. Six months later the patient presented
FIG. 1—Preoperative intravenous pyelo­
gram showing marked obstruction of right kid­
ney and ureter.
with gross hematuria and pain in the right loin. 
Intravenous pyelography showed obstruction 
of the right ureter with moderate hydronephro­
sis (Fig. 1). No calculus was seen. Cys- 
tourethroscopy revealed mucosal edema with 
redness around the right ureteric orifice. No 
bladder tumour was seen. Multiple biopsy 
specimens of this area and of the prostate were 
taken. Histologically there was a  chronic 
inflammatory reaction. Prostatic tissue was 
normal. Because of persistent hematuria and 
right flank pain, the patient was transferred to 
our centre for further investigation 1 year after 
his initial presentation. Culture of a midstream 
urine sample showed no growth, three early 
morning samples showed no acid-fast bacilli 
and cytologic examination of the urine showed 
no abnormality. Systemic eosinophilia of 6% 
with a total eosinophil count of 475/mL was 
found. Repeat intravenous pyelography rev­
ealed worsening of the right hydronephrosis. 
Extensive biopsy specimens taken from the 
depths of the involved area revealed no malig­
nant tissue. The patient subsequently had a par­
tial cystectomy and a lower segmental ureterec­
tomy. Right ureteric reimplantation with a 
psoas hitch was carried out. There were no 
complications postoperatively (Fig. 2). Histo­
logic examination of the excised tissue showed 
eosinophilic cystitis with ureteritis (Fig. 3).
Case 2
A 37-year-old woman had a history of supra­
pubic and vague lower abdominal pain 
associated with urinary frequency and persis­
tent episodes of gross hematuria. Culture of 
midstream urine samples showed no growth 
and an intravenous pyelogram was normal. At 
cystoscopy, mucosal edema and congestion 
around the right ureteric orifice suggested a 
retained or a recently passed calculus. The rest 
of the bladder was normal. Her symptoms 
recurred 6 weeks later, and at a second cys­
toscopy, biopsy of an edematous, red, velvety 
area around the right ureteric orifice was done. 
Histologic examination of the specimen showed 
esoinophilic cystitis, similar to that seen in Fig. 
3. One year later she continued to have recur­
rent suprapubic pain relieved by voiding. 
Repeated cystoscopic examinations have shown 
typical features of interstitial cystitis. Her blad-
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der symptoms improved with periodic 
hydrostatic dilatation.
Discussion
Eosinophilic cystitis has been reported 
to affect all age groups.1,4 The etiology 
remains unknown but allergy to foods, 
drugs and alcohol2 and parasitic 
infections5 have been suspected. The 
occurrence of eosinophilic cystitis and 
interstitial cystitis as in our second case 
has been noted by others,1 although no 
causal relation has been established.
The clinical presentation of eosino­
philic cystitis varies. The most constant 
clinical feature is recurrent hematuria, but 
frequency and dysuria with urgency are 
common.5 Physical findings are often 
normal and usually no abnormality is 
found on the intravenous pyelogram. 
U reteral obstruction secondary to 
eosinophilic ureteritis, as seen in our first 
case, is most unusual; this is only the 
second reported case of ureteric obstruc­
tion. Sidh and associates5 reported a 
similar case in which both ureteric orifices 
as well as the bladder neck were involved 
and resulted in renal failure.
Proteinuria, pyuria and bacteriuria 
may be present6 as well as a positive 
urine culture,7 but urine cytologic find-
Fig. 2a
Fig. 2b
FIG. 2—Postoperative intravenous pyelo­
gram showing good drainage.
ings are usually normal. Cystoscopic find­
ings include hyperemic mucosal eleva­
tions,1 often described as edematous 
polyps. Proliferative and ulcerative 
lesions simulating sarcomas or papillary 
carcinoma have also been reported.7 In 
most of these series, the initial diagnosis 
was that of carcinoma of the bladder.1 
This remains the single most important 
condition to be excluded; biopsy is there­
fore m andatory. H ellstrom  and 
associates1 reported a case of 
eosinophilic cystitis associated with in- 
situ, invasive, anaplastic, giant-cell car­
cinoma. Tuberculous cystitis as well as 
hemorrhagic cystitis have occasionally 
been mentioned in the differential diag­
nosis.1
Eosinophilia of peripheral blood has 
been found in about 35% of the reported 
series.5 Rubin and Pincus2 have sug­
gested that immunoglobulin levels should 
be elevated to confirm an allergic 
response as a causative factor.5 In our 
first case, eosinophilia was present but 
was not diagnostic. Histologic examina­
tion usually demonstrates an intact 
mucosa with marked congestion and 
eosinophilic infiltration of the submucosa 
and muscularis mucosae.6 Fibrosis of the 
muscularis occurs late and a moderate 
number of mast and plasma cells may 
occasionally be prominent.
The treatment of eosinophilic cystitis 
varies,6 ranging from symptomatic to 
surgically aggressive (as in our case 2). 
When culture shows bacteriuria, 
appropriate antibiotic therapy may be 
helpful. Steroids and antihistamines have 
also been tried. Wenzl and associates8 
reported a single case with good response 
to radiotherapy. Cystectomy may be indi-
FIG. 3—Photomicrograph of bladder mus­
cle demonstrates marked eosinophilic and 
inflammatory cell infiltration (hematoxylin and 
eosin, reduced by 54% from x 250).
cated for intractable hematuria.5 Aug­
mentation cystoplasty5 for contracted 
bladder may help some of the irritative 
bladder symptoms.
The disease tends to become chronic 
with periods of remission and exacerba­
tion.2 No malignant transformation has 
been reported.
We thank Dr. H. Idikio, Department of 
Pathology for his assistance and Mrs. Cathy 
Breen for her secretarial help.
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Deep Brain Stimulation for 
Alleviating Chronic Intractable Pain
The authors present their 4-year 
experience with 18 patients who had 
deep brain stimulation. Most were 
referred because of chronic pain of 
varied etiology. All conventional modali­
ties of management had failed.
Both the paraventricular gray matter 
and the sensory thalamus were target 
sites. The 18 patients underwent a 
total of 21 implants. Follow-up 
ranged from 6 months to 4 years with 
moderate relief of prestimuiation pain in 
14 patients (77%). Patients with failed 
back syndrome secondary to multiple 
disc operations fared well. Patients with 
pain secondary to progressive neurologic 
disorders or cancer had only short-lived 
benefits, while those with pain from 
cauda equina injury or vascular disease 
had a poor result.
Deep brain stimulation appears to be 
an effective means of controlling chronic 
pain in selected cases.
Les auteurs rendent compte d'une expe­
rience de 4  ans chez 18 patients qui ont 
subi une stimulation c6r£brale profonde. 
La piupart avaient ete repus en consulta­
tion pour douleur chronique de diverses 
etiologies. Tous les modes de traitement 
conventionnels avaient echoue.
Les foyers cibles ont et§ aussi bien la 
substance grise paraventriculaire que le 
thalamus sensitif. Les 18 patients ont 
regu un total de 21 implantations d'elec- 
trodes. La periode de surveillance de 
post-cure s'etale de 6 mois a 4 ans. 
Quatorze patients (77%) ont b£nefici£ 
d'un soulagement modere de la douleur. 
Les patients souffrant d'un syndrome
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d'affaissement du dos consecutif a des 
operations multiples pour hernies disca­
les ont eut de bons resultats. Les dou- 
leurs reliees a des troubles neurologiques 
evolutifs ou au cancer n'ont eu qu'une 
amelioration de courte duree. Les rgsul- 
tats ont et£ mauvais dans les douleurs 
associees a des blessures de la queue de 
cheval ou d des maladies vasculaires.
La stimulation cerebrate profonde 
parait etre un moyen efficace de maitri- 
ser la douleur chronique dans des cas 
choisis.
Control of chronic intractable pain has 
been a challenge to physicians for many 
years. There has been a shift in the treat­
ment of chronic pain from ablative to 
stimulative procedures. Our work was 
encouraged by the studies of Hosobuchi 
and associates,1"3 Richardson and 
Akil,4'5 Ray and Burton,6 Mazars,7 
Turnbull and colleagues,8 Terenius,9 and 
Mayer and colleagues,10’11 among others, 
and by the lack of a satisfactory alterna­
tive treatment.
With the discovery of endogenous opi­
ate compounds1214 that can be activated 
or released by electric stimulation of the 
paraventricular grey matter, this target 
site has gained increasing importance in 
the relief of intractable chronic pain and 
is now being effectively utilized.
This report summarizes the long-term 
results of stimulation of the paraventric­
ular grey matter and the specific sensory 
thalamic nuclei to treat chronic pain.
Patients and Methods
Over a 4-year period, 18 patients with 
chronic intractable pain were treated by 
deep brain stimulation. The pain was due 
to various causes (Table I); 11 (61*%) were 
in the failed back category. There was a 
2:1 preponderance of men over women. 
An average of three operations had been 
performed before the deep brain implant.
Our patients met the following basic 
criteria:
• The pain was of known organic 
origin.
• All reasonable conventional methods 
had failed.
• Psychologic testing had revealed no 
underlying psychosis or evidence of 
secondary gain.
• The surgical risks were explained and 
informed consent was obtained. A 
favourable response to a morphine- 
naloxone test was a helpful adjuvant, 
especially when the paraventricular grey 
matter was selected as a target site.
Technique of Electrode Implantation
A four-contact Schreiver-type electrode 
(Medtronic Inc., Minneapolis, Minn.) 
was used in this series, with contacts 1 
mm long and 2 mm apart on a flexible 
shaft. The surgical procedure is done in 
two stages. The first stage is carried out 
under local anesthesia with the patient 
lightly sedated to allow for stereotactic 
placement of the electrode and for 
intraoperative testing. For this purpose, 
after the head has been fixed in a Trent- 
Wells (Trent-Wells Inc., South Gate, 
Calif.) stereotactic unit, a burr hole is 
made 3 cm parasagittally at the coronal 
suture on the side contralateral to the 
most intense pain. Ventriculography 
using Conray is done and a target site is 
plotted. When the paraventricular grey 
matter is selected, the target site lies 2 mm 
anterior to the posterior commissure on 
the line joining the anterior and posterior 
commissures and 2 to 3 mm lateral to the 
posterior third ventricle, which is the 
parafascicularis-centre-median complex. 
Stimulation is begun 2 mm above the tar­
get and the final choice of electrode loca­
tion is determined by a favourable 
response to stimulation.
A good prognostic sign when stimulat­
ing is a sensation of heat or cold on the 
contralateral side to the stimulation or all 
over the body. Some patients have 
described a sensation of relaxation or 
pleasure, likened to the post-ejaculation 
state. Because of the proximity of the tar­
get site to the Edinger-Westphal nucleus 
and to the third-nerve nucleus, most 
patients initially complain of blurred 
vision, and on stronger stimulation, nys­
tagmus can be observed, but this disap­
pears as soon as stimulation is stopped. 
Usually, after 10 minutes of stimulation,
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there is definite hypalgesia and reduction 
of pain in successful cases. Anterior 
placement o f the electrode leads to 
sympathetic-nervous-system responses, 
whereas posterior or deeper placement 
produces adverse responses such as a sen­
sation of smothering, vertigo and nausea. 
Ray and Burton6 and others have also 
found this.
When the decision was made to use the 
specific thalamic sensory nucleus (nucleus 
ventralis posterior) as the implantation 
site, we found the use of Tasker and 
Schaltenbrand-Bailey maps and atlas very 
useful in plotting the target site.15,16 For 
physiologic confirmation, as suggested by 
Turnbull and associates,8 stimulation is 
undertaken in 2-mm steps, beginning 10
mm above the intercommissure line and 
continuing for 6 mm beyond. Low- 
voltage stimulation should produce 
paresthesia in the painful region when the 
proper site is reached.
Once the tip of the electrode has 
reached the target, percutaneous lead 
extensions are brought out through a 
separate stab incision. This permits the
Tab le  I - C lin ica l Data
P a tie n t
no.
Age,
y r Sex E tio lo g y
S ite  o f 
im p lan t Pain re lie f R em arks
F o llo w -u p ,
y r
i 5 5 M M e ta s ta tic  d e p os it 
b rach ia l p lexus
PVG/STN In it ia lly  p a r t ia l,  
bu t g ra d u a lly  
regressed to  
fa ilu re
Needed co rd o to m y 
u lt im a te ly
0 .5  (d ied)
2 57 M M u ltip le  lu m b a r 
d isc o p e ra tio n s , 
a ra ch n o id itis
PVG Good 4
3 4 7 M M u ltip le  lum ba r 
disc o p e ra tio n s , 
a ra ch n o id itis
PVG Good Needed im p la n t on 
oppos ite  s ide 1 y r 
la te r  due to  
e lec trode  m ig ra tio n
4
4 3 9 M M ye lo p a th y . M u lt ip le  
arachno id  
d ive rticu la
PVG Good fo r  1 y r , 
then g ra d u a lly  
regressed
P rogression  o f 
d isease caused 
poor end re su lt
3 .5
5 7 0 M M u ltip le  d isc 
opera tions , 
a ra ch n o id itis
PVG Fair Needs supp lem en ta ry  
ana lgesics
3
6 5 4 M M u ltip le  d isc  
opera tions , 
a ra ch n o id itis
PVG Fair Needs supp lem en ta ry  
ana lgesics
3
7 5 6 M M ultip le  d isc 
opera tions , 
a ra ch n o id itis
PVG Good 3
8 4 8 M M u ltip le  d isc 
opera tions , 
a ra ch n o id itis
PVG Good 3
9 5 4 M S c ia tic  n e u ro p a th y STN Good Needs som e ana lges ic  
help
2
10 4 6 M G unshot w o u n d  o f 
cauda equ ina
PVG Failure E lectrode  rem oved
11 5 6 M M u ltip le  ce rv ica l 
d isc o p e ra tio n s
PVG Failure E lectrode  rem oved
12 5 3 M M u ltip le  deep ve in 
th rom boses
PVG Fair S eizures developed 
and delayed sm a ll 
in tra ce re b ra l 
hem atom a 1 w k  a fte r 
second e lec trode  
im p la n t
F irs t im p la n t 
N ov. 1 9 8 0  and 
o p p o s ite  side  
Feb. 1 9 8 2
13 3 2 M M u ltip le  d isc 
opera tions. 
Epidural f ib ro s is
PVG Fair Needs supp lem en tary 
ana lges ics . Gets 
pa res thes ia  on 
s tim u la tio n
1 .2 5
14 3 2 M M u ltip le  d isc  and 
sp inal fu s io n s , 
ope ra tions  w ith  
ep ineura l f ib ro s is
PVG Good No m ed ica tions  
needed
1
15 4 5 F M u ltip le  d isc 
opera tions , 
a ra ch n o id itis
PVG Good Had sing le  seizure 
p o s to p  due to  
e x tra v a sa tio n  o f 
C onray ove r co rte x
1
1 6 3 2 F N eu ro fib rom a  o f 
cauda equina
STN Good Needs ana lgesics 
o cca s io n a lly
1
17 3 2 M M u ltip le  d isc and 
fus ion  o p e ra tio n s
PVG Good Needs ana lgesics 
o ccas iona lly
0 .7 5
18 54 F M u ltip le  d isc fu s io n  
and decom press ive  
lam inec tom ies
PVG Good Needs ana lgesics 
o ccas iona lly
0 .5
PVG - p a ra ve n tr icu la r g rey m a tte r. S TN  -  sensory  th a la m ic  nucle i.
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patient to test various combinations of 
contact areas and evaluate their effective­
ness for relieving pain. If pain relief is 
satisfactory during this trial period of 1 
to 2 weeks, the system is internalized by 
connecting the combinations selected to 
the receiver placed in the infraclavicular 
region; the placement of the receiver is 
done under general anesthesia. The next 
day, the patient can begin stimulation 
using a small transmitter-stimulator cou­
pled to the receiver by a doughnut-shaped 
antenna.
The transmitter-stimulator has three 
parameters: frequency, pulse width and 
amplitude, each of which can be altered 
to produce the best results. Initially, we 
prefer to set the pulse width moderately 
wide at about 0.5 ms with a frequency 
between 50 and 100 cps. The amplitude 
is gradually increased until the patient 
feels stimulation, usually at 3 to 4 V. The 
equipment is then used under supervision; 
the amplitude is varied only to obtain pain 
relief. Over the next week the physician 
may alter the frequency or pulse width to 
produce the best stimulation results and 
to avoid side effects due to spread of 
stimulation current to the neighbouring 
structures. Once the pulse width and fre­
quency are at optimal levels, the patient 
is discharged with instructions to regulate 
the stimulation program by controlling 
only the amplitude and length of each 
stimulation period. Usually 15 to 20 
minutes of stimulation, two to three times 
a day, is sufficient to obtain pain relief 
all day. The pulse width and the fre­
quency may be altered by the physician, 
if deemed necessary on follow-up visits.
Findings
The paraventricular grey matter was 
utilized 20 times as the target site, while 
the sensory thalamic nucleus was used 
three times. The 18 patients underwent 21 
implantations. Two patients needed two 
implantations each, and one required a 
second implantation on the opposite side 
1 year later, due to the migration of the 
first electrode in the third ventricle result­
ing in failure of stimulation.
The result was considered to be 
“ good” when patients had good pain 
relief and could return to employment or 
full-time housework without having to 
resort to analgesics, or at least only an 
occasional one. The result was considered 
to be “ fair” when patients could not 
return to employment or full-time house­
work and needed analgesics regularly, 
but, in their estimation, obtained at least 
50% pain relief.
The follow-up period was from 6 
months to 4 years. Good relief of pain 
was obtained in 10 patients (55%) and 
fair relief in 4 (22%). Thus, 77% of 
patients benefited from deep brain stimu­
lation which relieved 50% or more of 
their prestimulation pain. The duration 
of pain, age or the number of operative 
procedures before the deep brain implan­
tation had little bearing on the ultimate 
degree of pain relief.
Patients with failed back syndrome 
secondary to disc operations fared very 
well (Table I). We learned early in our ser­
ies that pain secondary to progressive neu­
rologic disorders or cancer is improved 
only for a short time. When pain was due 
to cauda equina injury or vascular dis­
ease, the relief of pain was poor.
Two patients had superficial wound 
infections that cleared with suitable 
antibiotic therapy without the need to 
remove the system. In another instance, 
a small delayed intracerebral hematoma 
formed when a second electrode was 
implanted 1 year after the first.
Following the documentation of 
Hosobuchi and associates3 and King,17 
that pain perception can be altered by 
pharmacologic manipulation of serotonin 
levels, we found that the adjuvant use of 
drugs such as levo-tryptophan and 
amitriptyline, improved the pain-relieving 
effectiveness of the stimulation, possibly 
by augmenting serotonin production or 
sparing it.
Discussion
The pain relief obtained from stimula­
tion of the paraventricular grey matter is 
not only due to release of enkephalins and 
endorphins, as observed by Akil and 
colleagues18 and subsequently by 
Hosobuchi and colleagues,19 who 
demonstrated increased concentrations of 
(3 endorphins in the ventricular fluid, but 
also to activation  of descending 
serotonergic inhibitory impulses via the 
raphe nucleus to the substantia gelatinosa 
in the posterior horn of the spinal cord. 
At the same time, one can postulate a 
beneficial effect of higher cortical centres 
on pain modulation and emotions 
through known specific and nonspecific 
hypothalamic and medial limbic relays.
The mechanism of pain relief through 
stimulation of the specific sensory tha­
lamic nucleus is not well understood. It 
is quite possible that stimulation here 
restores the inhibitory input to the 
somatosensory neurones in the postcen­
tral gyrus or the thalamus which had 
earlier been disturbed by the pain- 
producing condition. Once the pain is 
suppressed, the natural inhibitory 
mechanisms such as proprioception come 
into play and keep the pain away long 
after the stimulation is finished. Further 
studies are, however, needed to define the 
precise mechanism by which thalamic 
stimulation suppresses neurotropic pain.
Conclusions
Deep brain stimulation is an effective
means of controlling chronic intractable 
pain in selected cases. Nociceptive- 
mediated pain does well with stimulation 
by paraventricular grey implants and, in 
these cases, the morphine-naloxone test 
is a good prognosticator of beneficial 
results. The pain in this group of patients 
is usually diffuse, midline, deep and bor­
ing, and may be bilateral with one side 
more painful.
For deafferentation pain, which is 
unilateral and localized, and felt on the 
surface, an implant in the specific sensory 
thalamic nucleus gives the best results.
We believe that deep brain stimu­
lation is a safe alternative to ablative sur­
gery or narcotic use for relief of chronic 
pain of benign origin, in a selected group 
of patients. When the underlying disease 
is progressive or the pain is secondary to 
malignant disease, the beneficial effects 
may be short-lived.
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Mycotic Abdominal Aortic Aneurysm: 
a Case Report
A case of mycotic aneurysm of the 
abdominal aorta, arising as a complica­
tion of subacute bacterial endocarditis in 
a 75-year-old white woman, is presented. 
The dramatically expansile nature of 
this aneurysm is well documented.
The history, clinical presentation, etiol­
ogy, microbiology and surgical manage­
ment of this rapidly progressive and 
often fatal condition are discussed 
through a review of the literature.
Un cas d'un anevrisme mycotique de 
I'aorte abdominal, suite d I'endocardite 
bacterienne subaigue d'une dame cauca- 
sienne agee de 75 ans, est presente, 
dans lequel le cours actif de cette mala- 
die est bien documentee.
L'histoire, presentation clinicaie, cause, 
microbiologie et soins chirurgicaux de 
cette maladie grave, qui est frdquem-
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ment fatale, sont discutdes par revue de 
la literature.
The association of arterial aneurysm with 
infectious disease was first made by Am­
brose Pare in his 16th-century writings on 
lues (syphilis).1 Thomas Koch in 1851 
first described bacterial infection of an ar­
terial aneurysm.2 The term “ mycotic” 
was first applied by Sir William Osier3 in 
1885 when he described “ aneurysms that 
resulted from septic emboli originating 
from bacterial endocarditis” .2
Mycotic abdominal aortic aneurysm re­
mains a rare condition,2’4-6 known for its 
fulminant clinical course and associated 
high morbidity and mortality.2,6 We 
present a case of the unequivocally 
documented development over a 13-day 
period of a massive abdominal aortic 
aneurysm and we discuss this disease en­
tity and its management.
Case Report
A 75-year-old white woman had a history of 
cholecystectomy in 1977, right-sided segmen­
tal mastectomy for mucinous carcinoma in 
1978 and total abdominal hysterectomy with 
bilateral salpingo-oophorectomy in 1980. She 
smoked an occasional cigarette. She had 
repeated episodes of asymptomatic bacteriur-
ia. Before her illness she was well and took no 
medications. There was a remote history of al­
lergy (rash) to ampicillin.
After 3 weeks of progressive malaise and dull 
pain in the right shoulder, she suffered rapid­
ly progressive weakness over 4 days, culminat­
ing in collapse and emergency admission to the 
medical service of another hospital. She sub­
sequently had a spiking fever with splinter 
hemorrhages, septic arthritis of the left knee, 
acute right-sided occlusion of the central reti­
nal artery and multiple punctate skin lesions, 
all consistent with the clinical diagnosis of 
subacute bacterial endocarditis. There was con­
comitant, generalized, low-grade back pain, at­
tributed to osteoarthritis. Broad-spectrum an­
tibiotic therapy was initiated intravenously and 
she became clinically stable; all cultures (blood, 
urine and knee-joint aspirate) showed no bac­
terial growth.
Echocardiography gave normal results, as 
did abdominal ultrasonography (performed to 
rule out liver abscess as a cause of shoulder and 
back pain). Abdominal ultrasonography 
showed a normal-looking abdominal aorta 2 
cm in diameter (Fig. 1).
Echocardiography repeated 1 month later 
again failed to reveal any mitral or aortic val­
vular endomyocardial vegetations, but diastolic 
fluttering of the anterior leaflet of the mitral 
valve suggested new-onset aortic valvular 
insufficiency.
After another 2 weeks there was markedly 
increased abdominal pain with suggestion of 
pulsatile midabdominal fullness. The patient
FIG. 1—Abdominal ultrasonography, transverse plane, immediately 
caudad to renal arteries shows abdominal aorta, 2 cm in diameter.
FIG. 2—Two weeks later, abdominal aortic aneurysm measures 4 
X 7 cm.
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remained lucid with stable vital signs (blood 
pressure 130/85 mm Hg, heart rate 100 
beats/min and regular, temperature 36.5°C, 
respiratory rate 18/min) and the groin pulses 
were full bilaterally. There were neither 
peritoneal signs nor abdominal bruit. Labora­
tory investigation revealed a normal hemogram 
with a platelet count of 244 x 109/L  and mild 
hyponatremia (serum sodium 127 mmol/L); 
other serum electrolyte levels, bilirubin and 
blood urea nitrogen levels were unremarkable. 
A chest film revealed slight elevation of the 
right hemidiaphragm.
The patient was transferred to our hospital 
where abdominal ultrasonography revealed an 
infrarenal abdominal aortic aneurysm, meas­
uring 4 x 7  cm (Fig. 2). Abdominal aortogra­
phy confirmed the presence of the lesion (Fig. 
3).
At laparotomy, the infrarenal abdominal 
aortic aneurysm was found to measure 4 x 8  
cm. There was minimal, frank, recent 
retroperitoneal hemorrhage. The lesion was 
subtotally resected, the posterior aortic wall 
being left in place for technical reasons, with 
oversewing of the proximal and distal aortic 
stumps; right axillofemoral bypass was per­
formed to perfuse the lower extremities at the 
same sitting.
Postoperatively, the patient was treated 
intravenously with cephazolin, clindamycin 
and tobramycin; she remained afebrile with sta­
ble vital signs, but sterile gross hematuria and 
transient abnormalities of liver function deve­
loped (serum bilirubin level 44.5 /tmol/L, alka­
line phosphatase 291 U/L and serum glutamic 
oxaloacetic transaminase 100 Karmen U/L). 
On postoperative day 3, thrombocytopenia 
developed (44 x 109/L  and the prothrombin 
time was elevated (15.1 seconds, control 10.9 
seconds); these abnormalities responded to 
transfusion of platelet packs and fresh-frozen 
plasma.
Special staining of the resected aneurysm 
wall did not reveal any bacteria; culture of this 
tissue produced heavy growth of enterococci, 
sensitive to ampicillin and clindamycin but 
resistant to erythromycin. Cephazolin and 
tobramycin were discontinued. After 3 weeks 
of intravenously administered clindamycin, a
FIG. 3—Abdominal aortogram confirms 
presence of major infrarenal abdominal aor­
tic aneurysm (single smaller aneurysm is seen 
immediately distally).
rash developed thought to be secondary to this 
drug, which was discontinued. After sensitiv­
ity testing for penicillin, she was maintained 
on high-dose penicillin (2.5 million units 
intravenously every 4 hours) for 6 weeks, dur­
ing which she remained clinically well and 
repeated blood and urine cultures remained 
sterile.
She was discharged home in good condition 
on no antibiotic therapy.
Discussion
The rapid development of the massive, 
unstable abdominal aortic aneurysm in 
our case illustrated both the malignant 
nature and the need for acute awareness 
of this condition for its management to 
be successful.
Mycotic abdominal aortic aneurysm is 
rare; most published series from major 
teaching centres report fewer than 20 
cases.2 A recent review of experience at 
the Massachusetts General Hospital over 
14 years revealed only 17 cases;2 in a ser­
ies of 10 000 autopsies reviewed in 1972, 
there were 428 aneurysms, of which only 
37 (9%) were either syphilitic or 
mycotic.4
The most common presenting symp­
toms include fever (70% of cases), 
abdominal pain (18%) and back pain 
(6%); signs include leukocytosis greater 
than 10 x 109/L  (65%), a palpable pul­
satile abdominal mass (53%) and erosion 
of lumbar vertebrae (18%). It is interest­
ing that in a recent series only 40% of 
cases of mycotic abdominal aortic 
aneurysm showed radiologic evidence of 
calcification, whereas 70% to 80% of 
atherosclerotic abdominal aortic aneur­
ysms are calcified;2 the absence of cal­
cification in plain films may be a helpful 
diagnostic sign.
Etiologically, mycotic aneurysm is 
most commonly related to trauma and 
vascular surgery, or to bacterial endo­
carditis.6 The condition can be primary 
(infection of a nonaneurysmal vessel 
resulting in aneurysm formation) or 
secondary (infection of a preexisting 
aneurysm). Mycotic aneurysm can be 
classified according to the preexisting 
condition of the involved vessel (normal 
artery, atherosclerotic artery, true or false 
aneurysm, arterial prosthesis) and to the 
source of infection (intravascular, as in 
septic embolization in cases of bacterial 
endocarditis or septicemia, or by exten­
sion of adjacent erosive endocardial infec­
tion; and extravascular, as in direct exten­
sion from adjacent infective foci, iatro­
genic infection secondary to arterial 
catheterization, puncture or cannulation, 
or parenteral drug abuse).5 Cases of 
mycotic aneurysm in which the source of 
infecting organisms is obscure are 
referred to as “ cryptic” .7
Before the introduction of aggressive 
vascular surgery, when the majority of
mycotic aortic aneurysms could be related 
to bacterial endocarditis, cases in which 
a pathogen could be isolated were usually 
associated with streptococcal, pneumo­
coccal and Hemophilus influenzae infec­
tions.6 More recent series2,6 have rev­
ealed a 70% incidence of positive blood 
cultures, with 59% of cases involving iso­
lated gram-positive infection and 35% 
isolated gram-negative organisms. The 
most common gram-positive pathogens 
are Staphylococci (41% to 50% of 
cases)6 and Salmonella (18%).2
Mycotic aneurysm can also be caused 
by fungal organisms such as Actinomyces 
and Candida, as well as by Mycobac­
terium tuberculosis,6
Principles of management of mycotic 
abdominal aortic aneurysm include (a) 
aggressive parenteral antibiotic therapy, 
involving bactericidal levels of antibiotics 
for a minimum of 6 weeks after resection, 
(b) wide surgical debridement of infected 
tissues and (c) arterial reconstruction 
through noninfected tissue planes. This 
most commonly necessitates extra- 
anatomic prosthetic grafts, completely 
bypassing the infected field.5,6,8 In cases 
in which the diagnosis is suspected 
preoperatively and the patient is clinically 
stable, it is suggested that an extra- 
anatomic bypass be performed before 
surgical violation of infected tissue 
planes.7
Mycotic abdominal aortic aneurysm is 
a morbid condition even with optimal 
management. Recent series6,7 report a 
mortality of 84% in cases involving gram­
negative organisms and 50% in cases 
involving gram-positive bacteria.
Our case illustrates the fulminant 
progression of this disease, and empha­
sizes the need for acute clinical awareness 
and aggressive medical and surgical ther­
apy in its successful management.
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Ender’s Nailing of Hip Fractures: 
the Operation and the Radiation Hazards
Sixty-two intertrochanteric and 3 sub­
trochanteric fractures of the femur were 
treated by Ender's nailing. The method 
was safe and effective in stable fractures 
but in unstable fractures malunion was 
common. Exposure of the operating team 
to radiation during the procedure was 
well within acceptable limits.
Soixante-deux fractures intertrochante- 
riennes et 3 fractures sous-trochante- 
riennes du femur ont ete reparees par 
enclouage de Ender. Cette technique 
s'est averee sure et efficace dans les 
cas de fracture stable mais les fractures 
instables ont fr6quemment donne des 
cals vicieux. Durant I'intervention, 
I'exposition de i'6quipe chirurgicale aux 
radiations est demeur^e bien a I'intSrieur 
des limites acceptables.
Surgeons who have treated intertrochan­
teric fractures of the femur with Ender’s 
intramedullary nails have been enthusias­
tic about the results of their use. 
However, these reports may contain the 
same inaccuracies as do those of other 
methods used to treat this fracture. In a 
series of 232 patients with an average 
follow-up of 33 months, Cleveland and 
associates1 reported that 81 had died and 
that 98 were not available for examina­
tion. Taylor and associates2 found that 
of 3650 patients with trochanteric frac­
ture treated by open reduction, only 1500 
had roentgenographic studies adequate 
for review. Niemann and Mankin’s care­
fully controlled series3 of 190 inmates of 
a county hospital for the aged and infirm 
showed a 1-year survival rate of 33%. Of 
patients with intertrochanteric fractures 
who survived and whose fracture healed, 
only 45% walked again and 18% of frac­
tures became infected. Kempf and 
associates4 reported a series of 120 inter-
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trochanteric fractures treated by Ender’s 
nailing; only 79 patients were available 
for a 6- to 24-month follow-up (30 had 
died and 11 were lost). We acknowledge 
similar limitations in reporting our 
experience with Ender’s nailing of these 
fractures.
Patients
Sixty-two consecutive patients with 
intertrochanteric and 3 with subtrochan­
teric fractures, admitted to the Edmon­
ton General Hospital over an 18-month 
period, were treated by Ender’s nailing. 
Thirty fractures were stable, showing no 
comminution,5 while 32 were unstable 
and comminuted. The average age of the 
patients was 76 years (range from 28 [a 
paraplegic] to 95 years).
All operations were scheduled during 
normal operating hours and as soon as 
the patient’s condition appeared stable. 
The operating time varied from 15 to 80 
minutes (average 37 minutes). No trans­
fusions were required during or immedi­
ately after operation. In the case of one 
very poor-risk patient, the fracture was 
nailed using a local anesthetic.
Technique
The technique for inserting Ender’s 
nails has been adequately described.6’7 
Three nails should penetrate the denser 
cancellous bone of the central portion of 
the femoral head to within 1 cm of the 
articular cortex. The isthmus of the 
medullary canal should be filled with one 
or more shorter nails. The opening in the 
medial cortex at the site of insertion in the 
lower femur should be small so as to 
preserve as much cortex as possible.4
Results
Nine patients died within 1 year of 
operation. All who survived more than 3 
months had a healed fracture. Callus 
appeared early and was abundant in dis­
placed fractures. Three types of compli­
cations resulted from this procedure: 
external rotation deformity, nail extrusion 
and infection at the site of insertion, and 
supracondylar fracture.
External Rotation Deformity
The most obvious shortcoming of 
Ender’s nail is its failure to prevent rota­
tion deformity if there is comminution of 
the posterior cortex of the femur at the 
fracture site. The failure of round nails 
inserted so close to the mechanical axis 
of the femur is not surprising7 and may 
occur either in the shaft or in the head as 
we have demonstrated in a cadaver. This 
deformity occurred in all our 32 com­
minuted fractures and was of an apprecia­
ble degree. However, many of these 
patients were bedridden or senile and the 
malunited fracture presented no problem 
for them.
In the healthier group with com­
minuted fractures, we prebent the nails 
into anteversion; we also deferred weight 
bearing, used skin traction with internal 
rotators and applied a plaster boot incor­
porating an outrigger for 3 weeks. None 
of these measures was effective in 
preventing an eventual external rotation 
deformity that approached 50° in 11 
cases.
None of the 30 fractures without com­
minution showed any important external 
rotation deformity although full weight 
bearing with aids was allowed within 48 
hours of the operation.
Nail Extrusion and Infection 
at the Insertion Site
Axial settling of the fracture in a sta­
ble position after operation results in nail 
extrusion. This extrusion usually occurs 
in the lower end of the femur but in two 
of our patients in whom the nails were 
accidentally driven through the head or 
neck at the time of insertion, proximal 
extrusion occurred within 1 week. In three 
patients, distal extrusion occurred during 
the first 4 weeks, before sufficient heal­
ing had occurred. In three other patients, 
the nails were removed after the fracture 
healed because of ulceration over the nail 
or severe discomfort.
There were no persistent infections 
among the long-term survivors. The ulcer 
over the extruded nails healed promptly 
after they were removed. In the three 
patients in whom the extruded nails
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caused wound ulceration and failure of 
fixation, the nails were removed and 
replaced with a conventional nail-plate. 
In none of these cases was there any 
spread of infection to the proximal 
wound.
Supracondylar Fracture
One supracondylar fracture occurred at 
the time of a secondary insertion of a nail- 
plate in an osteoporotic femur.
Radiation Exposure of the 
Operating Team
As the technique involved prolonged 
use of image intensifiers, the exposure of 
the operating team to radiation was meas­
ured (in 31 procedures) by means of ther­
moluminescent lithium fluoride ring dosi­
meters. The dosimeters were calibrated, 
free in air, against a standard cesium-137 
source and were processed and read 
according to standard procedures.8 
Background values, based on an addi­
tional dosimeter kept with each set of 
dosimeters when not in use, were sub­
tracted from the readings to obtain the 
net exposures. The accuracy of each read­
ing is estimated to be ± 15%.
The radiation source for the lateral 
image intensifier pointed cephalad across 
the patient’s involved hip, while the 
posteroanterior source pointed towards 
the ceiling. Both units were operated at 
3 mA and 100 kVp. Average exposure 
was 177 seconds (ranging from 21 to 690 
seconds). The image intensifiers were not 
equipped with an image recall disc.
The doses of radiation received by the 
surgeons were less than 70 mrem; more 
than 90% were less than 20 mrem (Table 
I). The anesthetists’ and nurses’ doses 
were all less than 15 mrem. The highest 
average dose of radiation per operation 
was received by surgeons (10.6 mrem) 
(Table II). For comparison, radiation 
received during two other procedures is 
also shown in Table II; one involves the 
removal of a metal foreign body from the 
lateral femoral condyle of a child and the 
other, the insertion of Pugh’s hip nail.
The surgeons’ average doses varied 
more than those of the nurses or 
anesthetists. This fact, coupled with the 
lack of correlation between the doses and 
the total exposure times, suggests that the 
surgeon’s hands may occasionally come 
close to the roentgen beam.
The values in both tables are less than 
the typical annual dose of 90 mrem 
attributed to external background radia­
tion in Canada. However, these low doses 
should not be used to justify a reduction 
in radiation safety precautions; all 
unnecessary exposure to radiation should 
be avoided.
Conclusions
Ender’s nailing is an ideal method of 
treating intertrochanteric fractures that 
show minimal or no comminution of the 
posterior and medial cortex of the upper 
femur. The method can be used in com­
minuted fractures if a substantial exter­
nal rotation deformity (30° to 50°) is 
acceptable, due to the patient’s inactivity 
or impaired mental status. The method 
should not be used in comminuted frac­
tures if near anatomical reduction must 
be maintained. The radiation received by 
the operating team is well within the 
acceptable limits.9
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Table I—Radiation Doses Received by the Operating Team 
patjent _______Exposure time, s_______ ________ Radiation dose, mrem
no. Posteroanterior Lateral Surgeon Nurse Anesthetist
i 10 11 17 0 3
2 120 95 17 4 3
3 65 55 26 0 0
4 40 90 17 4 3
5 40 75 0 0 0
6 90 95 0 1 0
7 20 65 0 0 0
8 120 11 9 4 3
9 34 65 0 0 0
10 105 72 5 0 0
11 540 150 29 0 3
12 70 150 1 0 0
13 18 30 6 3 0
14 45 120 12 0 0
15 150 108 8 6 0
16 60 60 6 1 0
17 210 150 69 2 3
18 120 70 2 7 2
19 30 360 10 1 6
20 300 18 19 6 0
21 30 30 4 6 12
22 90 8 4 0 0
23 90 60 14 2 4
24 60 90 13 9 3
25 20 40 13 0 0
26 9 60 0 4 0
27 60 90 0 3 0
28 60 60 0 3 0
29 90 30 15 14 8
30 90 90 4 0 0
31 150 90 5 14 0
Table II-Average Radiation Doses Received by the Operating Team 
_______________ Average dose, mrem
Procedure Surgeon Nurse Anesthetist
Ender's nailing
Surgeon 1 8.6 1.3 3.0
Surgeon 2 19.7 1.8 2.8
Surgeon 3 11.9 1.8 3.0
Overall 10.6 1.7 2.9
Removal of metal foreign
body from femoral condyle 1.0 0.0 0.0
Insertion of Pugh's nail 13.0 0.0 0.0
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Pressure Necrosis Is the Primary Cause 
of Wound Dehiscence
Wound dehiscence occurs because the 
distracting forces in a wound exceed the 
holding forces. Critical analysis of these 
forces indicates that pressure necrosis 
from sutures is the primary factor in 
wound dehiscence. Other factors play a 
secondary role, either in delaying the 
healing of a wound or in increasing the 
stress on it. To prevent pressure necro­
sis, a mechanically sound method of cra­
dling the entire wound in a series of 
wide-biting encircling retention sutures, 
2.5 cm apart, is described. Each reten­
tion suture is tied loosely with a meas­
ured tension sufficient to hold the 
wound together while avoiding pressure 
necrosis. In this prospective study the 
tension used is equal to 300 g, far less 
than surgeons usually use. There were 
no wound dehiscences in 787 consecu­
tive abdominal incisions repaired by this 
method.
La desunion des sutures d'une plaie sur- 
vient quand les forces de rupture depas- 
sent les forces d'union. L'analyse criti­
que de ces forces indique que la necrose 
provoquee par la pression des sutures 
est le principal facteur causant la disu­
nion des sutures de plaie. Les autres fac- 
teurs n'ont qu'un role secondaire. soit en 
retardant la cicatrisation de la plaie, soit 
en augmentant la contrainte sur celle-ci. 
Dans le but d 'iviter la nicrose de pres­
sion on dicrit une mithode micanique- 
ment sure pour maintenir la plaie enti&re 
dans une serie de sutures de retention 
larges, a 2.5 cm I'une de I'autre. Chaque 
suture de retention est attachie de fapon 
lache avec une tension mesuree pour 
maintenir I'incision ensemble tout en iv i- 
tant la pression de necrose. Dans cette 
etude prospective la tension utiiisie a 
ete de 300 g, soit beaucoup moins que 
ce que les chirurgiens utilisent habituelle-
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ment. On n'a constati aucune desunion 
de plaie dans 787 incisions abdominaies 
riparees par cette mithode.
The word dehiscence comes from the 
Latin, dehiscere — to gape. Other terms 
used to describe this condition are wound 
separation, wound disruption and, in the 
case of abdominal wounds, burst abdo­
men and evisceration. Baggish and Lee1 
defined it as a “ separation of all tissue 
layers of the abdominal incision down to 
and including the peritoneum” .
In this study, as in most reviews, 
McBurney and inguinal hernia incisions 
were excluded because dehiscence of these 
incisions is rare.
Individuals110 report widely varying 
rates of dehiscence, ranging from 0%2 to 
2.7% .9'10 Old and Stokes11 found an 
incidence of 0.2% to 1.7% and a mortal­
ity of 31% in the American literature 
before World War II and an average inci­
dence of 0.6% and a mortality of 21.7% 
after the war.
Etiology
Many factors have been identified as 
contributing to wound dehiscence — mal­
nutrition, abdominal distension and 
increased intra-abdominal pressure due to 
coughing or vomiting. Evidence is 
presented here that these are indeed 
important, but that all are secondary fac­
tors. The primary factor is one that we 
have not recognized because we cannot
see it and that is pressure necrosis of the 
incision from tight sutures.
Whether a wound comes apart or 
remains intact depends at any moment on 
the balance between the forces pulling it 
apart and the forces holding it together. 
Fig. 1 shows the balance between these 
forces. Enough is now known about all 
of these forces to justify examining them 
individually. It will be demonstrated here 
that this examination will, by exclusion, 
identify the primary cause of wound 
dehiscence.
The Disrupting Forces
Increased Intra-abdominal Pressure
This is common but not universal in 
wound dehiscence. Pressure measure­
ments by Drye12 have shown that cough­
ing, vomiting and exertion raise the intra­
abdominal pressure up to 10 times 
normal.
Muscular Pull
Muscular pull was measured by 
Sloan13 using spring scales attached to 
wound edges before closing. Vertical inci­
sions are subject to more pull than trans­
verse and long incisions to more pull than 
short ones.
The Holding Forces
Strength o f  Sutures
Sutures were broken in only 12% of
FIG. 1—Diagram showing balance between disrupting and holding forces.
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Alexander and Prudden’s14 series; it is 
easy to exclude this factor by using non- 
breakable sutures.
Strength o f  the Healing Wound, 
Independent o f  Sutures
Many factors, such as use of the wound 
as a colostomy exit,6 hypoproteinemia8 
and advanced age,15 affect wound heal­
ing and strength. Other factors, such as 
wound infection,4 malignant disease,8 
vitamin C deficiency, hematoma, anemia 
and obesity,14 are much less important. 
However, most dehiscences begin 5 or 6 
days postoperatively when the wound 
cannot be expected to have enough intrin­
sic strength and must depend on the 
suture for support. Such dehiscences 
therefore must be due to failure of the 
sutures to provide that support.
Ability o f  Soft Tissues to Sustain the Pull 
o f  Sutures
There are a number of important fac­
tors here.
Method o f  placing sutures.—Surgeons 
pay too little attention to the engineering 
principles involved in suturing wounds to 
take full advantage of the possibilities.16 
Tension sutures offer no protection unless 
they go deeper than the anterior aponeu­
rosis.6 To date, the two methods of 
suturing that give the lowest dehiscence 
rates are the Smead-Jones far-near reten­
tion sutures1 and Jenkins’s3 continuous 
suture, where the suture is at least four 
times as long as the wound. Both methods 
take large bites of tissue.
Effect o f  sutures on soft tissues.—If 
the sutures are able to hold the wound 
together on day 1 when there is no intrin­
sic strength due to healing of the wound, 
why should they not still hold it on day 
5 when there is at least some intrinsic 
strength due to healing? If the sutures 
have not broken, they must have “ cut 
through the soft tissues” . Why should 
this occur?
One possibility is softening of tissues 
due to foreign body reaction. However, 
even the use of suture materials that are 
almost inert17 does not prevent dehis­
cence.
Another possibility is necrosis of the 
soft tissues under the sutures due to exces­
sive, unrelenting compression by them. If 
we sutured the skin as tightly as the fas­
cia, we would see necrosis under every 
suture.
The following 10 observations support 
the argument that pressure necrosis is the 
most likely primary factor in wound 
dehiscence, and coughing, distension and 
vomiting are simply secondary precipitat­
ing factors.
• If the wound edges are sutured
together tightly enough, necrosis will 
occur and dehiscence may follow. Simi­
larly, if they are sutured too loosely, 
dehiscence may occur. There is an ideal 
tension for suturing the incision that does 
not favour necrosis. Since we do not 
measure suture tension, we do not know 
the accuracy of our manual methods. It 
is unlikely that all surgeons pull all sutures 
equally tightly and that the tension we 
apply remains constant while the wound 
is healing.
• All tissues submitted to excessive and 
continuous pressure die. Witness bed 
sores, pressure sores under casts, dentures 
and appliances and prostheses in bone. 
However, in abdominal incisions, since 
we do not see the results of deep suture 
pressure, we have not been aware that it 
poses a problem.
• Necrosis from sutures does occur, as 
illustrated in Fig 2. Reid’s18 observations 
in 1936 have not received the attention 
they deserve. Here, two incisions in a 
dog’s fascia are sutured, one too tightly, 
the other correctly. The incisions are 
shown reopened 5 days later. It is not 
hard to imagine that with a sudden 
increase in intra-abdominal pressure the 
incision with tight sutures might dehisce, 
whereas the other would not.
• There are no reported measurements 
of the compression required to cause pres­
sure necrosis of soft tissues.
• Jenkins3 demonstrated that abdomi­
nal wounds may lengthen by 30% because 
of postoperative distension. To minimize 
the resulting increase of suture tension, 
he recommended a continuous suture, at 
least four times as long as the incision, that 
takes large bites and is tied loosely. He 
stated that “ the expressions tight and 
loose suturing and small and large tissue 
bites have no accurate meaning unless 
they refer to measured quantities and few 
surgeons have applied measurements to 
wound closure” .
• Microangiography has shown that 
tightly tied sutures produce areas of avas­
cular necrosis in wounds whereas loosely 
tied ones do not.19
• The lowest rates of dehiscence are in 
wounds in which the sutures are furthest 
from the wound edges, for example the 
Smead-Jones far-near retention suture 
and Jenkins elongated suture. When some 
pressure necrosis occurs under the suture, 
it automatically loosens and tension is 
reduced to a tolerable level. Because of 
the large bites there is still enough viable 
tissue left to hold the wound together. 
Sanders and associates20 measured the 
pressure required to rupture incisions in 
rats and showed the importance of large 
bites of tissue.
• Tera and Aberg21 showed that when 
tested on the abdominal wall removed 
from cadavers, a midline incision closed 
with a single layer of sutures placed far
enough laterally to include portions of the 
rectus muscle is three times more resistant 
to a bursting force than a paramedian 
incision closed in layers, two times more 
than a midline incision closed in the 
linea alba and 1.7 times more than a 
transverse incision above the umbilicus.
• Dehiscences commonly are recog­
nized about 8 days postoperatively and 
probably start a day or two before that.8 
At this time the wound is just emerging 
from the lag phase of healing and has 
minimal tensile strength of its own. 
Without the aid of sutures, it could not 
withstand coughing or vomiting or other 
activities that cause a rise in intra­
abdominal pressure. If tight sutures have 
produced pressure necrosis extending to 
the wound margins, dehiscence is likely 
to occur when the intra-abdominal pres­
sure is suddenly raised. The risk is still 
higher if the healing of the wound has 
been delayed by such problems as hypo­
proteinemia.
• There are two requirements in sutur­
ing of wounds — anatomical apposition 
of layers and provision of tensile strength. 
Many methods of wound closure attempt 
to satisfy both of these with a single 
suture. In some incisions this is possible 
but not in abdominal incisions. It is neces­
sary to use both approximating and reten­
tion sutures. The function of the latter is
FIG. 2—Reid’s 1936 experiments on suture 
tension in dogs (reproduced by permission 
from the New England Journal o f  Medicine 
1936; 215: 753-66)
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to provide support and to remove the 
strain from the approximating sutures.
These observations provide evidence 
that the primary cause of wound dehis­
cence is pressure necrosis from tight 
sutures, and that other factors play a 
secondary role by either delaying the heal­
ing of the wound or increasing the stress 
on it.
Prospective Study
R.C. Bartlett, an inventive engineer, 
and I developed an instrument in 1968 for 
tying retention sutures at an accurately 
measured tension (Fig. 3). This method 
was tested on 787 consecutive abdominal 
incisions of various types.
Technique o f  Closure
Dexon was used for closure of all layers 
except skin. The retention sutures are
FIG. 3—Tensiometer for measuring suture 
tension.
placed first. They are interrupted sutures 
of no. 1 Dexon on a no. 2 Ferguson round 
needle. They are extraperitoneal and 
buried, passing widely through all layers 
except skin and peritoneum (Fig. 4). Each 
suture enters the subcutaneous fat and 
includes as large a bite of anterior 
aponeurosis as possible, at least 3.75 cm 
from the wound edge. The suture then 
passes deeply through the muscle and 
posterior aponeurotic sheath but not 
through the peritoneum. The needle then 
turns back towards the wound margin, 
between peritoneum and posterior rectus 
sheath. If the peritoneal cavity is entered, 
it is important that the intraperitoneal 
portion should not exceed 1 cm so as to 
avoid bowel. The suture then traverses the 
tissues on the opposite side of the wound 
in reverse order. To aid in placing these 
sutures, the anterior and posterior 
aponeurotic sheaths (e.g., rectus sheath) 
are each firmly grasped in Kocher forceps 
at the middle point of the wound and by 
pulling the aponeurosis towards the centre 
of the wound, a wide purchase bite is pos­
sible. The retention sutures are placed 2.5 
cm apart. Halsted forceps are placed on 
each end of the suture and the ends left 
hanging over the wound margins until the 
peritoneum and aponeurotic layers are 
sutured (Fig. 5).
The peritoneum  and posterior
aponeurotic layer are then closed as a sin­
gle layer with a continuous atraumatic 
single suture of no. 0 Dexon, taking tis­
sue bites of 1.5 to 2 cm and approximately 
1 cm apart.
The anterior aponeurosis is next 
sutured in a similar manner. No attempt 
has yet been made to measure or regulate 
other than by the usual manual methods 
the tension on these two continuous 
suture lines.
The retention sutures are now all tied, 
each with a measured tension on the ten­
siometer equal to 300 g. This figure was 
determined by initiating the series with a 
tension of 800 g, which is much less than 
the usual manual tension and, as the ser­
ies progressed, gradually reducing it. Ten­
sions under 300 g have not been used. The 
incidence of incisional hernia has not been 
determined; it appears to be rare at 300-g 
tension, but did occur occasionally at 
800-g tension.
To tie the retention sutures at the 
desired tension, the suture ends are 
crossed (Fig. 6). One end of the crossed 
suture is hooked in the tensiometer which 
the surgeon grasps by the handle. The sur­
geon holds the other end of the crossed 
suture in the other hand and pulls both 
ends until the desired tension is reached; 
the suture is then clamped at the point of 
crossing without disturbing the axis. 
A sliver forceps has been found most use­
ful for this purpose since it is pointed and 
does not have cross striations which could 
drag the suture on removal. Three firm 
knots are now tied down tightly onto the 
forceps, the suture is cut 0.5 cm long and
FIG. 5—Series of retention sutures before 
closure of fascia.
FIG. 4—Method of placement of retention sutures.
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the forceps withdrawn. The net result is 
that the final tension is slightly less than 
300 g, due to space that was taken up by 
the forceps blade in the first knot. 
Observers are always surprised by the 
slackness of these retention sutures. They 
can be lifted up quite easily and a finger 
inserted loosely beneath them. The skin 
is then closed with clips or sutures.
The result is a wound in which appo­
sition  and strength are achieved  
separately. Anatomic apposition is 
achieved by the two continuous sutures 
and strength by the retention sutures.
Postoperatively no restrictions are 
placed on patients’ activities.
Using this method of wound closure, 
there were no dehiscences or partial dehis­
cences in any of the 787 abdominal inci­
sions. The wound infection rate was less 
than 1%, and there were no wound 
hemorrhages that required intervention.
I acknowledge the encouragement and 
advice I received from the late Dr. J.W.R. Ren­
nie, University o f Manitoba, and the techni­
cal assistance and suggestions o f Dr. Gordon 
B. Griggs o f the Winnipeg Grace General 
Hospital.
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Post-traumatic Ischemic Necrosis of the Common Bile Duct
A case of blunt injury to the extrahepatic 
bile ducts is reported. The injury was 
more likely caused by ischemia than by 
forces acting directly on the ducts.
When disruption occurs at the time of 
injury, its recognition may be delayed 
considerably, because the leaked bile is 
encapsulated or remains sterile and is 
therefore well tolerated. When there is 
ischemia without disruption, as in the 
case presented, perforation due to necro­
sis may also take some time (days to 
weeks) to occur. In the interval, loss of 
appetite, nausea, vomiting, abdominal 
distension and jaundice may develop. 
Bile-stained ascitic fluid is present.
Cet article decrit un cas de contusion 
des canaux biliaires extrahepatiques. La 
blessure semble davantage etre le resul- 
tat de I'ischdmi'e que des forces exercees 
directement sur les canaux. Lorsqu'une 
rupture survient au moment d'un trauma- 
tisme, son diagnostique peut etre retarde 
considerablement, du fait que la bile qui 
s'echappe demeure encapsulee ou ste­
rile, ce qui est bien supports par le 
malade. Quand il y a ischemie sans rup­
ture, comme dans le cas qui occupe les 
auteurs, la perforation consecutive e la 
necrose peut aussi prendre du temps (de 
quelques jours e quelques semaines) a 
s'installer. Dans I'intervalle, anorexie, 
nausee, vomissement, distension abdo- 
minale et ictere peuvent apparaitre. II y a 
presence d'un liquide d'ascite teinte de 
bile.
Disruption of the extrahepatic bile ducts 
is an uncommon sequel o f blunt trauma 
to the abdomen.1-5 A characteristic fea­
ture o f this type of injury is that it escapes 
early detection; signs and symptoms 
develop so insidiously that days, weeks or
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even months may elapse before the injury 
becomes apparent.1 Even when the 
severity of associated injuries necessitates 
emergency laparotomy, an injury to the 
bile duct is often overlooked. Zollinger 
and colleagues5 reviewed five cases in 
which the ductal injury was missed at the 
time of emergency operation. There was 
considerable delay before the injury was 
recognized; the interval between the first 
operation and the operation to deal with 
the damaged bile duct averaged 3 weeks 
(ranging from 9 days to 5 weeks).
Fletcher2 has described the typical 
clinical manifestations of the injury. In 
the days or weeks following the initial 
trauma, the patient suffers from loss of 
appetite, nausea, vomiting, abdominal 
distension and jaundice. Diagnosis is 
made by the finding of bile-stained ascitic 
fluid on abdominal paracentesis.
The mechanism of blunt injury to the 
extrahepatic bile ducts and the reasons for 
the delayed appearance o f bile ascites are 
poorly understood. Recent studies6 of 
the arterial supply of the bile ducts lend 
support to the supposition that some of 
these injuries may result from local 
ischemia.
We report a case of bile-duct injury in 
which the anatomy of the lesion and 
mode of presentation suggest that ische­
mia may have been an important factor 
in the mechanism of injury.
Case Report
A 34-year-old woman was the driver of a car 
involved in a head-on collision. The estimated 
collision velocity was 180 km /h. The patient 
had been wearing a seat belt. She was admit­
ted to the trauma service at the Hamilton 
General Hospital, conscious and cooperative.
On examination her heart rate was 110 
beats/min and blood pressure 95/70 mm Hg. 
Her injuries were as follows: lacerations of the 
face and the right hand; fractures of the right 
wrist, both patellae and right talus. Lateral cer­
vical spine roentgenogram revealed no injury. 
There were fractures of the 7th and 12th ribs 
on the right side. There was no widening of 
the mediastinum, pneumothorax or effusion 
on the right side of the chest. There was gener­
alized abdominal tenderness. On catheteriza­
tion of the bladder, 180 mL of clear urine were 
obtained. Peritoneal lavage produced frank 
bjood.
After a tube was placed in the right side of
the chest (because of the fractured ribs and 
intent to apply positive-pressure ventilation), 
an upper midline abdominal incision was 
made. Gross hemoperitoneum was confirmed. 
The principal injury was a large laceration of 
the superior surface of the right lobe of the 
liver. This laceration extended from the right 
coronary ligament to the inferior surface of the 
liver, deep to the gallbladder fossa and close 
to the porta hepatis. It did not cross the porta 
hepatis. A second laceration ran parallel to the 
first but was shorter and confined to the 
superior surface of the liver. There was con­
tusion of the lesser omentum as evidenced by 
scattered petechiae and small areas of ecchy- 
mosis. The structures in the lesser omentum 
did not appear to be disrupted. The gallblad­
der looked healthy and well vascularized. The 
duodenum was kocherized and no retroduo- 
denal gas or bile leak was seen. The pancreas 
appeared normal. No other intra-abdominal 
injury was found. Hemostasis was achieved by 
repairing the lacerations of the liver with deep 
through-and-through catgut sutures, care being 
taken to obliterate the dead space in the depth 
of the wound.
During preoperative resuscitation and oper­
ation, nine units of packed red cells and two 
units of fresh frozen plasma were given. Crys­
talloid was given at the beginning of resusci­
tation and was continued throughout the oper­
ation. Urine output was satisfactory.
The immediate postoperative period was 
uncomplicated. The patient was discharged 
from the intensive care unit within 3 days. The 
right subcostal drain was removed on day 4. 
By the 10th day the patient was feeling well and 
she was mobile within the limits imposed by 
her fractures. Her stools and urine were of nor­
mal colour. However, 13 days after operation, 
increasing abdominal distension and discom­
fort developed. Abdominal ultrasonography 
confirmed that the distension was due to 
ascites. On the 17th day, needle aspiration 
produced heavily bile-stained fluid. The amy­
lase content of this fluid was 30 Somogyi 
units/dL (55 U/L). The patient was not jaun­
diced and her stool colour remained normal. 
At this stage we thought that the lateral seg­
ment of the liver had perhaps undergone necro­
sis. A hepatic arteriogram revealed separation 
of the liver from the undersurface of the 
diaphragm on the right side. This finding was 
considered to be consistent with loss of liver 
substance. Scanning with N-(2,6-dimethyl 
phenyl carboxymethyl) iminodiacetic acid 
(HIDA) labelled with technetium 99m showed 
that the liver was of normal contour but 
reduced in size and that there was a perihepatic 
flush, indicating that material passed from the 
liver into a perihepatic space.
At a second operation for debridement, the
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liver was found to be intact without any 
necrotic areas. The right lobe, however, was 
compressed by a large collection of bile 
enclosed within a thick capsule. After dissec­
tion of this capsule, it became apparent that 
bile was leaking from the free edge of the lesser 
omentum. Two thirds of the circumference of 
the common bile duct and common hepatic 
duct had undergone necrosis and only a thin 
strip of duct adjacent to the hepatic artery was 
viable (Fig. 1). The gallbladder, which was col­
lapsed, looked healthy. Injection of saline into 
the gallbladder revealed a leak above and below 
the junction of the cystic duct with the necrotic 
bile duct. Cholecystectomy was carried out and 
continuity between liver and bowel was estab­
lished by a hepaticojejunostomy, using a Roux- 
en-Y loop of jejunum. The anastomosis was 
fashioned with a single layer of silk sutures and 
no stent was used. During mobilization of the 
small bowel, a large pseudocyst of the pancreas 
was found adhering to the first 25 cm of jeju­
num below the ligament of Treitz. This was 
drained externally through the left flank.
Within 3 days urobilinogen appeared in the 
urine and H1DA scanning showed bile enter­
ing the small intestine. The pseudocyst stopped 
draining after 2 weeks. Apart from an inci­
sional hernia, the patient is free of symptoms 
and leads a normal life.
Discussion
Northover and Terblanche6 have 
recently shed new light on the blood sup­
ply to the human bile duct. Using high 
resolution resin casts prepared from fresh
FIG. 1—Common-duct necrosis above and 
below junction with cystic duct. 1 = necrotic 
free edge of common bile duct, 2 = healthy 
gallbladder.
FIG. 2—Arterial blood supply of common 
(com.) duct and gallbladder (GB).
cadavers, they demonstrated that the 
arterial supply of the supraduodenal duct 
is axial (Fig. 2). The main vessels, which 
they named the 3 o’clock and 9 o’clock 
arteries, run along the left and right 
borders of the duct respectively. The axial 
vessels are, in turn, fed by the retroduo- 
denal and retroportal arteries from below 
and by the right hepatic artery from 
above. These workers suggested that this 
anatomical arrangement might explain 
why minimal surgical trauma can lead to 
almost total disappearance of the extra- 
hepatic ducts in some patients with bile- 
duct strictures postoperatively.
The bile-duct injury we describe is not 
typical of previously reported blunt inju­
ries, which have been variously charac­
terized as disruption, laceration, transec­
tion, avulsion or rupture. None of these 
terms would adequately describe the 
injury in our case. Moreover, the proce­
dures performed to repair the ductal 
injury have been either repair of the duct 
over a T-tube stent or choledocho- 
enterostomy;7 neither procedure was 
feasible in our patient because of the 
length of the injury. The extent of tissue 
loss conformed to the distribution of the 
9 o’clock axial artery, suggesting that the 
lesion was produced by damage to this 
vessel. That part of the bile duct supplied 
by the 3 o’clock artery appeared intact.
Several theories regarding the mechan­
ism by which blunt abdominal trauma 
causes damage to the extrahepatic bile 
ducts have been advanced. These include:
• Compression of the duct against the 
spine, which might cause laceration of the 
duct.
• External compression of a full gall­
bladder, which produces a rise in 
intraductal pressure large enough to cause 
a blowout.
• Tearing of the duct by a shearing 
force. This theory is supported by the 
observation that the usual sites of injury 
are the distal common bile duct where it 
enters the head of the pancreas and, less 
commonly, the hepatic ducts in the porta 
hepatis. Both these sites represent junc­
tions between mobile and relatively fixed 
segments of the ductal system where 
shearing forces would have maximum 
effect.
• Compression of the upper abdomen 
driving the liver cephalad, thus causing 
traction on the bile duct and a tear at its 
point of fixation behind the duodenum.
Any one, or a combination, of these 
forces, applied directly to the duct, could 
account for the injuries described previ­
ously in the literature. However, the 
nature of the lesion in our case suggests 
that the brunt of the injury was borne by 
the blood supply of the duct, rather than 
by the duct itself. The duodenum was 
kocherized at the time of the initial 
laparotomy, and this maneuver may have
further damaged an already compromised 
blood supply. Northover and Ter­
blanche6 pointed out that the retroportal 
artery could easily be injured where it lies 
in a thin layer of fascia on the back of 
the head of the pancreas.
Others have investigated the role of 
ischemia in producing damage to the bile 
duct. Cameron and Hou8 produced 
ischemic necrosis of a segment of the duct 
wall in the guinea pig by occluding the 
blood supply for 1 to 2 minutes. Maier 
and associates,7 however, were unable to 
reproduce these results in similar experi­
ments on dogs. Despite the lack of con­
vincing evidence that ischemia plays an 
important role in the production of the 
ductal injury, other authors4,7 have com­
mented on the absence of associated inju­
ries to the hepatic artery and portal vein; 
if the injury to the bile duct is caused by 
deforming forces acting directly on the 
duct, then it is difficult to explain why the 
same forces rarely produce disruption of 
the other structures at the free edge of the 
lesser omentum.
The reason why appearance of ascites 
is delayed following missed cases of dis­
ruption of the bile ducts has been the sub­
ject of much speculation. It has been sug­
gested that bile may become entrapped in 
the retroperitoneal tissues where it 
produces few symptoms.7,8 More impor­
tantly, perhaps, Cohn and associates9 
have shown in dogs that bile only 
becomes intensely irritating to the 
peritoneal cavity when it is infected; 
sterile bile is well tolerated. These factors 
might explain the delay in diagnosis in 
those patients in whom disruption actu­
ally occurs at the time of injury; in our 
case the interval between injury and the 
appearance of ascites could well be 
accounted for by the time taken for 
ischemic necrosis to lead to perforation 
of the duct.
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Thrombosis of a Prosthetic Valve Managed 
by Thrombolysis: a Case Report
Thrombosis of a prosthetic valve is one 
of the most serious cardiovascular 
events. Emergency replacement of the 
prosthetic valve has been the standard 
method of management but carries a 
high operative risk. This paper describes 
the successful use of streptokinase, 
given intravenously, to manage a patient 
with this complication in the acute 
phase. Eventually, operation was neces­
sary because the presence of residual 
organized clot was suspected, but the 
procedure was performed electively 10 
days later.
La thrombose de prothese valvulaire est 
une des plus sgrieuses complications car- 
diovasculaires. Un urgent remplacement 
valvulaire a ete jusqu'a date la methode 
de traitement de choix; cependant cette 
methode comporte un risque operatoire 
eleve. Cet article dgcrit I'emploi de strep­
tokinase intraveineux en phase aigue 
pour le traitement d'un patient ayant 
cette complication. Un remplacement 
valvulaire fut necessaire, du a la suspi­
cion Clinique de presence residuelle de 
thrombose organisee, mais ceci a gtg 
accompli glectivement 10 jours aprgs la 
phase aigue.
Intravalvular thrombosis is a life- 
threatening complication that can occur 
in any patient with a mechanical prosthet­
ic valve. Improvements in valve design 
and material have decreased the frequen­
cy of thrombosis but have not eliminat­
ed it and it has even been reported in the
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presence of apparently adequate an­
ticoagulation. Its traditional manage­
ment—replacement of the prosthetic 
valve—is associated with high operative 
mortality;1 moreover there is the risk of 
embolization during removal of the clot­
ted valve.
Recently, an alternative to emergency 
operation has been introduced,2,3 name­
ly, the use of streptokinase or urokinase 
given intravenously to lyse the clot. In 
some cases this has restored valve func­
tion to normal thus avoiding operation. 
In other instances, success was only par­
tial but made elective surgery possible.
We describe a case in which thrombo­
lytic therapy effectively opened a clotted 
Bjork-Shiley mitral valve and restored the 
patient’s hemodynamic status to normal. 
The presence of residual organized clot 
was still suspected and eventually the 
valve was replaced. In particular, this 
report emphasizes the usefulness of a new 
noninvasive diagnostic technique—sound 
spectral analysis—for this condition.
Case Report
A 31-year-old woman had a no. 31 Bjork- 
Shiley mitral valve inserted in 1975 for acute 
gonococcal endocarditis and mitral regurgita-
Fig. lb
FIG. 1—Baseline click analysis before treatment, (a) Phonocardiogram of 4-ms window 
around first heart sound, (b) Frequency data, which are derived from 50-ms window centred 
on first heart sound. Y axis is in relative decibel scale with loudest sound at zero.
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tion of sudden onset. In the succeeding years 
she remained generally well. She took warfa­
rin but had major problems in controlling an­
ticoagulation. Her prothrombin times were 
quite erratic and her drug compliance was ques­
tionable. In March 1982, dipyridamole (100 mg 
three times a day) was added to her regimen.
She remained well until early September 1983 
when she had increasing dyspnea, orthopnea 
and night chills. Evanescent episodes of left 
homonymous hemianopia occurred and valve 
clicking that was previously quite loud, became 
inaudible.
One month later she was admitted to the
FIG. 2—Klictrax system for obtaining spec­
tral analysis of prosthetic valve clicks. Micro­
phone is taped to patient’s chest at location of 
loudest clicks.
Toronto General Hospital. She was afebrile, 
had a sinus tachycardia of 100 beats/min, a 
blood pressure of 90/70 mm Hg and a respira­
tory rate of 30/min. She could not lie flat. 
However, her peripheral perfusion was ade­
quate and she was in no distress. Her chest was 
clear and there was no increase in venous pres­
sure and no hepatomegaly. No valve clicking 
was heard. A long, early, diastolic rumble was 
audible at the left sternal border, fourth inter­
space. Echocardiography showed minimal disc 
movement, which was also confirmed on cine- 
fluoroscopy (estimated disc excursion 10°). A 
spectral analysis of the closing-sound frequency 
of the Bjork-Shiley valve, using the Klictrax 
(Medtronic Inc., Minneapolis, Minn.) system, 
was obtained and is shown in Fig. 1. The high 
amplitude sound at approximately 300 Hz is 
the normal first heart sound. There are no high 
frequency sounds (above 1000 Hz) of significant 
amplitude. The computer picked up a high fre­
quency sound at 2704 Hz but this was only 
background noise. The admission prothrom­
bin time was 35 seconds (control 11 seconds).
The provisional diagnosis was a clotted 
mitral valve. Associated endocarditis could not 
be ruled out. She had a history of rigors and 
a Doppler test suggested that the murmur at 
the left sternal border was due to aortic regur­
gitation. Her condition was clinically stable. 
Therefore, we decided that a nonsurgical 
approach should be attempted, at least tem­
porarily until the status of her aortic valve and
the possibility of endocarditis could be clar­
ified.
After the administration of Solu-Cortef 
intravenously over 10 minutes and Benadryl 
(10 mg) intravenously over the next 10 minutes, 
streptokinase infusion was begun. In the first 
30 minutes, 250 000 units were infused. This 
was followed by a constant infusion of 100 000 
units/h. The infusion was continued for 32 
hours. The hematocrit did not vary apprecia­
bly during the streptokinase treatment. The 
thrombin time was maintained between two 
and four times the baseline control reference 
values. Platelet function was intact. No cir­
culating aggregates were found.
Hourly spectral analyses were obtained using 
the apparatus shown in Fig. 2. The microphone 
pick-up was left in place and recordings could 
be made without disturbing the patient, a dis­
tinct advantage during prolonged thrombolytic 
therapy. Seven hours after beginning therapy, 
a high-frequency closing click at 1802 Hz with 
appreciable amplitude was recorded for the 
first time (Fig. 3) and in the next hour the blood 
pressure increased to 110/70 mm Hg, the heart 
rate decreased to 70 beats/min, the valve clicks 
reappeared and the mid-diastolic murmur 
decreased in intensity.
When we decided to terminate the strep­
tokinase, heparin was infused intravenously at 
the rate of 1000 units/h as well as dipyrida­
mole (125 mg), continuously, for 24 hours.
Aortic root angiography was then performed 
and showed no aortic regurgitation. She re­
mained afebrile, blood cultures were negative 
and there was no clinical evidence of endocardi­
tis. For the next 7 days her condition remained 
stable. Closing-click spectral analyses, taken 
daily, consistently revealed peak frequencies 
between 1800 and 2000 Hz. She continued to 
have fleeting symptoms of homonymous hemi­
anopia which a neurologist attributed to 
emboli. This, together with persistent incom­
plete opening of the disc as seen on 
fluoroscopic examination, led to the conclu­
sion that organized clot still remained within 
the valve housing; the valve was replaced with 
a no. 29 Hancock bovine pericardial valve 10 
days after admission.
On opening the left atrium no recent or old 
clot was seen on the disc (Fig. 4a) but after 
removing the valve and tilting the disc open, 
a crescent-shaped rim o f organized clot could 
be identified on the atrial side of the disc in 
the major orifice (Fig. 4b).
Twelve hours after hemostasis was complete, 
the original infusion of heparin and dipyrida­
mole was resumed (the heparin concentration 
had been decreased to 100 units/h for 3 hours 
preoperatively) and continued until the patient 
was adequately anticoagulated with warfarin 
and 100 mg of dipyridamole, given orally, four 
times a day.
After discharge it was intended that the 
warfarin and dipyridamole regimen be con­
tinued for 3 months. This was not possible, 
however, because compliance was lacking and 
prothrombin times were persistently erratic. 
Accordingly, the patient was given dipyrida­
mole (75 mg three times a day) and Aspirin (325 
mg three times a day). No thromboembolic 
events have been observed with this treatment.
Discussion
Fibrinolytic therapy of a thrombosed 
prosthetic heart valve was first attempted
Fig. 3b
FIG. 3—Phonocardiogram and spectral analysis after 7 hours of thrombolytic therapy. 
Frequency data show high-frequency sound (1802 Hz) of appreciable amplitude.
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more than 10 years ago.4 Since then 
reports of its successful use in at least 30 
patients have appeared in the litera­
ture.2'4 It has been used for a variety of 
mechanical valves (e.g., Bjork-Shiley, 
St. Jude medical, Kaster-Omniscience 
and Starr-Edwards) in all three major 
valvular positions (aortic, mitral and 
tricuspid) and in a variety of clinical pre­
sentations, including pulmonary edema, 
low-output state and systemic embolism.
The best result that can occur from this 
form of treatment is a prompt reversal of 
acute hemodynamic compromise (a con­
sequence of lysis of fresh clot) and a 
complication-free long-term result with­
out the need for prosthetic replacement 
because there is no residual clot. In the 
two largest series in the literature2,3 with 
a total of 24 patients, 12 had excellent 
immediate and long-term results.
If the valve is obstructed not only by 
fresh but also by organized thrombus 
then lytic therapy will be less satisfactory. 
One might expect initial hemodynamic 
improvement but with clinical or labora­
tory evidence of residual clot. In the 
above two reports, 10 patients fitted into 
this category, with initial improvement
Fig. 4b
FIG. 4—Bjork-Shiley valve, (a) Viewed 
from inlet side showing no fresh clot, (b) Vie­
wed from outflow aspect showing rim of orga­
nized clot.
but late sequelae such as rethrombosis or 
embolism usually requiring eventual 
prosthetic valve replacement. Our patient 
represented an example of this partial suc­
cess. Thrombolysis reversed the acute 
hemodynamic deterioration but transient 
cerebral episodes, possibly due to micro­
emboli arising from the valve, persisted, 
suggesting that a thrombogenic nidus still 
remained on the valve in the form of 
organized clot resistant to thrombolysis; 
this was confirmed at operation. Further­
more, as additional evidence of incom­
plete success, the closing-sound frequency 
did not return to normal and the disc 
excursion did not reach the optimum 
value of 60° for this valve. The long 
period antedating her symptoms, during 
which anticoagulation was not well main­
tained, and the insidious presentation 
were early clues that success would not 
likely be complete. However, thrombol­
ysis did permit operation to be performed 
with less risk and also provided time for 
the proper investigation to rule out other 
conditions such as endocarditis and aor­
tic regurgitation.
Finally, thrombolysis may be totally 
unsuccessful if most of the clot is old and 
highly organized; one would then antici­
pate no hemodynamic improvement. In 
such a case lytic therapy may be detrimen­
tal if surgical correction is unnecessarily 
delayed or anticoagulation cannot be 
effectively and quickly reversed. Hence, 
thrombolysis should be abandoned if the 
patient’s hemodynamic status continues 
to deteriorate or a severe low-output state 
persists for more than 1 hour or if there 
is not marked improvement within 
8 hours. In our case, there was a latent 
period of 6 hours before lysis became clin­
ically evident, but during this time the 
patient was stable and although in a low- 
output state showed no evidence of organ 
hypoperfusion. In the two series referred 
to above, 2 of 24 patients were immedi­
ate failures and 1 died in transit to a sur­
gical centre.
A hemorrhagic complication is one of 
the greatest risks of thrombolytic therapy 
when used for extended periods of 24 to 
48 hours in contrast to the 1 to 2 hours 
for an evolving myocardial infarction. 
Witchitz and associates2 reported two 
serious hemorrhages in 13 patients. 
Hemorrhage is more likely to occur if the 
patient is moved out of bed for investi­
gations, and herein lies one of the major 
advantages of spectral click analysis 
described in this report. Not only is it sen­
sitive to changes in the disc-stent contact 
interface but it is totally nontraumatic, 
painless and without risk, and can be per­
formed as frequently as desired without 
disturbing the patient. In our case, the 
microphone pick-up was attached to the 
patient’s apex with tape and hourly 
recordings were obtained for 36 hours
-A
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Host-Defence Mechanisms in Surgical Patients: 
a Correlative Study of the Delayed Hypersensitivity 
Skin-Test Response, Granulocyte Function and Sepsis
To identify associations between abnor­
mal measurements and development of 
life-threatening surgical sepsis, host- 
defence parameters were a sse ssed  in 
2 2 02  patients upon adm ission to hospi­
tal for operation. Measurem ents included 
the response to delayed type hypersensi­
tivity (DTH) skin-test antigens, circulat­
ing blood-cell counts and hemoglobin 
levels, neutrophil adherence, chemotaxis, 
phagocytic and bactericidal function, and 
circulating serum albumin, serum globu­
lin, serum immunoglobulin and comple­
ment levels.
Sepsis was considered to be present 
when there w as bacteremia, proven 
cholangitis or intracavitary ab sce ss proven 
by operation or autopsy. The admission 
DTH  response stratified patients into a 
reactive group (responding to tw o or 
more antigens out of five, 1 3 7 3  pa­
tients), a relatively anergic group (with a 
response to one antigen, 3 0 6  patients) 
and an anergic group (with no antigen 
response, 523  patients). Sex, age and 
type of disease were similar in the three 
groups. There were abnormalities in neu­
trophil adherence, neutrophil chemotaxis, 
serum albumin and blood hemoglobin 
levels in all groups, compared with 
out-of-hospital controls. The reactive 
group had an 8 %  sepsis rate and a mor­
tality of 4 % ,  compared with 2 1 %  and 
1 5 %  in the relatively anergic and 3 3 %  
and 3 1 %  in the anergic groups respec­
tively (X2 ~  186, p <  0.0001). The 
same observation w as made in 1 1 8 4  
patients who were studied preopera- 
tively: sepsis rates were 8 % ,  1 6 %  and 
3 1 %  in the reactive, relatively anergic 
and anergic groups respectively
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(x2 =  76, p <  0 .0001 ) and mortality w as 
4 % ,  1 2 %  and 2 7 %  respectively (x2 = 
99.7, p <  0 .0001). Those who remained 
reactive on sequential weekly skin testing 
had a 2 %  mortality compared with 5 6 %  
in those who remained anergic through­
out their hospital stay. Of the autopsy 
proven causes of death, 8 0 %  were sepsis 
related. There w as a strong exponential 
correlation between the sum  of the 
diameters of the DTH reaction and sepsis. 
Neutrophil adherence and chemotaxis, 
serum albumin, hemoglobin, 
beta-2-globulin, gamma globulin, IgG  and 
IgA  levels and the DTH score were s ig ­
nificantly different in the septic versus 
nonseptic patients. The DTH  response in 
patients on admission to hospital or in the 
preoperative period can identify, if sup ­
pressed, a group of patients with a four­
fold increase in the risk of life-threatening 
sepsis and an eightfold increase in the 
risk of sepsis-related death. The D TH  
response globally a sse sse s a patient's 
bacterial host-defence capability and, if 
suppressed, signals a failure of multiple 
com ponents of host-defence m echanisms.
Afin d'identifier les associations entre 
certaines mesures anormales et I'appari- 
tion d 'infections chirurgicales menacant 
le pronostic vital, on a evalue I'etat 
immunitaire chez 2 2 0 2  patients lors de 
leur entree a I'hopital pour une operation. 
Les mesures comprennent la reaction 
intradermique e des antigfenes d 'hyper- 
sensibilite retard6e (HR) le decompte glo- 
bulaire et le taux d 'hemoglobine, I'adh6- 
rence des neutrophiles, la chimiotaxie, 
les fonctions phagocytaire et bactericide, 
ainsi que la determination des concentra­
tions seriques en albumine, globulines, 
immunoglobulines et complement.
Une sepsie a ete definie par la pre­
sence d 'une  bacteriemie, d 'une  cholan- 
gite ou d 'un  abc6s intracavitaire verifie a 
I'operation ou £ I'autopsie. A  I'arriv6e, 
les reactions d 'H R  ont ete stratifiees en 
un groupe reactif (reagissant e deux anti­
genes ou plus sur cinq, 1 3 7 3  patients), 
un groupe relativement anergique (rdagis- 
sant a un antigene. 3 0 6  patients) et un 
groupe anergique (sans reaction antig6ni-
que, 5 2 3  patients). Les trois groupes ne 
differaient ni par le sexe, Tage ou le type 
de maladie. On observait des perturba­
tions de I'adherence des neutrophiles, de 
la chimiotaxie de neutrophiles, de I'albu- 
mine serique et de I'hem oglobinem ie 
dans tous les groupes com parativement 
a des temoins non hospitalises. Le 
groupe reactif a accuse un taux de sep ­
sie de 8 %  et une mortalite de 4 %  com ­
parativement e 2 1 %  et 1 5 %  respective- 
ment pour le groupe relativement 
anergique et 3 3 %  et 3 1 %  pour le groupe 
anergique (x2 =  186, p <  0 .00 01 ). La 
meme observation obtenue en preop£ra- 
toire chez 1 1 8 4  patients a donne les 
resultats suivants: des taux de sepsie de 
8 % ,  1 6 %  et 3 1 %  respectivem ent pour 
les groupes reactif, relativement anergi­
que et anergique (x2 =  76, p <  0 .0 0 0 1 ) 
et une mortalite de 4 % ,  1 2 %  et 2 7 %  
respectivement (x2 =  99.7, p <  
0 .0001). Les patients qui demeurerent 
reactifs lors des tests cutan£s hebdoma- 
daires subsequents ont eu une mortalite 
de 2 %  par rapport a 5 6 %  pour ceux qui 
resterent anergiques pendant toute leur 
hospitalisation. D es dec6s ayant fait 
I'objet d 'une autopsie, 8 0 %  etaient relics 
a une sepsie. On a constate une forte 
correlation exponentielle entre la som m e 
des diamfetres des reactions de HR et les 
sepsies. L 'adherence et la chim iotaxie 
des neutrophiles, les taux seriques 
d'albumine, d 'hem oglobine, de 
beta-2-globuline, de gammaglobuline, 
d 'lgG  et d 'lgA , ainsi que les cotes d 'H R  
differaient significativement entre les 
groupes infectes et non infectes. L 'eta- 
blissement de la r^ponse d 'H R  des 
patients lors de leur entree h I'hopital ou 
dans la periode pr6operatoire permet 
d'identifier par son im m unosuppression 
un groupe qui pr£sente un risque quatre 
fois plus eievee de sepsie potentielle- 
ment letale et un risque huit fo is plus 
grand de mortality par infection. La reac­
tion d 'H R  gvalue globalement la capacity 
d 'u n  individu ci se d6fendre contre les 
bacteries et, en ca s d 'im m unosuppres- 
sion, elle signale I'in suffisance de plu- 
sieurs com posantes des m 6canism es de 
defense immunitaire.
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The demonstration by Koch and Pasteur 
of the pathogenicity of bacteria and their 
relation to infectious diseases has stimu­
lated efforts to decrease human infec­
tions. Despite scrupulous aseptic tech­
niques, a myriad of antibiotics and 
advances in operative methods, infectious 
complications after surgery and trauma 
continue to occur. Interest in preventing 
these costly complications has recently 
focussed investigations on host-defence 
mechanisms. An understanding of the 
normal function of host defence might 
help to identify patients in whom this 
defence is faulty. This would be most 
desirable preoperatively when steps can 
be taken to correct the defect and thus 
reduce septic complications.
A means of globally assessing host 
defence in surgical patients was 
introduced by MacLean and associates1 
in 1975. They used the delayed type 
hypersensitivity (DTH) skin-test response 
to ubiquitous antigens. Delayed type 
hypersensitivity is the term introduced by 
Zinsser2 in 1921 for the erythematous 
indurated reaction elicited in specifically 
sensitized subjects by intracutaneous 
challenge with a bacterial antigen. The 
basis of the DTH response is the recog­
nition of foreign antigens by sensitized T 
lymphocytes. A sensitized lymphocyte 
(long-lived T cell capable of antigen 
recognition because of previous exposure) 
encounters the antigen in the dermis. This 
cell releases lymphokines (mostly pro­
teins), which attract nonsensitized lym­
phocytes (short-lived T lymphocytes), 
macrophages and polymorphonuclear 
neutrophils (PMNs) to the skin-test site. 
The release of other proteins by these cells 
causes fluid to accumulate. The resulting 
inflammatory reaction normally eradi­
cates the antigen and produces the indu­
ration that is measured in assessing the 
DTH response.
Most of the initial DTH testing was 
used to evaluate tuberculosis. It was noted 
occasionally that patients with active 
tuberculosis were anergic (nonreactive) to 
full strength purified protein derivative 
(PPD).3 Most healthy people respond to 
common antigens such as mumps4 and 
Candida,5 Palmer and Reed6 showed 
that in a general hospital patient popula­
tion of 742 subjects, the overall response 
rate to mumps was only 68% and to Can­
dida 63 %. This was not in keeping with 
the nonhospitalized population. They 
identified associations between anergy, 
leukocytosis, anemia and fever. MacLean 
and associates1 reported that in 105 sur­
gical patients, anergy at the time of 
admission to hospital was associated with 
major sepsis in 37% and with a 28% mor­
tality. These findings have been con­
firmed by others.714 There is an oppos­
ing view that the DTH response is not 
associated with postoperative sepsis and
mortality.15 Others believe that in-vitro 
evaluation of the DTH response is 
superior to the skin-test method for iden­
tifying patients at risk for sepsis, espe­
cially following burns and trauma.16
The purpose of this study was to 
address the following points.
• Is there an association between the 
response to skin testing with DTH anti­
gens and sepsis and mortality in hospital­
ized, surgical patients?
• In the preoperative patient, can this 
association identify patients at risk for the 
development of major sepsis and death 
following operation?
• Are there other abnormalities of host 
immunocompetence in surgical patients 
and, if so, could they contribute to the 
development of sepsis and mortality?
• Which of these abnormalities in host 
resistance, if any, should be measured and 
used in a multivariate analysis of factors 
that contribute to adverse hospital out­
come, so that surgical patients at risk for 
major sepsis can be identified more pre­
cisely and preventive measures taken?
Patients and Methods
Study Population
The study population comprised 2202 
patients admitted to the wards and the 
surgical intensive care unit of the Royal 
Victoria Hospital in Montreal. The study 
was approved by the hospital ethics 
review board. All patients, including 
those admitted for major surgery and 
those who sustained traumatic injuries, 
were evaluated within 24 hours of admis­
sion. Some patients were operated upon 
at other hospitals and were transferred to 
the Royal Victoria Hospital for tertiary 
care because of severe complications. A 
history was obtained and physical exami­
nation carried out on all patients on 
admission to the study, taking care to 
note the presence of sepsis. Twenty-five 
healthy control subjects, ranging in age 
from 18 to 56 years (mean 38.3 ± 2.3 
years, mode 28 years), were also studied.
Skin Testing
Skin tests were performed with five 
recall antigens using the arm or volar sur­
face of the forearm. The sites were 
rotated for sequential testing, usually 
once a week. No skin testing or blood 
investigations were carried out in the first 
24 hours after operation, in order to avoid 
the effect of anesthetic agents on these 
measurements. The antigens used were 
those most likely to have provided previ­
ous sensitization to patients in the Mont­
real area. These were Candida (Candidin 
1:100 dilution), mumps skin-test antigen 
(undiluted), purified protein derivative (5 
TU), trichophyton and streptokinase- 
streptodornase (Varidase, 100 U/mL). 
The antigens were injected intradermally 
in a volume of 0.1 mL so that a weal was 
visible. A saline control was also used. 
The resulting area of induration at 24 and 
48 hours was delineated by delicately 
approaching the lesion from the normal 
skin towards its centre with a felt-tipped 
pen. The two greatest diameters were 
measured, summed and divided by two, 
and the resulting mean sum for each anti­
gen was recorded. The erythema sur­
rounding the induration was ignored. A 
positive response was defined as a mean 
diameter of induration of 5 mm or more. 
A reactive subject was defined as one with 
two or more positive responses. A rela­
tively anergic subject was one who re­
sponded to only one antigen and an aner­
gic subject did not respond to any of the 
antigens at any time.
Hematologic Tests
Blood was obtained by venepuncture as 
soon as patient stratification was deter­
mined, for the following analyses: cir­
culating erythrocyte and leukocyte counts 
(including differential counting of the leu­
kocytes), hemoglobin concentration, total 
serum proteins, serum albumin, alpha, 
beta and gamma globulin levels, 
immunoglobulins A, G and M, total 
hemolytic complement and circulating C3 
levels. Testing of neutrophil adherence to 
nylon wool was performed by a modifi­
cation of McGregor’s technique.17 The 
adherence results are expressed as the per­
centage of total leukocytes that adhere to 
the nylon-wool column. Polymorphonu­
clear neutrophil chemotaxis was measured 
by a modification of Boyden’s tech­
nique.18 The PMN chemotactic migra­
tion to an attractant (casein or zymosan- 
activated serum) is expressed as the dis­
tance of cell migration in micrometres. 
The data on chemotaxis were confirmed 
by the agarose chemotactic migration 
method of Nelson.19 Polymorphonuclear 
neutrophil phagocytosis and bacterial kill­
ing ability were measured by a modifica­
tion of the technique of Quie.20 The rate 
o f phagocytosis of preopsonized 
Staphylococcus aureus 502A at 5, 10 and 
20 minutes after bacterial-PMN mixing 
was measured. The results are expressed 
as the percentage of the original radio- 
labelled bacterial inoculum associated 
with the PMNs at each sampling time. 
Similarly, bactericidal function was 
assessed at 10, 20, 40, 80 and 160 minutes 
and expressed as a percentage of the origi­
nal bacterial inoculum killed by the 
PMNs at each sampling time.
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Data Collection and Analysis
The following data were recorded for 
all patients: demographic information, 
including sex, age, diagnosis, duration of 
hospital stay, past medical history, previ­
ous related surgery, the timing o f surgi­
cal interventions, the extent of surgery (a 
simplified grading scale was used, giving 
simple surgery such as herniorrhaphy a 
value of 1 and more invasive surgery such 
as an esophagogastrectomy a value of 4),
duration of operation in minutes, the 
organ operated upon and whether the 
procedure was clean, clean-contaminated, 
contaminated or dirty. Also recorded 
were the presence or subsequent develop­
ment of major or minor sepsis and the 
causative organism(s). Data were col­
lected on antibiotic use, both prophylac­
tic and therapeutic, the duration of each 
therapeutic course o f  antibiotics and the 
number of treatment courses per patient, 
the final outcome and cause o f death if 
this occurred. Data were collected  
prospectively during the hospital stay for 
each patient by examining the chart 
records and the patients on a daily basis. 
Data were first recorded on specially 
designed sheets and then transferred to 
coded computer sheets before entering 
them in the computer using a relational 
data base management system. The 
statistical analyses used were the x2 
method, analysis o f  variance or the 
unpaired Student’s f-test. Means and 
standard errors o f the mean are reported.
Definitions
Major sepsis was said to be present if 
there was a positive blood culture, an 
abscess that was identified at operation 
or autopsy or confirmed by percutaneous 
aspiration using computerized tomogra­
phy or ultrasonic guidance, or a proven 
ascending cholangitis. Minor sepsis was 
said to be present if there was a wound 
discharging pus, pneumonia, a urinary 
tract infection, cellulitis or similar infec­
tion. Based on the autopsy report or the 
death certificate if no autopsy was done,
Table —Admission Diagnosis in the Three Patient Groups 
(Separated According to Skin-Test Response)
Reactive, Relatively anergic, Anergic,
no. (%) no. (%) no. (%)
Diagnosis (n -  1373) (n -  306) (n -  523)
Abdominal aortic aneurysm 32(2.3) 2 (0.7) 3 (0.6)
Biliary tract disease 110(8.0) 11 (3.6) 12 (2.3)
Carcinoma 380(27.7) 81 (26.5) 120 (22.9)
Crohn's disease 33 (2.4) 9 (2.9) 5(1.0)
Cirrhosis of liver 4 (0.3) 3(1.0) 6(1.1)
Cystic disease 
(liver, ovary) 7 (0.5) 1 (0.3) 3(0.6)
Diverticular disease 
of colon 70(5.1) 6(2.0) 4(0.8)
Gastrointestinal bleeding 117(8.5) 21 (6.9) 61 (11.7)
Gastrointestinal fistula 13(0.9) 3(1.0) 5 (1.0)
Gastrointestinal polyps 26(1.9) 0(0) 1 (0.2)
Gastrointestinal stricture 6(0.4) 1 (0.3) 1 (0.2)
Hernia 26(1.9) 2 (0.7) 7(1.3)
Leiomyoma (gastric 
and intestinal) 5 (0.4) 1 (0.3) 1 (0.2)
Lymphoma 7 (0.5) 3(1.0) 1 (0.2)
Major sepsis 58(4.2) 40(13.1) 96(18.4)
Minor infection 29(2.1) 18(5.9) 44 (8.4)
Morbid obesity 51(3.7) 0(0) 0(0)
Obstructed viscus 41 (3.0) 5(1.6) 15(2.9)
Pancreatic disease 64 (4.7) 9 (2.9) 13 (2.5)
Peptic ulcer disease 72(5.2) 5(1.6) 0(0)
Peripheral vascular 
disease 20(1.5) 1 (0.3) 0(0)
Radiation enteritis 11 (0.8) 0(0) 4(0.8)
Trauma 58(4.2) 44(14.4) 73(14.0)
Ulcerative colitis 10(0.7) 6(2.0) 3(0.6)
Miscellaneous 123(9.0) 34(16.0) 4b (9.6)
Table II—Skin-Test Response and Host-Defence Data on Admission to Hospital
Test
Control
subjects Reactive
Relatively
anergic Anergic
Age, yr
DTH score, mm 
Neutrophil adherence, % 
Neutrophil chemotaxis, U 
Neutrophil phagocytosis, 
% at 5 min 
Bacterial killing,
% at 40 min 
Total protein, g/L 
Serum albumin, g/L
38.3 ±2.3 * 
41.9 ±  2.1* 
65.5 ±  1.8*
128.3 ±1.7 *
%
37 ± 2
70 ± 2 *  
74 ± 1 *  
44 ± 1 *
58.9 ±0.4  
35.7 ±0.5 * 
74.4 ±0 .6 * 
115.8 ±  0.7*
32 ± 4
81 ± 4  
63 ±  1 * 
35 ±  1 *
58.6 ±  1.1
10.2 ±0 .3 *
80.3 ±1 .0 * 
108.2 ± 1 .2 *
42 ± 3
60 ± 6  
58 ±  1 * 
31 ±  1*
62.5 ±1.1 
1.4 ±  0.1* 
77.4 ± 0 .9 * 
106.6 ± 0 .9 *
40 ± 3
70 ± 5  
55 ±  1 * 
29 ±  1 *
Total immunoglobulins,
g/L
IgG, g/L 
IgA, g/L 
IgM, g/L 
C3, g/L
Total hemolytic complement 
(CH50), UlmL 
Hemoglobin, g/L 
Polymorphonuclear 
neutrophils, X 109/L 
Lymphocytes, X 109/L 
Mononcytes, X lOj’/L
12 ± 1 
8.54 ±0.38 
1.41 ±0.17 
1.31 ±0.10
1.05 ±0.05
186 ±  13 
143 ±  3*
3.58 ±0.16*
2.06 ±0.13* 
0.35 ±0.032*
12 ± 1 
8.65 ±0.51
2.25 ±0.19 
1.14 ±  0.12 
1.22 ±0.06
184 ±  12 
125 ±  1*
6.26 ±0.40* 
1.74 ±0.09 
0.50 ±0.03
10 ± 1 
7.05 ±0.65 
1.77 ±0.16 
0.97 ±0.14 
1.23 ±  0.10
141 ±  13 
117 ±  1*
6.96 ±0.60* 
1.28 ±0.08 
0.67 ±0.07
11 ± 1  
8.16 ±0.64  
2.33 +  0.20 
1.03 ±  0.10 
1.18 ±  0.07
169 ±  10 
114 ±  1 *
8.40 ±0 .63 * 
1.31 ±0.093 
0.60 ±0.071
'Values that differ significantly between each group at p <  0.05, using analysis of variance.
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deaths were defined as septic if sepsis was 
the stated cause of death, sepsis-related 
if sepsis contributed but was not the 
stated cause of death, or nonseptic if 
major sepsis as defined did not occur dur­
ing hospitalization. The DTH score was 
defined as the sum of the average 
diameters of each individual DTH anti­
gen response and is used as an alternative 
representation of the delayed hypersen­sitivity skin-test response.
Results
Demographic Data: All Patients
All 2202 patients (1211 men and 991 
women) underwent skin testing. The 
majority had all the hematologic assess­
ments except for the phagocytosis and 
killing tests, which were performed on a 
subpopulation of 152 patients, and the 
immunoglobulin data, which were avail­
able for 302 patients. There were 1373 
reactive patients on admission to hospi­
tal (769 men, 604 women), ranging in age 
from 17 to 95 years (mean 58.9 ± 0.4 
years, mode 59 years). There were 306 
relatively anergic patients (159 men, 147 
women), ranging in age from 16 to 95 
years (mean 58.6 ±1 . 1  years, mode 53 
years). There were 523 anergic patients 
(285 men, 238 women), ranging in age 
from 16 to 96 years (mean 62.5 ± 1.1 
years, mode 63 years). The overall sepsis 
rate (major and minor sepsis combined) 
was 43% in the 2202 patients. This com­
pares with an overall hospital infection 
rate (including all surgical patients in 
other disciplines such as plastic surgery, 
orthopedic surgery and ophthalmology) 
of 3.9% yearly, based on 7986 annual dis­
charges. The initial analysis stratified the 
patients into three groups based on 
admission skin tests. Table I lists the 
admission diagnosis for the three patient 
groups: reactive, relatively anergic and 
anergic. There was no difference in the 
distribution of patients with cancer within 
the three groups. There were proportion­
ately more patients with an abnormal 
DTH reaction and the admission diagno­
sis of major sepsis, trauma, gastrointes­
tinal bleeding or minor sepsis.
Hematologic Data
Table II lists the additional variables 
measured in the three patient groups com­
pared with the healthy control subjects. 
The DTH response is expressed in this 
table as the DTH score, which decreases 
progressively as expected in the four 
groups, from control reactivity to patient anergy.
Neutrophil adherence was significantly 
(p < 0.05) increased and PMN chemo- 
taxis was significantly (p < 0.05) 
decreased in all patient groups compared 
with controls. There was a progressive
decrease in the PMN chemotaxis as DTH 
response worsened and a correspondingly 
increased neutrophil adherence. The aug­
mentation in bacterial killing demon­
strated in reactive patients compared with 
control subjects was not seen in nonreac- 
tive patients. The clinical importance of 
this finding needs further evaluation.
There were also alterations in total 
serum protein, serum albumin and 
hemoglobin levels among the three patient 
groups, and all were lower than the con­
trols. Interestingly, lymphocyte counts
were lower in each of the three patient 
groups than in the control subjects. 
However, there were no statistical differ­
ences in lymphocyte counts between the 
patient groups. Similarly, monocyte 
counts were increased in the three patient 
groups, when compared with those in the 
controls, but were not different between the patient groups.
Clinical Outcome: AH Patients
Table III lists the clinical outcome of
Table Ill-Clinical Outcome in All Patients 
Based on Admission Skin-Test Response
Skin-test
response No.
Sepsis, 
no. (%)*
Death, 
no. (%)t
Reactive 1373 113(81 54(4)
Relatively anergic 306 65(21) 45(15)
Anergic 523 175(33) 161 (31)
*X 2 -  186.3, 2 df, p <  0.0001. 
t * 2 -  265.1, 2 df, p <  0.0001.
Table IV—Clinical Outcome in 553 Patients in the 
Intensive Care Unit Based on Skin-Test Response 
on Entry to the Unit
Skin-test
response No.
Sepsis, 
no. (%)*
Death, 
no. (%)t
Reactive uT 58 (33) 25(14)
Relatively anergic 110 45(41) 29(26)
Anergic 268 128(48) 101 (38)
*X 2 -  9.3, 2 df, p -  0.0094. 
tX 2 -  28.9, 2 df, p <  0.0001.
Table V—Operations Performed in the Three Groups 
First Skin Tested Preoperatively
Type of operation
Reactive, 
no. (%)
(n = 876)
Relatively anergic, 
no. (%)
(n = 131)
Anergic, 
no. (%)
(n = 177)
Abscess (drainage) 13(1.5) 8 (6 .1 ) ~ 13(7.3)
Adrenal gland 2(0.2) 1 (0.81 0(0)
Anorectum 35 (4.0) 2(1.5) 3(1.7)
Appendix 1 (0.1) 1 (0.8) 0(0]
Arteries 55(6.3) 0(0) 2(1.1)
Biliary tract 137(15.6) 20(15.3) 33(18.6)
Bladder 5 (0.6) 211.5) 0(0)
Bones 3 (0.3) 3(2 .3) 6(3.4)
Breast 3(0.3) 0(0) 1 (0.61
Colon 257(29.3) 40130.5) 45(25.4]
Esophagus 11 (1.3) 211.5) 5(2.8)
Hernia 3 (0.3) 1 (0.8) 0(0)
Kidney 4(0.5) 1 (0.8) 3(1.7)
Laparotomy 42 (4.8) 11 (8.4) 16(9.0)
Liver 7(0.8) 0(0) 0(0)
Neck 4 (0.5) 0 (0) 0(0)
Ovary 4(0.5) 0 (0) 2(1.1)
Pancreas 14(1.6) 5(3.8) 3(1.7)
Skin 9(1.0) 4(3 .1) 7 (4.0)
Small Bowel 48(5.5) 4(3 .1) 4(2 .3)
Stomach 162(18.5) 17(13.0) 26(14.7)
Lung 5 (0.6) 2(1 .5) 3(1.7)
Veins 17(0.8) 3(2.3] 5(2.8)
Miscellaneous 45(5.1) 4(3 .1) 0(0)
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all patients in the three groups. There is 
a statistically significant association 
between decreased skin-test reactivity on 
admission to the study and the subsequent 
development of major sepsis or mortal­
ity, or both.
Further, the anergic patients showed a 
difference in the ability to control major 
sepsis once this became established. Of 
175 of the patients who were anergic on 
admission to hospital and who subse­
quently suffered from major sepsis, 92 
(53%) died. Eighty percent of the autopsy 
proven causes of death were septic or 
sepsis-related. In contrast, only 25 (23%) 
of 115 reactive patients who subsequently 
had major sepsis died as a result of their 
infection (x2 = 26.1, 1 df, p < 0.0001).
Clinical Outcome: Patients in 
Intensive Care Unit
There was a similar strong association 
between decreased skin reactivity, major 
sepsis and mortality in patients who were 
seriously ill and required admission to the 
intensive care unit (Table IV). The sepsis 
rate and mortality were higher in all three 
groups of intensive-care-unit patients, 
reflecting the seriousness of their disease.
Clinical Outcome: Patients 
Tested Preoperatively
Table V shows the operations done on 
1184 patients whose first skin test was per­
formed preoperatively. The operative 
time was 165 ± 3.7 minutes in the reac­
tive group, 156 ± 7.7 minutes in the rela­
tively anergic group and 160 ± 7.1 
minutes in the anergic group. The extent 
of operative trauma was similarly equal: 
2.7 ± 0.1, 2.9 ± 0.2 and 2.8 ± 0.1, re­
spectively. The distribution of operations 
in the three patient groups was uniform. 
There was also an even distribution 
among clean, clean-contaminated, con­
taminated or dirty classes of operation, 
with two exceptions. Vascular surgery 
included a higher proportion of reactive 
patients, and there were more patients 
requiring drainage of an intracavitary 
abscess who had depressed DTH 
responses. The clinical outcome in these 
patients (Table VI) was similar to that for 
the overall patient population. There was 
a strong association between preoperative 
depressed DTH skin reactivity and sub­
sequent development of major sepsis or 
death. These findings demonstrate the 
actual predictive value of the DTH 
response in that they identify a group of
Table VI—Clinical Outcome in Patients First Skin Tested Preoperatively, 
Based on Preoperative Response
Skin-test Sepsis, Death,
response No. no. (%)* no. (%)t
Reactive 876 66(8) 36 (4)
Relatively anergic 131 21(16) 16(12 )
Anergic 177 54(31) 4 7 (2 7 )
*X 2 -  76.5, 2 df, p <  0.0001.
t x 2 -  99.7, 2 df, p <  0.0001.
Table VII—Clinical Outcome of Elective Operations 
Based on Preoperative Skin-Test Response
Skin-test
response No.
Sepsis, 
no. (%)*
Death, 
no. (%)t
Reactive 666 45(7) 2 9 (4 )
Relatively anergic 83 8(10) 9 (11 )
Anergic 96 15(16) 23 (24)
‘ X2 = 9.23, 2 df, p -  0.0099. 
t x 2 = 47.8, 2 df, p <  0.0001.
Table VIII—Sequential Skin-Test Response and 
Clinical Outcome in Patients With the Same 
Skin-Test Response Throughout the Hospital Stay
Skin-test
response No.
Sepsis, 
no. (%)
Death, 
no. (%)
Reactive 295 35(12) 6 (2 )
Relatively anergic 30 15(50) 6 (20 )
Anergic 140 59(42) /8  (bbl
patients at a higher risk for postoperative 
sepsis.
To assess the validity of these results 
in patients operated upon electively, 845 
of the 1184 patients were examined. All 
of these patients required major surgery. 
Their operation could be delayed for up 
to 3 weeks without endangering their 
health. No patient had any form of sep­
sis at the outset. The distribution of oper­
ative procedures was similar to that of all 
operations. The outcome data on these 
patients is shown in Table VII. Although 
the sepsis rates were lower in the anergic 
group compared with the overall anergic 
population, even those patients who had 
no sepsis before operation demonstrated 
a higher rate subsequently of major sep­
sis or death, or both, compared with the 
reactive group. These patients who were 
anergic preoperatively also showed a 
difference in their ability to control major 
sepsis once it developed postoperatively. 
Of anergic patients who underwent elec­
tive surgery, 9 (60%) of 15 who had 
major sepsis postoperatively died, com­
pared with 12 (27%) of 45 reactive 
patients.
Analysis o f  Sequential 
Skin-Test Data
We analysed the data on sequential skin 
tests (Table VIII) in 465 patients, who had 
from 2 to 31 weekly skin tests with a mean 
of 5.3 ± 0.4 repeat skin tests. Sepsis and, 
particularly, deaths were much lower in 
reactive patients throughout their hospi­
tal stay than in those who maintained 
depressed skin reactivity throughout. 
Skin-test reactivity (or nonreactivity) was 
not a fixed phenomenon but could change 
during the course of a patient’s hospital 
stay. For example, 50% of reactive 
patients who underwent grade 4 surgery 
were anergic 3 days after operation. The 
majority recovered their skin reactivity 
spontaneously by postoperative day 7. 
The 5% who remained nonreactive for 
more than 1 week had major sepsis at a 
rate similar to those with anergy before 
operation (i.e., 32%). Drainage of an 
abscess and control of a serious intracavi­
tary infection in most instances resulted 
in recovery of skin-test reactivity within 
7 days of operation. If recovery did not 
occur, inadequate drainage of an abscess 
or hemorrhage was usually the cause.
Such changes in skin-test reactivity 
showed a strong association with the 
development of sepsis and with death. 
Ninety-eight patients were reactive on 
admission and deteriorated to nonreac­
tivity during hospitalization. Sepsis deve­
loped in 43 (44%) and 39 (40%) died. In 
contrast, 326 patients who were anergic 
on admission recovered their DTH 
response during hospitalization. In this 
group, major sepsis developed in 81
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(25%), usually during the period of 
anergy. Only 23 (7%) died as a result of 
their sepsis.
Sequential data were also analysed to 
find out the percentage of time during the 
hospital stay that patients were anergic 
and therefore at risk for sepsis. Those 
patients who had no sepsis and survived 
were at risk for 38.1% ± 1.4% of the 
hospital stay (mean of 9.6 days), while 
those who had sepsis or who died were 
at risk for 67.4% ± 1.9% of the hospi­
tal stay (mean 28.6 days) (p <  0.01). A 
further analysis of this subgroup showed 
that septic patients who died of their 
infection were at risk (i.e., nonreactive) 
for 84.2% ±  2.6% of their hospital stay 
(mean 35.6 days), compared with 48.6% 
± 2.9% of the time (mean 20.4 days) for 
patients with sepsis who survived.
Analysis o f  Host-Defence Variables 
o f  Survivors and Nonsurvivors
The hematologic and immune 
parameters, measured on admission to 
the hospital, were analysed by the 
unpaired Student’s t-test to pick those 
variables that might distinguish survivors 
from nonsurvivors. Table IX shows that 
age, DTH score, total serum protein, 
serum albumin, hemoglobin, /3-2-globu- 
lin, gamma-globulin, serum IgG and 
serum IgA levels, and circulating total 
leukocyte, PMN and lymphocyte counts 
were all significantly different in survivors 
from those in nonsurvivors. Table X 
shows similar survival data in the 1184 
patients tested preoperatively.
Analysis o f  Host-Defence Variables o f  
Septic and Nonseptic Patients
An analysis of host-defence variables 
between septic and nonseptic patients 
(Table XI) shows that a different set of 
variables differs significantly between the 
septic and the nonseptic patients. Since 
20% of deaths were not related to sepsis, 
this was not unexpected. Different mul­
tiple linear or logarithmic regression 
equations would be needed to predict the 
risk of sepsis or death in these patients.
A n Alternative Method o f  Representing 
the D T H  Response
As a prerequisite to using the DTH 
response meaningfully in a multivariate 
regression analysis, the validity of 
representing the DTH reactivity of 
patients as a continuum, the DTH score 
(in millimetres) rather than as three fixed 
classifications of reactive, relatively aner­
gic and anergic, was tested. This was done 
by performing a bivariate logarithmic 
regression, using the percentage of 
patients within a particular DTH score 
range (e.g., 0 mm to 3 mm), who had sep­
sis as the dependent variable and the DTH 
score as the independent variable. A 
4-mm range was arbitrarily used. There 
was a strong correlation between the sum 
mean diameter of the DTH skin-test 
response (X) and sepsis (Y): Y = 35.1 -  
7.5 In X, r = -0.91 (Fig. 1). A similar 
result was obtained when mortality (Y)
was used as the dependent variable, 
Y = 32.1 -  7.9 In X, r = -0.95 (Fig. 2).
Other Variables That Might 
Affect Outcome
Examination of the episodes of minor 
sepsis showed a significantly greater num-
Table IX—Host Immunocompetence in All Survivors Compared With 
Nonsurvivors Following Hospitalization
Test Survivors Nonsurvivors p value
Age, yr 57.5 ± 0 .4 66.9 ± 0 .8 <  0.001
DTH score, mm 25 .8  ± 0 .5 7 . 6 +  0.8 <  0.001
Neutrophil adherence, % 76.3 ± 0 .4 77.5 +  1.2 NS
Neutrophil chemotaxis, U 
Neutrophil phagocytosis,
111.5 ±  0.9 110.5 ±  1.3 NS
% at 5 min 
Bacterial killing,
43 .8  ±  1.5 41.1 ± 4 .2 NS
% at 10 min 40 .7  ± 2 .4 36.6 ± 3 .8 NS
Total proteins, g/L 61 ±  1 55 +  1 <  0.001
Serum albumin, g/L 34 ±  1 29 ± 7 <  0.001
Hemoglobin, g/L 122 ±  1 115 +  2 <  0.05
Leukocytes, X 109/L 
Polymorphonuclear
9 .56 ±  0.17 11.65 ± 0 .4 6 <  0.001
neutrophils, X 109/L 7.00 ± 0 .3 5 8 .34 +  0.06 <  0.05
Lymphocytes, X 109/L 1.54 ± 0 .0 6 1.23 +  0.16 <  0.05
Mononcytes, X 10 9/L 0 .54 ± 0 .0 3 0.70 +  0.15 NS
<r-1-globulin, g/L 4.0 ± 0 .1 3 . 9 +  0.1 NS
a-2-globulin, g/L 7.1 ± 0 .2 6 . 3 +  0.2 NS
8-2-globulin, g/L 7.8 ± 0 .1 6 . 9 +  0.1 <  0.05
y-globulin, g/L 10.4 ± 0 .3 14.3 +  6.7 <  0.001
IgG, g/L 7.85 ± 0 .3 4 9.53 ±  1.37 <  0.001
IgA, g/L 2.11 ± 0 .1 2 2.59 +  0.34 <  0.001
IgM, g/L 1.03 ± 0 .0 7 1.20 +  0.21 NS
C3, g/L
Total hemolytic complement
1.22 ± 0 .0 4 1.17 ±  0.12 NS
ICH50), U/mL 173.6  ± 7 .2 158.9 +  18.9 NS
NS -  not significant.
Table X—Host Immunocompetence of Survivors and Nonsurvivors 
Following Operation
Test Survivors Nonsurvivors p value
Age, yr 58.9 ± 0 .5 68.1 ±  1.2 <  0.001
DTH score, mm 30.5 ± 0 .7 11.5 +  1.4 <  0.001
Neutrophil adherence, % 75.1 ±  1.1 75.3 +  1.7 NS
Neutrophil chemotaxis, U 111.4 ±  0.9 109.2 +  3.0 NS
Neutrophil phagocytosis, 
% at 5 min 45 .8  ± 2 .2 40.5 +  2.9 NS
Bacterial killing, 
% at 10 min 40.2 ± 3 .1 32.8 +  3.0 NS
Total proteins, g/L 62 ± 1 60 +  1 NS
Serum albumin, g/L 35 ± 1 32 +  1 <  0.05
Hemoglobin, g/L 125 ±  1 118 +  17 <  0.05
Polymorphonuclear 
neutrophils, X 109/L 8.92 ± 0 .2 5 10.32 +  0.77 <  0.001
Lymphocytes, X 109/L 1.71 ± 0 .0 8 1.53 +  0.30 NS
Mononcytes, X 109/L 0.50 ± 0 .0 3 0.61 + 0 .1 4 NS
a -1-globulin, g/L 3.8 ± 0 .1 3 . 9 +  0.1 NS
a-2-globulin, g/L 7.5 ± 0 .2 5 . 8 +  0.2 NS
R-2-globulin, g/L 8.6 ± 0 .1 7 . 0 +  0.1 NS
y-globulin, g/L 11.7 ± 0 .1 14.4 +  0.1 NS
IgG, g/L 8.91 ± 0 .5 3 9.54 +  2.21 NS
IgA, g/L 2.50 ± 0 .1 9 2.20 +  0.40 NS
IgM, g/L 1.03 ± 0 .0 9 0.93 +  0.23 NS
C3, g/L 1.34 ± 0 .0 6 1.00 +  0.10 <  0.05
Total hemolytic complement 
(CH50I, units/mL 183.7 ±  10.3 143.5 +  17.6 NS
NS ■= not significant.
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ber in nonreactive than in reactive 
patients (Table XII). The therapeutic use 
of antibiotics reflected this overall minor 
sepsis rate. The anergic group required a 
second course of antibiotics in 39% of 
patients compared with 12% in the reac­
tive group. Three or more courses were 
required in 25% of anergic patients com­
pared with only 5% of reactive patients. 
The duration of either the first, second 
or third antibiotic course did not differ 
in the three groups (average 9.9 ± 0 . 5  
days). There was an equal distribution of 
abscesses, bacteremia, or both, among the 
episodes of sepsis in the three patient 
groups. The infecting organisms are iden­
tified in Table XIII. There was no 
predominance of virulent organisms in 
the anergic group, compared with the 
reactive group, that might lead to a worse 
outcome. The number of episodes of 
major sepsis within each patient group 
was also equal.
Discussion
This paper clearly demonstrates the
strong association between a decrease in 
the delayed hypersensitivity skin-test 
response, sepsis and death. Since 80% of 
the deaths were related to sepsis, a 
diminished DTH response strongly sug­
gests a failure of host-defence mechan­
isms and a concurrent inability to control 
life-threatening sepsis. This observation 
was made in an unselected population of 
surgical patients stratified by the first 
skin-test response on entry to the study. 
The same observation was also made in 
patients preoperatively, w hether 
unselected to include those with major 
sepsis as the need for the surgery, or 
limited to a strictly elective group. With 
the elective group, the DTH response 
actually shows a truly predictive value in 
that, if suppressed, it identifies a sub­
group of patients who run double the risk 
of major life-threatening sepsis and a six 
times greater risk of dying postoperatively 
than do those who have normal DTH 
responses.
Others have confirmed the association 
between sepsis and anergy. Johnson and
Table Xl-Host Immunocompetence of A 
Major Sepsis (N -
Test Nonseptic
Age, yr 58.6 ± 0 .5
DTH score, mm 26.6 ± 0 .5
Neutrophil adherence, % 75.9 ± 0 .5
Neutrophil chemotaxis, U 112.7 ±  0.9
Neutrophil phagocytosis, 
% at 5 min 37.2 ± 2 .5
Bacterial killing, 
% at 10 min 36.9 ± 2 .4
Total proteins, g/L 60 ± 1
Serum albumin, g/L 34 ±  1
Hemoglobin, g/L 126 ±  1
Leukocytes, X 109/L 9.41 ± 0 .1 7
Polymorphonuclear 
neutrophils, X 109/L 6.78 ± 0 .3 5
Lymphocytes, X 109/L 1.53 ± 0 .0 6
Mononcytes, X 109|L U.bb ±  0.03
a-1 -globulin, g/L 4.0 ± 0 .1
a-2-globulin, g/L 6.9 ± 0 .2
B 2 globulin, g/L /.9  ±  0.1
y-globulin, g/L 10.4 ± 0 .3
IgG, g/L / . / l  ±  0.33
IgA, g/L 2.06 ± 0 .1 2
IgM, g/L 1.04 +  0.07
C3, g/L 1.23 +  0.05
Total hemolytic complement 
(CH50), U/mL 173.6 ± 7 .2
2202 )
Septic
7 9 J h ± 0 .8
12.9 ± 0 .9
78.4 ± 1.1  
107.2 ± 1.1
42.4 ± 4 .5
38.2 ± 6 .5  
55 ± 1  
29 ± 1  
115 ±  12 
11.79 ± 0 .4 2
8.85 ± 0 .0 6  
1.34 ± 0 .1 6  
0.63 ± 0 .1 2  
3.9 ± 0 .1  
6.7 ± 0 .2  
6.6 ± 0.1 
13.7 ± 6 .7  
9.70 ± 1 .1 5  
2.67 ± 0 .2 7  
1.11 ± 0 .1 8  
1.15 ± 0 .0 8
158.9 ± 1 8 .9
p value 
NS
< 0.001
<  0.05
<  0.05
NS
NS
< 0.001 
< 0.001
<  0.05
<  0.001
< 0.05  
NS 
NS 
NS 
NS
<  0.05
< 0.001 
< 0.001 
< 0.001
NS
NS
NS
NS -  not significant.
Table XII—Rates (%) of Major and Minor Sepsis and Use of Antibiotics
Antibiotic Use
Skin-test
response
Reactive (n -  1373) 
Relatively anergic (n = 306) 
Anergic (n = 523)
* p <  0.0001.
t p <  0.001.
Major Minor Thera­
sepsis* sepsist peutic Prophylactic
8 ” 26 26 27
21 46 47 29
33 61 59 28
associates7 skin tested 197 patients and 
found a sepsis rate of 8% and a mortal­
ity of 2% in reactive patients, in contrast 
to a 30% sepsis rate and 16% mortality 
in anergic patients. Griffith and Ross21 
in a preoperative study of 50 patients 
scheduled to undergo colonic surgery, 
found a sepsis rate of 9% in reactive 
patients, compared with 28% in anergic 
patients. Associations between DTH and 
sepsis were found by Tasseau and associ­
ates,9 Mullen and colleagues,10 Morath 
and colleagues,11 Harvey and associ­
ates,12 Casey’s group,13 and Kienlen and 
colleagues.14
Brown and associates15 skin tested 244 
patients preoperatively and identified 70 
(29%) who had depressed DTH 
responses. The rates of major sepsis were 
9.2%, 6.2% and 10.5% respectively for 
the reactive, relatively anergic and aner­
gic groups (x2 = 0.41, p = 0.81), and 
the corresponding mortalities were 6.4%, 
12.5% and 15.8% (x2 = 4.2, p = 0.12). 
There was a trend towards higher rates 
of sepsis and death in the groups with 
suppressed reactivity but statistical sig­
nificance was not reached. They con­
cluded that the DTH response has no 
predictive value and that it is not 
associated with increased risk of surgical 
sepsis. A beta error due to the small sam­
ple size was not ruled out, however. In 
a subsequent publication, Brown and 
associates22 did demonstrate a signifi­
cantly higher rate of sepsis and death in
FIG. 1—Sepsis regression curve fit. Delayed 
type hypersensitivity (DTH) score (mm) and 
sepsis rate in 2202 surgical patients assessed by 
DTH response on entry into study.
FIG. 2—Death regression curve fit. DTH 
score (mm) and mortality in 2202 surgical 
patients assessed by DTH response on entry 
into study.
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patients who were anergic throughout 
their hospital stay — a sepsis rate of 57170 
and mortality of 35% compared with 
16% and 0% for those who were reactive 
throughout the hospitalization.
A n exam ination of additional 
parameters of host-defence mechanisms 
in this study demonstrated alterations in 
phagocytic cell function, serum 
immunoglobulin and albumin levels and 
circulating blood counts, including 
hemoglobin levels, in all patients when 
compared with control subjects. Close 
examination of these data showed that the 
alterations are not unique in anergic 
pa tien ts ; ra ther, they are more 
pronounced in those with skin-test 
anergy. The clear variation in all aspects 
of host resistance examined in this study 
is seen when the three patient groups are 
compared with the control subjects. The 
examination of variables that are abnor­
mal in patients with sepsis as opposed to 
those without, or those who died as 
opposed to those who survived, showed 
that several variables can contribute to the 
adverse outcome. All such variables need 
to be used in a future probit or multivar­
iate type analysis to define better those 
with abnormal host defence.
The DTH score can be useful in assess­
ing host defence. This approach treats 
sepsis risk as a continuum that can be 
represented by the sum mean diameter 
DTH response in the form of a DTH 
score in millimetres. This differs from the 
representation of DTH results as the three 
fixed stepped measurements of reactivity, 
relative anergy and anergy. The validity 
of representing the assessment of sepsis 
risk by the DTH response as a continuum 
is borne out by the very close correlation 
between the decreases in the DTH score 
and the risk of major sepsis or death 
(Figs. 1 and 2). Furthermore, this relation 
is not linear, but worse, exponential, 
indicating that as host resistance decreases 
(decreased DTH score), the risk of sepsis 
increases exponentially.
The data pose the following questions: 
Why does a component of host defence, 
classically thought to represent a failure 
of the cell-mediated arm, predict the func­
tion of the phagocytic arm of host 
defence and, more so, the overall risk of 
bacterial sepsis? Classic theory would 
have viral, parasitic and fungal infections 
developing in anergic patients. What does 
a failed DTH response really indicate in 
these surgical patients? Is it a failure of 
classic cell-mediated immunity or is there 
a combined failure of cell-mediated 
immune function and nonspecific inflam­
matory response?
In vivo, all components of host defence 
interact precisely during eradication of 
invading pathogens. The events leading 
to induration in the DTH reaction are 
very similar, although the timing of the
events differs from that involved in the 
localization of a bacterial infectious 
process. In both reactions the foreign 
antigen or bacterium must be recognized. 
In the DTH reaction this recognition leads 
to lymphokine release and chemoattrac- 
tion of primarily nonsensitized lympho­
cytes, macrophages and in most cases 
PMNs (especially at 6 hours after injec­
tion).23 All these cells process and 
dispose of the antigen. In the bacterial 
inflammatory defence reaction the same 
must occur; the invading pathogens set 
off the local chemoattraction releasing 
mechanisms that lead to the initial 
chemoattraction of PMNs, which phago- 
cytose and kill the invading bacteria. The 
subsequent influx of the macrophages 
aids in this process.
The presented data and above process 
suggest the following hypothesis: the 
depressed delayed hypersensitivity skin- 
test response measured in these surgical 
patients indicates a transient, acquired, 
immunodeficiency in which there is 
failure of the immune system at various 
levels. Such failure could involve specific 
cell-mediated immune function or non­
specific inflammation, or both. This leads 
to decreased mobilization of sufficient 
phagocytes to an area of bacterial inva­
sion. The decisive period for establishing 
or eradicating an infection is the first 
2 hours following bacterial invasion.24 
The weakened inflammatory response 
mounted by these patients facilitates the
establishment of the initial infection. The 
infection, which is itself immunosuppres­
sive, creates a vicious circle. If the 
invaders break through these “ first-line” 
defences, then a local infection is estab­
lished, usually in the form of an abscess. 
This abscess must be contained or the 
infection will spread by local extension or 
by the blood. At this level of infection 
control, other failures of host resistance, 
indicated by suppressed DTH response, 
could include depressed antibody synthe­
sis,25 decreased complement levels and 
abnormal function of the reticuloen­
dothelial system. Other cellular functions 
not clearly understood, such as the regula­
tory control of the macrophage-T- 
lymphocyte system, may also be involved.
Separation and understanding of the 
various components of the immune 
response are required to assess the con­
tribution that failure of each of the 
individual components makes to the over­
all function of host defence (i.e., control 
of invasive sepsis). Only then can proper 
treatment be developed to improve host- 
defence function and reduce surgical sep­
sis and the accompanying morbidity and 
mortality.
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Table XII I -  Infecting Organisms Identified in Patients 
With Major Sepsis
Organism
Reactive 
no. (%)
Relatively anergic, 
no. (%)
Anergic, 
no. (%)
Acinetobacter sp 0 0 1 (0 .6 )
Bacteroides sp 1 2 ( 1 0 . 6 ) 4 ( 6 . 2 ) 1 0 ( 5 . 7 )
Bacteroides fragilis 3 ( 2 . 7 ) 4  (6 .2 ) 1 3 ( 7 . 4 )
Candida albicans 0 0 3 ( 1 . 7 )
Corynebacterium sp 3 ( 2 . 7 ) 2 ( 3 . 1 ) 5 ( 2 . 9 )
Diplococcus pneumoniae 0 0 1 (0 .6 )
Escherichia coli 2 7 ( 2 3 . 9 ) 11 (1 6 .9 ) 2 8 ( 1 6 . 0 )
Enterobacter sp 2 ( 1 . 8 ) 0 5 ( 2 . 9 )
Enterococcus sp 7 ( 6 . 2 ) 4 ( 6 . 2 ) 8 ( 4 . 6 )
Fusobacterium sp 1 (0 .9 ) 1 (1 .5 ) 1 (0 .6 )
Klebsiella sp 5 (4 .4 ) 1 (1 .5 ) 1 (0 .6 )
Klebsiella oxytoca 0 1 (1 .5 ) 2 ( 1 . 1 )
Klebsiella pneumoniae 1 (0 .9 ) 0 1 (0 .6 )
Lactobacillus sp 0 0 1 (0 .6 )
Micrococcus sp 0 0 1 (0 .6 )
Peptococcus sp 0 1 (1 .5 ) 2 ( 1 . 1 )
Proteus mirabdis 3 ( 2 . 7 ) 2 ( 3 . 1 ) 2 ( 1 . 1 )
Pseudomonas sp 2 ( 1 . 8 ) 1 (1 .5 ) 6 ( 3 . 4 )
Pseudomonas aeruginosa 0 0 1 (0 .6 )
Pseudomonas ftuorescens 0 1 (1 .5 ) 1 (0 .6 )
Pseudomonas maltophilia 0 1 (1 .5 ) 1 (0 .6 )Serratia sp 1 (0 .9 ) 0 4 ( 2 . 3 )
Staphylococcus aureus 7 ( 6 . 2 ) 5 (7 .7 ) 17  (9 .7 )
Staphylococcus epidermidis 1 8 ( 1 5 . 9 ) 1 8 ( 2 7 . 7 1 31 (1 7 .7 )
Miscellaneous 21 (1 8 .6 ) 8 ( 1 2 . 3 ) 2 9 ( 1 6 . 6 )
Single organism, % 6 4 6 8 6 7
2 +  organisms, % 33 31 2 9
3 +  organisms, % 11 11 11
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ADMINISTRATION
Intramuscular:
CEFOBID (cefoperazone sodium) should be administered by deep intramuscular injection into a large 
muscle mass such as the gluteus maximus or anterior thigh. The maximum dose of CEFOBID 
(cefoperazone sodium) should be two (2) grams.
Intravenous:
Direct Intravenous (bolus) Injection: The reconstituted solution should be injected slowly over a 
period of no less than three (3) minutes. The maximum dose of CEFOBID (cefoperazone sodium) 
should be two (2) grams.
Intermittent Intravenous Infusion The reconstituted solution may be infused over a period of 15 
minutes to 1 hour through the tubing of an administration set while any of the intravenous solutions 
(See Solutions for I.V. Infusion) are being infused. During infusion of the solution containing 
CEFOBID (cefoperazone sodium), it is desirable to temporarily discontinue administration of the other 
solution.
Continuous Intravenous Infusion: CEFOBID (cefoperazone sodium) may also be administered over a 
longer period of time.
Note: If therapy with CEFOBID (cefoperazone sodium) is carried out in combination with an 
aminoglycoside antibiotic, each should be administered at different sites because of a physical in­
compatibility. An aminoglycoside should not be mixed with CEFOBID (cefoperazone sodium) in the 
same container.
PHARMACEUTICAL INFORMATION
CHEMISTRY
Trade Name: CEFOBID
Proper Name: Cefoperazone sodium
Chemical Name:
Sodium (6R,7R)-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl) 
acetamidoj-3 f((1 -methyl-1 H-tetrazol-5-yl)thio]methyll-8-oxo-5-thia-1-azabicyclo[4.2.0] 
oct-2-ene-2-caiboxylate
C2H -N  IN-CONHCHCONH-i— [^ Svs1 N— N
<H> ( b  0^ V CH’SV “
S r  COONa i
Molecular Formula: C25H26Ng08S2Na Molecular Weight: 667.65 
Description:
Cefoperazone sodium is a white powder, soluble in water, sparingly soluble in methanol, poorly soluble 
in ethanol, and insoluble in ethyl ether, acetone, chloroform, or n-hexane.
Composition:
CEFOBID vials contain cefoperazone sodium (expressed in terms of free acid). The sodium content of 
each gram of CEFOBID is approximately 34 mg (1.5 mEq sodium ion). The pH of a 25% (w /v ) solution 
is 4.5 to 6.5 and the solution is colorless to straw yellow depending on the concentration.
RECONSTITUTION 
For Intramuscular Use:
Solution for Reconstitution
Sterile Water for Injection 
or, if required
Bacteriostatic Water for Injection
0.5% Lidocaine Hydrochloride Injection 
Reconstitute as follows:
Volume to be Approximate Approximate
Vial Size Added to Vial Available Average Concentration
(g) (mL) Volume (mL) (mg/mL)
1.0 3.5 4.0 250
2.0 7.0 8.0 250
Shake well until dissolved. Solutions should be allowed to stand after reconstitution to allow any foam­
ing to dissipate in order to permit visual inspection for complete solubilization. Vigorous and prolonged
agitation may be necessary to solubilize CEFOBID (cefoperazone sodium).
For Intravenous Use:
Solutions for Reconstitution and Dilution
Sterile Water for Injection
or, if required
Bacteriostatic Water for Injection 
Reconstitute as follows:
Volume to be Approximate Approximate
Vial Size Added to Vial Available Average Concentration
(g) (mL) Volume (mL) (m g/m l)
1 9.5 10.0 100
2 19.0 20.0 100
Shake well until dissolved. The prepared solution may be further diluted to the desired volume with any 
of the solutions for I.V. infusion listed below.
For direct intravenous (bolus) injection: Reconstitute as directed above 
For intermittent intravenous infusion: Reconstitute as directed above
For continuous intravenous infusion: Reconstitute with Sterile Water for Injection. The-reconstituted 
solution may be added to an appropriate intravenous bottle/bag containing any of the solutions for I.V. 
infusion listed below:
Solution for I.V. Infusion 
5% Dextrose Injection (USP)
5% Dextrose and Lactated Ringer’s Injection 
5% Dextrose and 0.9% Sodium 
Chloride Injection (USP)
5%Dextrose and 0.2% Sodium 
Chloride Injection (USP)
Stability of Solutions 
Storage:
Reconstituted solutions for intramuscular injection should be used within 24 hours if kept at room 
temperature, or 72 hours if stored under refrigeration (5°C).
Reconstituted solutions for I.V. injection or infusion should be used within 24 hours if kept at room 
temperature, or 72 hours if stored under refrigeration (5°C).
Incompatibility
CEFOBID (cefoperazone sodium) should not be added to blood products, protein hydrolyzates, or amino 
acids. CEFOBID (cefoperazone sodium) should not be mixed together with an aminoglycoside. 
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Electron Microscopic Study of an Infected Foley Catheter
A scanning and transmission electron 
microscopic study was made of material 
from the surface of a Foley catheter 
removed from an 87-year-old woman 
with antibiotic-resistant bacteriuria. A 
thick, adherent bacterial biofilm was 
found. The sessile adherent bacteria 
were surrounded by an extensive 
exopolysaccharide glycocalyx that 
appears to be fundamental in the patho­
genesis of catheter-associated urinary 
tract infections and their resistance to 
systemic antibiotic therapy.
Un examen minutieux et une etude 
microscopique electronique en transmis­
sion d'un catheter Foley enleve d'une 
femme de 87 ans avec une infection 
resistante aux antibiotiques de I'appareil 
urinaire ont demontre un epais biofilm 
bacteriel adherent aux surfaces du cathe­
ter. Ces bacteries adherentes, attachees 
a la base, etaient entourees d'un consi­
derable glycocaiice exopolysaccharide 
qui semble etre fondamental dans la 
pathogenese des infections de I'appareil 
urinaire reliees au catheter et leur resis­
tance a la therapie antibiotique syste- 
mique.
Catheterization of the urinary tract re­
mains the most common cause of 
nosocomial infection in medical prac­
tice.1,2 Despite extensive research over 
the past 20 years on the pathogenesis, 
prophylaxis and treatment of catheter- 
induced urinary tract infections, bacteri­
uria associated with substantial morbidi­
ty and m ortality  will eventually 
develop2,3 in the majority of patients 
with long-term catheterization.4 Once 
the bacteriuria develops, systemically ad­
ministered antibiotics usually fail to eradi­
cate the infection or, if the infection is 
presumably cured, the bacteriuria quick-
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ly recurs after treatm ent ends.1,5'9 
Although this concept is generally accept­
ed, the reason why catheter-induced uri­
nary tract infection persists in the 
presence of bactericidal levels of antibi­
otics is unclear.
Using electron microscopic techniques 
that are presently changing fundamental 
bacteriologic concepts in environmental 
and industrial microbial ecology, we 
studied a case of catheter-associated Pseu­
domonas aeruginosa bacteriuria. The 
study of the extensive colonization of the 
catheter surface illuminates the etiology 
of catheter-induced infections and partic­
ularly their relative insensitivity to system­
ically administered antibiotics.
Case Report
An 87-year-old woman was admitted to the 
orthopedic service with a hip fracture. Because 
of dribbling incontinence, a Foley catheter was 
inserted under sterile conditions after first 
washing the perineum and periurethral areas 
with povidone-iodine solution. A catheter 
specimen of urine was sterile. The fracture was 
stabilized and the woman did well; however, 
3 days postoperatively she complained of 
suprapubic discomfort and a urine culture rev­
ealed Pseudomonas aeruginosa bacteriuria 
(more than 10s bacteria/mL). She was given
a 5-day course of gentamicin, and her serum 
levels were monitored. Her symptoms resolved. 
Urine culture on the last day of treatment was 
sterile. One day later, the bacteriuria recurred. 
Gentamicin was given again and the catheter 
removed 2 days later. The antibiotic was 
changed to trimethoprim-sulfamethoxazole 
given orally. At the time of discharge her urine 
was sterile.
We then turned our attention to the electron 
microscopic features of the P. aeruginosa bac­
teriuria.
Material and Methods
The luminal surface of a small portion 
of the catheter, removed from the 
patient’s bladder 2 days after starting the 
second course of antibiotics, was scraped 
with a sterile scalpel blade to yield 
material for transmission electron 
microscopy and culture.
Scanning Electron Microscopy
The remaining Foley catheter was 
flushed with phosphate-buffered saline 
and placed in 5% glutaraldehyde in 
cacodylate buffer (0.1 M, pH 7.2) for 24 
hours at 20°C. The specimen was bisected 
and “ metallized” with osmium tetroxide 
and thiocarbohydrazide,10 dehydrated in
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FIG. 1—Scanning electron micrograph of luminal surface of Foley catheter. Note rod-shaped 
bacteria adhering to catheter surface. This micrograph shows rare area in which bacterial coloni­
zation was poorly developed and folded surface of catheter was still visible. Bar = 5.0 \xm.
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ethanol and Freon-113, before it was 
critical-point dried11 and examined, 
using a Hitachi 5450 scanning electron 
microscope.
Transmission Electron Microscopy
The material scraped from the catheter 
surface was fixed in 5% glutaraldehyde 
in cacodylate buffer (0.1 M, pH 7.2) with 
0.15% ruthenium red for 24 hours at 
20°C. The material was then washed five 
times in the buffer, postfixed in 2% 
osmium tetroxide in buffer, washed five
more times in the buffer and dehydrated 
through a series of acetone washes. All 
of the solutions used in processing the 
specimen, from the washes after 
glutaraldehyde fixation to dehydration 
with the 70% acetone solution, contained 
0.05% ruthenium red.
After further dehydration in propylene 
oxide, the specimen was embedded in 
Spurr12 low-viscosity embedding resin, 
sectioned, stained with uranyl acetate and 
lead citrate13 reinforced with evaporated 
carbon, and examined with a Hitachi 600 
transmission electron microscope at an 
acceleration voltage of 60 kV.
Results
Culture of the material scraped from 
the catheter surface yielded P. aerugi­
nosa that was sensitive to 1.0 jig/mL 
gentamicin on in-vitro testing.
Scanning electron photomicrographs of 
representative surfaces of the Foley 
catheter showed a colonizing bacterial 
population on the external and internal 
surfaces of the catheter, presenting as an 
adherent biofilm. The luminal surface of 
the catheter contained a relatively thin 
biofilm (Fig. 1), but most of the external 
(both intraurethral and intravesical) sur­
face (Fig. 2) was completely covered by 
a thick biofilm containing bacteria and 
intercellular amorphous residue. The 
biofilm was at least 50 cells and 250 g.m 
thick. Within these biofilms were conden­
sations and amorphous masses that prob­
ably represented exopolysaccharide 
glycocaliceal material that had condensed 
during the dehydration process.
Transmission electron micrographs of 
the material scraped from the surface of 
the catheter (Fig. 3) demonstrated 
extracellular condensed electron-dense 
fibrous strands. The distribution of this 
condensed exopolysaccharide glycocaliceal 
material suggested that in its hydrated 
state, it occupied all the intercellular space 
within the thick bacterial biofilm and con­
stituted its functional matrix.
Discussion
The risk of bacteriuria has been 
reduced from 95% within 4 days of 
catheterization with an open-drainage 
system14 to about 5% to 10% for each 
day of catheterization with the introduc­
tion of the closed system.7,15 However, 
urinary catheter-associated infection with 
its relative insensitivity to systemic antibi­
otics remains a major clinical problem1,4 
and bacteriuria will develop in almost 
100% of patients if the catheter remains 
in place for more than 30 days.3 Sys­
temic antibiotic therapy has been used to 
reduce the morbidity and mortality 
associated with catheter-induced bacteri­
uria but usually fails to eradicate the 
infection or causes substitution by a more 
resistant organism.7'9
Quantitative studies of a wide variety 
of natural ecosystems16 have established 
that more than 99.9% of bacteria within 
these systems live in glycocalyx-enclosed 
microcolonies within biofilm adherent to 
inert surfaces. In the ecology of streams 
the “ planktonic” or floating bacteria are 
an inaccurate reflection of the “ sessile” 
bacterial population adherent to the 
stream cobble.17 In industrial systems the 
importance and clear predominance of 
these sessile, adherent, biofilm-producing 
bacteria and their inherent resistance to 
chemical biocides has recently been recog-
FIG. 2—Scanning electron micrograph of highly colonized area of external surface of 
catheter. Bacterial biofilm at least 50 cells thick has fully covered catheter surface. Glycocalyx 
has been reduced by dehydration to accretions on cell surfaces and to sheets of amorphous material 
connecting adjacent cells (arrows). Bar = 5.0 nm.
FIG. 3—Transmission electron micrograph of ruthenium-red-stained preparation of biofilm 
material scraped from lumen of colonized Foley catheter. There is extensive reticulum of electron- 
dense condensed fibres (arrows) throughout intercellular spaces that is residuum of extensive 
glycoealyces of these cells, following 99% condensation by dehydration in preparation for elec­
tron microscopy. Large dense body in lower central portion is cross-section of P. aeruginosa 
bacterium. Bar = 0.1 (im.
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nized and documented. 18 This phenome­
non of bacterial growth has recently been 
reported with infected pacemakers, 19 
intrauterine devices , 20 intravenous 
catheters,21 peritoneal dialysis catheters22 
and biomaterials-related osteomyelitis.23
In this study we found similar bacterial 
biofilms on the urinary catheter taken 
from a woman with a P. aeruginosa bac- 
teriuria. The thick biofilm on the surface 
of the catheter served as a protected reser­
voir of organisms that persisted in spite 
of antibiotic therapy. The presence o f an 
extensive anionic matrix surrounding a 
bacterial cell in industrial systems appears 
to constitute an ion-exchange barrier 
between charged antibiotic molecules and 
their cellular targets.24 It is clear that 
antibiotic sensitivity testing, using labora­
tory cultures, in the absence of bacterial 
polysaccharide would not be helpful in 
predicting the efficacy of antibiotics in the 
treatment o f catheter-associated infec­
tions.25 Similarly, standard microbio- 
logic techniques that characterize and 
quantitate the planktonic bacteria in the 
urine do not reflect the sessile microbial 
ecology of the catheter surface and pos­
sibly of the bladder mucosa.
In our patient, in the absence of a 
precatheterization urinary infection and 
no break in sterile technique of the closed 
system, we can assume the bacteriuria was 
acquired via the Foley catheter. A con­
troversy of great clinical importance is 
whether the route of ascending infection 
is retrograde colonization from the col­
lection bag1-26 or transurethral around 
the Foley catheter. 27-30 It may be that 
either route is important in different clin­
ical situations. The invasion of organisms 
along the catheter (whether intra- or 
extraluminal) is likely accomplished by 
upstream colonization of the catheter sur­
face by adherent bacterial biofilms. The 
biofilm was thicker on the outer surface 
o f the catheter, suggesting that this sur­
face was more important in the pathogen­
esis o f bacterial entry. This may not indi­
cate the mode of entry into the urinary 
tract, but rather the different flow charac­
teristics of the two surfaces.
We have been sufficiently encouraged 
by this pilot study to research further into 
the mode of growth of this biofilm on uri­
nary catheters and to substantiate these 
observations with a prospective clinical 
trial and in-vitro studies. Ultimately, the 
most effective way of delaying or prevent­
ing infection of the catheterized urinary 
tract would be to control bacterial adher- 
ance to the catheter or to disrupt the bac­
terial glycocalyx to allow penetration of 
antibiotics.
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Mediastinal Packing for Refractory Nonsurgical Bleeding
After Open-Heart Surgery
Patients with infective endocarditis and 
disseminated intravascular coagulation 
may require emergency valve replace­
ment because of acute hemodynamic 
decompensation. After cardiopulmonary 
bypass is discontinued, nonsurgical 
hemorrhage, refractory to conventional 
treatment, may occur. The author 
describes a technique of mediastinal 
packing for temporary control of bleeding 
until the coagulation disorder can be cor­
rected. The pack can be removed trans- 
cutaneously without reoperation. This 
method should be used only when all 
other approaches have failed to achieve 
hemostasis.
Les patients qui souffrent d'endocar- 
dite infectieuse et de coagulation intra- 
vasculaire disseminee peuvent necessiter 
d'urgence un remplacement valvulaire a 
cause d'une brusque decompensation 
hemodynamique. Apr§s Tinterruption de 
la circulation extracorporelle, une hemor- 
ragie non chirurgicale refractaire au trai- 
tement conventionnelle peut survenir. 
L'auteur decrit une technique de tampon- 
nement du mediastin permettant d'arre- 
ter temporairement I'hemorragie jusqu'S 
ce que les troubles de coagulation soient 
corriges. Le tampon peut etre retire par 
voie transcutanee sans operation. Cette 
methode ne devrait etre utilisee que 
devant I'dchec de toutes les autres 
methodes d'obtention de I'hemostase.
Disseminated intravascular coagulation 
is rarely encountered during cardio­
pulmonary bypass.1 But when infectious 
endocarditis induces secondary dissemi­
nated intravascular coagulation, hemosta­
sis may fail. In the event of sudden hemo­
dynamic deterioration (i.e., prosthetic 
aortic insufficiency), emergency valve
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replacement is the treatment of choice. 
When cardiopulmonary bypass is termi­
nated, the administration of protamine 
sulfate and replacement of clotting fac­
tors and platelets may not be sufficient 
to restore effective coagulation. Hemo­
static substances, including denatured 
animal skin gelatin (Gelfoam; the Upjohn 
Company of Canada, Don Mills, Ont.), 
cellulose compounds (Surgicel; Johnson 
& Johnson Inc., Montreal, PQ) and 
microfibrillar collagen (Avitene; Alcon 
Surgical, Fort Worth, Tex.), may also not 
be able to contain such low-pressure 
bleeding. In these circumstances, the 
patient will die unless the capillary bleed­
ing is stopped. I describe a technique that 
has successfully controlled this problem 
in two patients in whom all the above 
methods had failed.
Technique
After cardiopulmonary bypass is dis­
continued, blood continues to accumulate 
in the pericardial sac. Cardiotomy suction
FIG. 1—Placement of gauze packing 
cephalad to aortic valve. Insert shows direc­
tion to follow. End of gauze strip secured with 
skin stitch and safety pin.
is used to return the blood to the oxygen­
ator. Blood is replaced volume for 
volume by means of the aortic cannula 
still in place. Once the surgeon is sure that 
there is no active bleeding from the oper­
ation, protamine sulfate is administered 
to neutralize the effect of the circulating 
heparin. The perfusion cannulas are 
removed. If bleeding persists due to dis­
seminated intravascular coagulation, 
fresh frozen plasma, cryoprecipitate and 
platelets should be used in sufficient 
quantities to restore clotting. If this is 
insufficient, hemostatic materials should 
be tried, but they may also prove ineffec­
tive. Most of the bleeding occurs from the 
level of the aortic valve cephalad because 
this is the area where most dissection has 
been done, particularly in patients who 
undergo reoperation. It is crucial to be 
sure that the bleeding is not due to an 
anastomotic leak, otherwise bleeding will 
recur when the packing is removed. With 
2.5-cm gauze strip, the packing is started 
in this area. The gauze is placed in an 
ordinate fashion, back and forth, start-
FIG. 2—Location of gauze ends in relation 
to median sternotomy. Diffuse edema due to 
sepsis and capillary leak are also seen in this 
patient with Candida endocarditis.
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ing from the left side, laying each row 
cephalad to the previous one (Fig. 1). This 
maneuver has to be done expeditiously 
and pressure should be applied simultane­
ously with the other hand to minimize 
blood loss. The packing is continued until 
the level of the suprasternal notch is 
reached. The gauze is brought under the 
sternum on the left side and through the 
corresponding intercostal space and skin 
(Fig. 2). Two mediastinal tubes are placed 
below the packed area for drainage (Fig. 
1). The chest is closed in the usual man­
ner . Since the right ventricle and atrium 
are not packed, tamponade does not 
occur. The patient is transferred to the 
intensive care unit and kept on a volume 
ventilator with 10 cm of positive end- 
expiratory pressure to add pressure in the 
area through the mediastinal pleura. 
Preload is brought to as good a level as 
possible to prevent hypotension. Aggres­
sive therapy to control the disseminated 
intravascular coagulation and sepsis is 
continued. Chest drainage is carefully 
monitored. Screening tests for dissemi­
nated intravascular coagulation are 
repeated as needed and as soon as the 
results are normal the packing is pulled 
slowly through the skin incision; this is
usually achieved in less than 24 hours. 
The mediastinal tubes are kept in place 
for another 24 hours.
Patients and Results
I have used this technique on two 
patients. Both presented with acute 
hemodynamic changes and severe cardi­
ogenic shock due to prosthetic aortic 
valve infections. Both patients had severe 
aortic insufficiency and secondary dis­
seminated intravascular coagulation. Pro­
fuse low-pressure bleeding could not be 
controlled after cardiopulmonary bypass 
had been discontinued by any method. 
Mediastinal packing was used as a last 
resort in the described fashion. In both 
cases bleeding stopped within 24 hours. 
In one patient laboratory values returned 
to normal and in the second, who had 
Candida endocarditis, the prothrombin 
time and partial thromboplastin time 
remained slightly elevated. In both 
patients the packing was successfully 
removed through the skin incision the 
next morning. If this is delayed longer, 
the vascular structures may be eroded. In 
neither case was reoperation necessary. 
One patient with bacterial endocarditis of
the aortic valve is alive and well 2.5 years 
later and the second patient with 
prosthetic candidiasis of the aortic valve 
died 1.5 years later of recurrent infection.
Comment
The technique of mediastinal packing 
is easy to apply and the materials are 
readily available in the operating room. 
It is not meant to replace careful opera­
tive technique, control of all surgical 
bleeding and appropriate therapy for dis­
seminated intravascular coagulation. 
Whenever possible, control of infection, 
pharmacologic support and correction of 
coagulation disorders should precede 
operation. This technique should be used 
only as a last resort for uncontrollable 
capillary bleeding.
I wish to express my appreciation to Miss 
Patti Snarr for her assistance in preparing this 
manuscript.
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Experimental Low Colorectal Anastomosis
The authors evaluated a side-to-end 
colorectal anastomosis carried out by the 
abdominoperineal approach, in which 
opening of the mucosal layer of the 
colon, and therefore the lumen, is 
delayed for 4 days. This technique was 
compared to transabdominal end-to-end 
anastomosis performed as low as possi­
ble, using the circular stapler and hand­
sewing with a one-layer technique.
Experimental end-to-end stapled and 
hand-sewn anastomoses were performed 
randomly in 24 female mongrel dogs.
The operating time was similar for each 
group. Anastomoses were examined for 
leaks at 7 to 10 days digitally and by 
roentgenography after barium enema. At 
sacrifice 14 days after anastomosis, 
measurements were made of bursting 
strength and the distance of 
anastomoses from the anus. The degree 
of inflammation was evaluated histologi­
cally. There were three leaks in the 
hand-sewn anastomoses and none in the 
experimental end-to-end stapled 
anastomoses. The mean bursting 
strength was similar for all three tech­
niques. The mean distance from the 
anus was lowest for the experimental 
anastomoses. Inflammatory changes 
were least in the end-to-end stapled 
anastomoses. Two dogs in this group 
and one in the experimental group were 
incontinent postoperatively.
The experimental anastomosis com­
pares favourably to end-to-end stapled 
and hand-sewn anastomoses and may 
have some advantages for low anasto­
mosis in man.
Les auteurs ont lvalue une methode 
d'anastomose colorectale latero-terminale 
pratiquee par un abord abdomino-p^rineal
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ou I'ouverture de la couche muqueuse du 
colon et, par consequent, de la lumiere 
intestinale, est retardee de 4 jours. Cette 
technique a ete comparee a I'anasto- 
mose transabdominale bout-a-bout prati­
quee aussi bas que possible a I'aide 
d une agraffeuse circulate ou d'une 
technique de suture a la main en mono- 
couche.
Des anastomoses experimentales, ainsi 
que bout-a-bout h I'agraffe ou a la suture 
manuelle ont ete effectuees au hasard 
chez 24 chiens batards femelles. Les 
temps operatoires ont ete les memes 
dans chaque groupe. Les fuites anasto- 
motiques ont et6 recherchees apres 7 a 
10 jours par examen digital et lavement 
baryte. Au moment du sacrifice, 14 jours 
apres I'anastomose, on a mesure la force 
d'6clatement et la distance de I'anasto- 
mose a I’anus. Le degr6 de I'inflamma- 
tion a ete evalude histologiquement.
Trois fuites ont §te observees dans le 
groupe des anastomoses avec sutures 
manuelles et aucune dans les groupes 
des anastomoses experimentales et bout- 
a-bout par agraffeuse. La force d'eclate- 
ment moyenne etait la meme pour les 
trois techniques. La distance moyenne 
de I'anus etait plus faible dans le groupe 
des anastomoses experimentales. Les 
changements inflammatoires etaient 
moins considerables avec les anastomo­
ses bout-&-bout a I'agraffeuse. En posto- 
peratoire, deux chiens de ce groupe et 
un du groupe experimental etaient incon­
tinents.
L'anastomose experimental se com­
pare favorablement aux anastomoses 
bout-a-bout a I'agraffeuse ou a la suture 
manuelle et peut presenter certains avan- 
tages dans les cas d'anastomose basse 
chez I'homme.
The surgical management of malignant or 
inflammatory disease very low in the rec­
tum is a difficult, challenging problem. 
Primary resection and anastomosis with 
normal colon or ileum is desirable if it can 
be done safely and without incontinence. 
Unfortunately, the low rectal anastom o­
sis is associated with an appreciable inci­
dence o f anastomotic disruption and sub­
sequent sepsis. Goligher and associates1 
found a 69% incidence o f anastomotic 
disruption, as shown radiologically, with 
anastomosis in the very low rectum. Sys­
temic, local and technical factors have 
been found to influence the incidence of 
anastomotic dehiscence.2'4 Since the first 
two factors are usually beyond the con­
trol o f the surgeon, the choice o f  surgi­
cal technique is particularly important in 
avoiding anastomotic leaks.
Recently the end-to-end surgical 
stapling devices have gained popularity 
for joining colon to the low rectum. 
Proponents claim that it reduces operat­
ing time and achieves a secure and very 
low anastomosis. However, as clinical 
experience with the stapling device 
accumulates, it is apparent that stapled 
anastomoses are not problem-free. There 
are mechanical failures, difficulties with 
exposure, anastomotic stenosis and dehis­
cence.5,6
Because of the limitations o f all current 
techniques to treat disease in the very low 
rectum, there is still room to develop 
alternatives. We have studied an 
experimental colorectal anastomosis 
which (a) avoids stool contamination of 
the suture line for several days and (b) 
facilitates its performance less than 2 cm 
from the anal mucosa. The experimental 
anastomosis is compared to hand-sutured 
and stapled anastomoses in an animal 
experiment.
Material and Methods
Female m ongrel dogs, weighing 
between 7 and 15 kg, were given clear 
fluids only for 48 hours preoperatively, 
the bowel was prepared by giving castor 
oil. All procedures were done under 
general anesthesia using halothane and a 
midline abdominal incision. Each dog 
received antibiotics, intraoperatively and 
on postoperative days 1 and 3 (streptomy­
cin, 250 mg and procaine penicillin, 
200 000 units).
The animals were randomly assigned to 
receive one of three types o f  low anterior 
resection. In all procedures, an attempt 
was made to perform the anastomosis as
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low as possible. In group 1, the rectum 
was transected and anastomosed using a 
one-layer, inverted closure with inter­
rupted silk sutures. In group 2, an end- 
to-end anastomosis was performed using 
the EE A Autostapler (Auto Suture Co., 
Division of United States Surgical Corp., 
Norwalk, Conn.). Dogs in group 3 under­
went an experimental anastomosis. The 
rectum was fully mobilized from above 
and then transected through the dilated 
anus approximately 1 cm above the den­
tate line, keeping the dissection on the rec­
tal wall to avoid injury to the pelvic floor. 
The end o f the proximal colon was then 
closed in two layers. Next, a 2-cm inci­
sion was made through the serosa and 
muscular layers of the stump of proximal 
colon in the longitudinal axis, leaving the 
mucosa bulging but intact (Fig. 1). Six 3-0 
Prolene sutures were placed circumferen­
tially around the serosal cut, and these 
were passed to the perineum through the 
pelvis and out of the rectal stump. The 
proximal colon was then delivered to the 
rectal stump using pressure from above 
and gentle traction from below until the 
serosal cut was within the rectal cuff. The 
sutures were then secured to the anal 
mucosa circumferentially and left long to 
mark the anastomosis (Figs. 2 and 3). 
Alternatively the proximal colon was 
delivered into the rectal stump and 
anastomosing sutures, as described 
above, were placed by the perineal sur­
geon. At 5 to 7 days the mucosa was 
opened under general anesthesia and 
intestinal continuity was restored. In three 
of eight animals the anastomosis opened 
spontaneously between 3 and 5 days.
The operating time was recorded for 
each procedure. Postoperatively the 
animals were observed for evidence of 
anal incontinence. The presence of an 
anastomotic leak was determined between 
7 and 10 days by digital rectal examina­
tion and roentgenography after barium 
enema under light general anesthesia.
The bursting strength of the anasto­
moses was tested in vivo under general 
anesthesia, 14 days after operation. To do 
this, the anterior pelvis was removed 
exposing the rectum and anal canal. A 
pressure transducer and an infusion 
catheter were placed in the lumen of the 
colon. A purse-string suture was placed 
around the anus and 3 cm above the 
suture line. Saline was then infused at a 
constant rate with a Harvard pump and 
the bursting of the anastomosis measured 
using a linear chart recorder. After the 
bursting strength had been measured, the 
animal was sacrificed, the level of the 
anastomosis recorded and the specimen 
sent for histologic examination.
The anastomoses were done in random 
fashion until there were eight dogs in each 
treatment group. Six animals were 
excluded because of distemper, kennel
cough with pneumonia, death from the 
anesthetic or volvulus of the intestine.
Results
The operating time was similar in each 
group, varying between 100 and 220 
minutes. Anal continence was assessed 
from observations by the animal handlers 
and surgeons. No animals were totally 
incontinent but one dog in each group 
appeared to be partially incontinent. 
Many animals were initially incontinent 
but regained continence during the 2-week 
postoperative period.
Three of eight dogs with conventional 
hand-sutured anastomoses (group 1) had 
radiologic evidence of dehiscence and one 
of these animals was clinically ill. All dis­
ruptions were small and located posteri­
orly. There were no dehiscences in groups 
2 and 3.
The mean bursting strength was 
378 mm Hg in group 1, 380 mm Hg in 
group 2 and 449 mm Hg in group 3. The 
differences are not significant.
The mean distance of the anastomoses 
from the anal verge was 2.9 cm in group 
1, 1.9 cm in group 2 and 1.3 cm in group 
3. The level of the anastomosis in groups 
2 and 3 was significantly (p <  0.05, Stu­
dent’s /-test) lower than in group 1.
Histologic examination o f the excised 
anastomoses showed satisfactory healing 
in all three groups. The stapled anas­
tomoses had less microulceration and 
inflammation than the other two.
Discussion
Incontinence, sepsis, stenosis, techni­
cal difficulty and anastomotic leakage are 
major problems and have a greater fre­
quency in low rectal or anal anastomoses 
than in anastomoses above the peritoneal 
reflection.7,8 These problems have not all 
been solved by use of the EEA Autosta­
pler, so there is reason for more innova­
tion and experimental study.
Clinical studies of patients with ileoanal
FIG. 1—To avoid opening proximal colon, 
incision is through serosa and muscularis of 
proximal colon. This facilitates suture place­
ment and delayed opening into lumen 4 days 
later.
anastomoses suggest that continence 
depends on an adequate reservoir func­
tion and a length of muscular rectum of 
at least 5 cm.9 For coloanal anastomoses 
there is evidence that the remaining colon 
usually provides adequate reservoir func­
tion and that continence is possible with 
a much shorter rectal cuff (1 to 3 cm).10 
Thus, the latter procedure is applicable 
to patients with carcinomas of the rectum
FIG. 2—View through dilated anus. Sutures 
are passed through all layers of proximal colon 
and rectal cuff. Suture ends are cut long to 
facilitate opening mucosa of proximal colon 
at 4 days.
FIG. 3—Longitudinal section of proximal 
colon.
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as low as 5 cm from the pectinate line. 
In terms of survival, patients with low 
anterior resection for carcinoma fare as 
well as those having abdominoperineal 
resection.11’12 Recent studies questioning 
the necessity of resecting at least 5 cm dis­
tal to the carcinoma may justify anterior 
resection at 5 cm and lower.13 Our 
experimental study shows that satisfac­
tory anastomosis within 2 cm of the 
anus can be achieved with the EEA 
Autostapler and our experimental tech­
nique.
The experimental anastomosis evalu­
ated in this study has several potential 
advantages. A very low join can be 
achieved. In this study we chose to leave 
a small cuff of rectal mucosa to facilitate 
comparison with the other two tech­
niques. However, the join could just as 
easily have been made to anal mucosa in 
the form of a coloanal anastomosis. The 
technique of leaving the mucosa of the 
proximal colon unopened prevents fecal 
contamination of the anastomosis during 
the first few days of healing. Dunphy14 
and Hawley15 found that bacterial con­
tamination was one factor that increased 
local collagenase activity, which would 
decrease the bursting strength of an 
anastomosis at 3 days. Leaving the 
mucosa unopened until 5 days after the 
anastomosis did not delay healing or 
predispose the anastomosis to leakage. 
The experimental anastomosis had no 
leaks and a high bursting strength, and 
on histologic examination at the time of 
sacrifice showed mucosal continuity. Ste­
nosis was not observed but the follow-up 
was short as all animals were sacrificed 
before 14 days.
Technical imprecision due to poor 
exposure is hard to measure but is likely 
a major cause of poor results. The 
experimental anastomosis also has some 
technical advantages over current tech­
niques. By using the endoanal approach, 
sutures can be accurately positioned, 
avoiding the problem of operating deep 
in the pelvis, as is necessary with the con­
ventional hand-suturing technique. Since 
there is no need to dissect the rectal cuff, 
there is less likelihood of damage to the 
sphincter. Both the stapled and 
experimental anastomoses can be per­
formed at very low levels. With the 
stapling device, however, occasional 
failure of the purse-string to secure a com­
plete doughnut of rectal tissue leads to 
major technical problems especially with 
the very low anastomosis.
In our experiment there were no leaks 
with either the experimental or the stapled 
anastomoses. There were three leaks in 
eight of the conventional hand-sutured 
anastomoses and one of these was clini­
cally evident. Clinical studies of sutured 
anastomosis of the very low rectum indi­
cate that the dehiscence rate is substan­
tial.13 Although the stapled anastomosis 
may be as secure as the sutured anasto­
mosis,11'12 dehiscence is still a problem. 
Goligher and colleagues6 who used the 
Russian device, found no radiologic evi­
dence of dehiscence in 38 patients with 
intraperitoneal anastomoses but six leaks 
in 24 patients (25%) with extraperitoneal 
anastomoses. More recently, Heald and 
Leicester16 found a 20% incidence of 
clinically evident anastomotic leaks in 
patients with very low stapled rectal 
anastomoses.
Both the experimental technique and 
the stapled anastomosis could be per­
formed at a considerably lower level than 
the conventional hand-sutured anastomo­
sis. In clinical practice, there is little doubt 
that the stapling device facilitates a lower 
anastomosis, the limit being the surgeon’s 
ability to achieve adequate placement of 
the purse-string suture.
We found no difference in operating 
time when the stapler was used. There are 
several reasons for this. Although it takes 
seconds to fire the staples and complete 
the anastomosis, considerable time is 
spent preparing the colon, inserting the 
purse-string sutures, assembling and posi­
tioning the stapler and finally checking to 
see if the anastomosis is satisfactory. 
Also, when the device fails to achieve a 
satisfactory join, the second attempt is 
difficult and time-consuming. In this sit­
uation, use of the experimental anasto­
mosis by the endorectal approach might 
well be a better alternative to restapling 
or hand sewing from above.
In a retrospective study, Scher and 
associates17 compared the use of stapled 
and sutured anastomoses in colonic oper­
ations and found no significant differ­
ences in operating time, complication rate 
or length of hospital stay. Beart and 
Kelly,18 in a randomized prospective 
study, found that 8 minutes could be 
saved by using the stapler for rectal 
anastomoses, but they also noted an 
increased risk of intraoperative compli­
cations, including rectal tears and anasto­
motic defects.
The long-term complications of using 
staples are not known. Polglase and 
colleagues19 found failure of mucosal 
healing in stapled anastomoses at 6 
months in dogs. There are also reports of 
anastomotic strictures developing in sta­
pled anastomoses.6,8 Whether these will 
become important clinical problems 
remains to be seen.
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ZANTAC® INJECTION (ranitidine hydrochloride) 
PHARMACOLOGICAL CLASSIFICATION
Histamine H2-receptor antagonist
ACTION
Ranitidine is a selective antagonist of histamine at gastric H2-receptor sites. Thus 
ranitidine inhibits both basal gastric secretions and gastric acid secretion induced 
by histamine, pentagastrin and other secretagogues. On a weight basis, ranitidine is 
between 4 and 9 times more potent than cimetidine. Inhibition of gastric acid secre­
tion has been observed following intravenous, intraduodenal and oral admin­
istration of ranitidine and it is dose related, a maximum response being achieved at 
an oral dose of 150 mg.
Pepsin secretion is also inhibited but secretion of gastric mucus is not affected. 
Ranitidine does not alter the secretion of bicarbonate or enzymes from the pancreas 
in response to secretin and pancreozymin.
Ranitidine is rapidly absorbed after oral administration, peak plasma concentra­
tions being achieved within 2 to 3 hours. These plasma concentrations are not 
significantly influenced by the presence of food in the stomach at the time of the 
oral administration nor by regular doses of antacids.
Bioavailability of ranitidine administered orally is approximately 50%. Serum 
protein binding of ranitidine in man is in the range of 10% to 19%. The elimina­
tion half-life is approximately 3 hours. The principal route of excretion is the urine 
(40% recovery of free and metabolised drug in 24 hours).
Intramuscular ranitidine is fully bioavailable in comparison to intravenous 
ranitidine. The median elimination half-life of ranitidine injection 50 mg, adminis­
tered intravenously or intramuscularly was found to be 140 minutes (range 120 to 
160 minutes.) The half-life of ranitidine in patients with renal dysfunction is 
prolonged. However, in a study of 27 patients with varying degrees of renal impair­
ment therapeutic plasma levels of ranitidine were shown to be achieved without 
risk of drug accumulation, using half the normal dose of ranitidine in patients with 
plasma creatinine concentration greater than 300 pmols/litre.
There is a significant linear correlation between the dose administered and the 
inhibitory effect upon gastric acid secretion for doses up to 150 mg orally.
A plasma’ ranitidine concentration of 50 ng/mL has an inhibitory effect upon stimu­
lated gastric acid secretion of approximately 50%. Estimates of the IC50 range from 
36 to 94 ng/mL. Following the administration of 150 mg ranitidine orally, plasma 
concentrations in excess of this lasted for more than 8 hours and after 12 hours the 
plasma concentrations were sufficiently high to have a significant inhibitory effect 
upon gastric acid secretion. In patients with duodenal ulcer, 150 mg ranitidine 
given by mouth every 12 hours significantly reduced mean 24 hour hydrogen ion 
activity by 69% and nocturnal gastric acid output by 90%.
Following intramuscular injection of 50 mg ranitidine, plasma concentrations 
in excess of 100 ng/mL were achieved within five minutes of administration and 
remained above this level for 4 to 6 hours.
Intravenous infusion of ranitidine in seriously ill patients at a rate of
0.125 mg/kg/hour produced a rise of intragastric pH between 5.6 and 7.0 after two 
hours and maintained this level over the test period. The volume of gastric secre­
tion was reduced by more than 55%. Doubling the infusion rate to 
0.25 mg/kg/hour produced no further increases in gastric acid inhibition.
A single 50 mg intravenous bolus dose of ranitidine produced significant acid 
inhibition 8 to 9 hours after administration. When 13 seriously ill patients with two 
or more risk factors (shock, sepsis, respiratory failure, jaundice, renal insufficiency 
and peritonitis) were treated with a 50 mg intravenous bolus dose of ranitidine 
followed by a continuous infusion of 0.2 mg/kg/hour the number o f‘at risk’ days 
when gastric pH was less than 3.5 on three consecutive four-hourly aliquots, was 
approximately half that for placebo treated patients.
Furthermore, in respect of both 24 hour acidity and nocturnal acid output, 
ranitidine, 150 mg twice daily was superior to cimetidine 200 mg three times daily 
and 400 mg at night (P <0.001 and <0.05, respectively).
Ranitidine injection is well tolerated following intravenous administration at 
dose levels of up to 100 mg four times daily for ten days. These levels are in excess 
of those recommended for normal clinical use.
Treatment of volunteers with ranitidine 150 mg twice daily for 7 days did not 
cause bacterial overgrowth in the stomach.
Volunteers treated with ranitidine have reported no significant gastrointestinal 
or central nervous system side effects; moreover, pulse rate, blood pressure, electro­
cardiogram and electroencephalogram were not significantly affected in man 
following ranitidine administration.
In healthy human volunteers and patients, ranitidine did not influence plasma 
levels of the following hormones: cortisol, testosterone, estrogens, growth 
hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating 
hormone, aldosterone or gastrin -  although like cimetidine, ranitidine reduced 
vasopressin output. Treatment for up to 6 weeks with ranitidine 150 mg twice 
daily by mouth did not affect the human hypothalamic-pituitary-testicular-ovarian 
or -adrenal axes.
At 50 mg intravenously, ranitidine had no effect on prolactin levels. Only at 
the 300 mg i.v. dose level was an increase in prolactin secretion, equivalent to that 
produced by 200 mg of cimetidine i.v., observed.
At the high dose levels used in the tolerance studies, minor, transient increases 
in serum alanine transaminase (ALT/SGPT) and aspartate transaminase 
(AST/SGOT) levels were observed in some patients. No other liver function tests 
were abnormal for these subjects and the cause and clinical significance of these 
findings are unknown.
Laboratory studies have shown that ranitidine has negligible affinity for the 
cytochrome P450-linked hepatic mixed function oxidase system. In man, ranitidine 
treatment has been shown not to impair the metabolism of antipyrine, 
aminopyrine, warfarin or diazepam.
INDICATIONS AND CLINICAL USE
Zantac injection is indicated for the treatment of duodenal ulcer, benign gastric 
ulcer, post-operative ulcer, reflux esophagitis, Zollinger-Ellison syndrome and 
other conditions where reduction of gastric secretion and acid output is desirable. 
These include the prophylaxis of gastrointestinal haemorrhage from stress ulcera­
tion in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients 
with bleeding peptic ulcers and before general anaesthesia in patients considered to 
be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients 
during labour.
For appropriate cases Zantac Tablets are also available.
CONTRAINDICATIONS
There are no known contraindications to the use of Zantac (Ranitidine).
WARNINGS
Gastric ulcer -  Treatment with a histamine H2-antagonist may mask symptoms 
associated with carcinoma of the stomach and therefore may delay diagnosis of the 
condition. Accordingly, where gastric ulcer is suspected the possibility of malig­
nancy should be excluded before therapy with Zantac is instituted.
PRECAUTIONS
Use in pregnancy and nursing mothers -  The safety of Zantac in the treatment 
of conditions where a controlled reduction of gastric secretion is required during 
pregnancy has not been established. Reproduction studies performed in rats and 
rabbits have revealed no evidence of impaired fertility or harm to the fetus due to 
Zantac. If the administration of Zantac during pregnancy is considered to be neces­
sary, its use requires that the potential benefits be weighed against possible hazards 
to the patient and to the fetus. However, therapeutic doses of Zantac administered 
to obstetric patients in labour or undergoing caesarean section have been without 
adverse effect on labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers but the clinical 
significance of this has not been fully evaluated.
Use in impaired renal function -  Ranitidine is excreted via the kidney and in 
the presence of severe renal impairment, plasma levels of ranitidine are increased 
and prolonged. Accordingly, in the presence of severe renal impairment, clinicians 
may wish to reduce the oral dose to half of the usual dose taken twice daily, simi­
larly it is recommended that ranitidine injection be administered in doses of 25 mg 
to patients with renal dysfunction.
Children -  Experience with Zantac in children is limited and such use has not been 
fully evaluated in clinical studies. It has however been used successfully in children 
aged 8-18 years in doses up to 150 mg orally twice daily without adverse effect.
ADVERSE REACTIONS
No serious adverse effects have been reported to date in patients treated with 
Zantac. There has been no clinically significant interference with endocrine, 
gonadal or liver function, nor has the drug adversely affected the central nervous 
system even in elderly patients.
The incidence of adverse events among Zantac-treated patients (8.1%) was very 
little greater than that among placebo-treated patients (7.7%). Only five adverse 
events, namely, tiredness (0.38%), headache (0.90%), dizziness (0.32%), diarrhea 
(0.52%) and skin rashes (0.52%) had a greater incidence in the ranitidine treated 
group than in the control group.
A small proportion (1.99%) of patients treated with ranitidine injection experi­
enced itching or burning at the injection site. This reaction was mild and usually 
subsided within 10-15 minutes.
Headache was experienced by 2.54% of patients receiving ranitidine injection. 
The majority of these cases were not thought to be treatment-related. In some in­
stances the headache was thought to be due to over-rapid injection of ranitidine, 
and did not recur on rechallenge with slow intravenous injection. Similarly, some 
patients experienced nausea after rapid injection of the drug, but on subsequent 
occasions with slow-intravenous injection, experienced no ill-effects.
OVERDOSAGE
Zantac is very specific in action and accordingly no particular problems are 
expected following overdosage with the drug. Symptomatic and supportive therapy 
should be given as appropriate. If need be, the drug may be removed from the 
plasma by haemodialysis.
DOSAGE AND ADMINISTRATION
Adults: Zantac injection may be given either as a slow (over one minute) intra­
venous injection of 50 mg, which may be repeated every six to eight hours; or as an 
intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be 
repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration in seriously ill 
patients or the prophylaxis of recurrent haemorrhage in patients bleeding from 
peptic ulceration, parenteral administration may be continued until oral feeding 
commences. Patients considered to be still at risk may then be treated with Zantac 
tablets 150 mg twice daily.
In patients considered to be at risk of developing acid aspiration syndrome 
Zantac injection 50 mg may be given intramuscularly or by slow intravenous injec­
tion (over one minute) 45-60 minutes before induction of general anaesthesia.
Experience with Zantac in children is limited and it has not been fully eval­
uated in clinical studies -  see PRECAUTIONS.
AVAILABILITY
Zantac Injection is available as 2mL ampoules each containing 50 mg ranitidine 
(as hydrochloride) in 2mL solution for intravenous or intramuscular administra­
tion. Packages of 10 ampoules.
Zantac Tablets are available as white film-coated engraved ZANTAC 150 on 
one face and GLAXO on the other containing 150 mg ranitidine (as the 
hydrochloride), in packs of 28 & 56 tablets.
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Rectal Prolapse in Scleroderma: Case Report 
and Review of the Colonic Complications of Scleroderma
Scleroderma of the colon is commonly 
associated with constipation, as was the 
case in a 70-year-old woman with rectal 
prolapse decribed by the authors. The 
chronic constipation in this patient may 
have been the cause of her rectal 
prolapse, but the onset of the prolapse 
and scleroderma at about the same time 
suggest that the scleroderma may have 
been a causative factor. A  Ripstein repair 
of the prolapse was carried out. The 
authors discuss some of the complica­
tions of colonic scleroderma, which 
include megacolon, transverse and sig­
moid colonic volvulus, telangiectasia, 
stenosis and diverticula and stercoral 
ulceration.
La sclerodermie du colon est frequem- 
ment associee a la constipation. Ce fut 
le cas chez une femme de 70 ans pre- 
sentant un prolapsus rectal. Chez cette 
patiente, la constipation chronique a pu 
entrainer le prolapsus rectal mais I'appa- 
rition du prolapsus et de la sclerodermie 
a peu pres au meme moment suggere un 
role 6tiologique de la sclerodermie. Le 
prolapsus a ete soumis S une reparation 
de Ripstein. Les auteurs commentent 
quelques unes des complications de la 
sclerodermie colique dont le megacolon, 
le volvulus colique transverse ou sigmoi­
dal, la telangiectasie, la stenose avec 
diverticule et I'ulceration stercorale.
Scleroderma of the colon can alter motil­
ity, which may result in a variety of clin­
ical problems. One of these, constipa­
tion,1’2 is a well-known predisposing 
factor in the genesis o f rectal prolapse.3 
We present an unusual case of rectal 
prolapse in a patient with scleroderma.
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The features of interest include the 
method of diagnosis and the complica­
tions following abdominal repairs o f the 
procidentia. We discuss some of the 
colonic manifestations of scleroderma.
Case Report
A 70-year-old woman first had minimal rec­
tal prolapse in 1971. She had complained of 
constipation since the age of 13 years but was 
able to have a daily bowel movement with the 
help of laxatives. The prolapse was initially 
controlled by increasing the amount of fibre 
in the diet.
In February 1982, she underwent laparo­
tomy for suspected small-bowel obstruction at 
another hospital. No mechanical lesion was
FIG. 1—Dilated, atonic esophagus.
found but there was histologic and radiologic 
evidence of pseudo-obstruction and sclero­
derma. Her prolapse subsequently enlarged 
appreciably, although the bowel could always 
be reduced manually. She was generally con­
tinent of feces. She also suffered from heart­
burn and dysphagia and mild joint pain 
without loss of motion. Her past history 
included well-controlled exertional angina and 
hypothyroidism. She had had an appendec­
tomy and removal of a tubal pregnancy about 
40 years previously.
When she was admitted to hospital in 
December 1982 for elective repair of rectal 
prolapse, she was noted to be well nourished 
with no gross signs of scleroderma. There were 
a few facial wrinkles, but her lips were thin and 
she could open her mouth 4 cm. She had small 
areas of telangiectasia on the bridge of her 
nose. There were no cardiopulmonary or 
abdominal abnormalities. The rectum had poor 
sphincter tone and was empty of stool. She 
could prolapse the rectum at will approximately 
5 to 7 cm.
FIG. 2—Dilated stomach.
FIG. 3—Redundant sigmoid colon and mul­
tiple wide-mouthed diverticula.
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A chest roentgenogram demonstrated mild 
cardiomegaly. The upper gastrointestinal ser­
ies showed a dilated, atonic esophagus (Fig. 1) 
and dilated stomach (Fig. 2). The roentgeno­
gram after barium enema revealed a redundant 
sigmoid colon and multiple wide-mouthed 
diverticula (Fig. 3). Upper gastrointestinal 
panendoscopy demonstrated free reflux of bile 
in the esophagus. The distal esophagus was 
ulcerated but there was no stricture or bleed­
ing. Biopsy specimens of the duodenum 
appeared normal; those of the esophagus 
showed necrosis and severe inflammation. Sig­
moidoscopy and rectal biopsy specimens were 
normal. Biochemical and hematologic findings 
and the electrocardiogram were also normal.
At laparotomy for repair of the prolapse, the 
sigmoid colon was found to be redundant. The 
rectum was on a mesentery and folded deeply 
into an android pelvis. A standard Ripstein 
repair4 was carried out, using a sling of 
Marlex mesh.
Early after the operation, acute-angle glau­
coma developed in the left eye. Seven and 20 
days after operation she had episodes of small- 
bowel pseudo-obstruction, characterized by 
nausea, vomiting and abdominal distension. 
Bowel sounds were normal or decreased and 
there were no signs of peritonitis. Abdominal 
roentgenograms on both occasions showed 
dilated loops of small bowel with air-fluid levels 
in the small bowel and colon. Each episode 
lasted about 6 days and was treated conserva­
tively with nasogastric suction and fluids given 
intravenously. She was discharged to a con­
valescent hospital 37 days after operation.
Discussion
The most common manifestation of 
scleroderma of the colon is constipation. 
This may alternate with diarrhea due to 
bacterial overgrowth; malabsorption 
results.5 There have been several reports 
of unusual complications o f scleroderma 
of the colon, such as megacolon,6 trans­
verse colonic volvulus,7 sigmoid colonic 
volvulus,8 telangiectasia,9 stenosis of 
large bowel and diverticula mimicking 
colonic neoplasm10,11 and stercoral ulcer­
ation with perforation.12-13 A  survey of 
the literature failed to reveal any case of 
rectal prolapse in a patient with 
scleroderma. The underlying anatomical 
defect (sliding hernia or intussusception) 
of rectal prolapse has been the subject of 
much debate.4’14-17 However, as Gold­
berg and Gordon18 pointed out, both 
processes are essentially the same; the 
sliding hernia is an intussusception that 
has not involved the total circumference 
of the bowel. In either case, the approach 
to treatment involves some method of fix­
ing the rectum to the sacrum.4
In our patient, simple chronic consti­
pation may have been the initiating fac­
tor in the genesis o f the prolapse. 
However, the onset o f scleroderma and 
prolapse at about the same time suggests 
that the scleroderma predisposed to rec­
tal prolapse because o f constipation 
secondary to altered colonic motility. One
would expect more cases to be reported, 
given the incidence of scleroderma and 
constipation in the general population. 
Porter3 reported constipation in 52% of 
his patients with prolapse, compared with 
15% of those who had diarrhea and 18% 
of patients with norma! function. Battle 
and associates19 studied 10 patients with 
progressive systemic sclerosis and found 
that in normal subjects, colonic contrac­
tile activity increased after they ate a 
4000-kJ meal while in 9 o f 10 patients 
with scleroderma it did not. They further 
divided the patients into group 1 — those 
who had a response to the administration 
of neostigmine and metoclopramide simi­
lar to that o f normal and group 2 — 
patients who did not. The patients in 
group 2 had severe progressive systemic 
sclerosis and two thirds o f them eventu­
ally died of their disease. Similarly, Rees 
and associates20 showed that patients 
with intestinal scleroderma had decreased 
interdigestive motor activity and response 
to metoclopramide and bethanechol. 
These findings suggest that as the disease 
progresses, bowel motility is increasingly 
impaired.21 Patients with pseudo­
obstruction of scleroderma may have 
prolonged impairment o f intestinal motil­
ity postoperatively.22
The long-term results of perineal 
approaches to the treatment o f rectal 
prolapse are not generally as good as 
those o f abdominal approaches.23 
However, it may be prudent to consider 
the perineal approach in patients with 
intestinal scleroderma.
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The first effective anti-herpes 
therapy is now available in an I.V 
infusion for treatment of initial and 
recurrent m ucosal and cutaneous 
herpes sim plex infections in im­
munocompromised adults and chil­
dren. It is also indicated for severe 
initial episodes of herpes simplex 
infections in im m unocom petent 
patients.
Highly efficacious in con­
trolled clinical studies, ZOVIRAX I.V 
selectively blocks the viral replica­
tion process and significantly short­
ens the period of viral shedding.
ZOVIRAX-treated patients 
become contagion-free faster.
W hat’s m ore, if therapy is 
initiated at the earliest possible m o­
ment, patients will heal faster and 
experience significantly less pain.
To date, efficacy has not 
been complicated or compromised 
by side effects.
Note: ZOVIRAX I.V Infusion 
is for intravenous infusion only
Therapy is recom m ended 
for at least 5 days for immunocom­
petent patients and for at least 7 
days for im m u n ocom p rom ised  
patients.
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Gallstone Ileus in the Absence of the Gallbladder: 
Case Report and Review of the Literature
Although small-bowel obstruction due to 
gallstone ileus is uncommon, it assumes 
increasing importance with advancing 
age. The obstructing gallstone enters the 
bowel through an internal fistula 
between gallbladder and duodenum. The 
authors describe the case of a patient 
who had undergone cholecystectomy 
and in whom gallstone ileus occurred 
secondary to a stone that entered the 
bowel through a choledochoduodenal 
fistula. Treatment was traditional with 
removal of the obstructing stone, but the 
fistula was left undisturbed. The authors 
believe that further biliary tract symp­
toms are unlikely. The patient was well 
8 weeks after operation and roentgeno­
grams indicated that the internal biliary 
fistula was patent.
Meme si I'obstruction intestinale du grele 
par il£us biliaire est rare, elle augmente 
en importance avec I'age. Les calculs 
passent dans I'intestin par une fistule 
cholecysto-duodenale. Les auteurs rap- 
portent un patient qui avait dejb subi une 
choldcystectomie et chez qui I'ileus 
biliaire s'est produit par un calcul qui 
avait penetrd I'intestin par une fistule 
choledocho-duodenale. Le traitement a 
consiste a extraire le calcul, mais la fis­
tule a ete laissee intacte. Suite a ceci, 
les auteurs croient que les problemes des 
voies biliaires sont peu probables. Huit 
semaines apres I'operation, la condition 
du patient 6tait bonne et les roentgeno- 
graphies indiquaient que la fistule per- 
siste.
Gallstone ileus is a mechanical obstruc­
tion of the gastrointestinal tract caused 
by impaction of a gallstone in the bowel 
lumen. The condition is relatively rare, 
representing only 1% to 3% of all intes­
tinal obstruction.1'3 This incidence in­
creases to 25% in patients over 65 years
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old.4 The obstructing gallstone enters the 
intestine through an internal biliary fistula 
between the gallbladder and duodenum.
Fistulas between the common bile duct 
and duodenum occur primarily as a result 
of peptic ulcer disease; calculous disease 
accounts for less than 10%.5,6 Such 
stones are usually small and readily 
traverse the gastrointestinal tract. We 
report a case of bowel obstruction due to 
a gallstone in a patient who had under­
gone cholecystectomy, in which the ob­
structing stone entered the duct through 
a choledochoduodenal fistula. A
FIG. 1—Dilatation of small-bowel loops. Arrow indicates gas in biliary tree.
1
FIG. 2—Small-bowel obstruction with sug­gestion of filling defect in jejunum (arrow). Contrast medium is seen in biliary tree, enter­ing presumably through choledochoduodenal fistula.
thorough search of the literature revealed 
only a single reported case.7
Case Report
An 86-year-old woman underwent elective 
cholecystectomy and removal of stones from 
the common bile duct. A postoperative T-tube 
cholangiogram showed a retained common- 
duct stone 1.2 cm in diameter. Attempts at 
basket extraction through the T-tube tract were 
unsuccessful. However, the stone was frag­
mented and withdrawn into the sinus tract. 
Since the ductal obstruction had been relieved, 
further manipulation was not attempted.
During the succeeding 6 years, the patient 
presented frequently with intermittent abdomi­
nal pain and fever. Ultrasonography revealed 
the presence of a solitary, large stone lying wi­
thin the common bile duct and associated with 
marked ductal dilatation. A diagnosis of recur­
rent cholangitis was made. Operation was 
recommended but the patient refused.The patient was admitted to the Ottawa 
General Hospital with fever, jaundice, crampy 
abdominal pain and vomiting. Biochemical 
findings were consistent with obstructive jaun­
dice. Abdominal roentgenograms showed air 
in the biliary tree and dilated loops of small 
bowel consistent with an internal biliary fistula 
and small-bowel obstruction (Fig. 1). 
Ultrasonography confirmed dilatation of the 
common bile duct and gas in the biliary sys­
tem but the stone previously demonstrated in 
the common bile duct was no longer present. 
Roentgenograms after barium enema con-
FIG. 3—Abrupt cut-off of contrast medium in proximal jejunum from obstructing gall­stone.
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firmed small-bowel obstruction with a large 
filling defect consistent with a gallstone in 
the proximal jejunum and reflux of con­
trast medium into the common duct presuma­
bly through a choledochoduodenal fistula 
(Figs. 2 and 3).
At laparotomy an impacted gallstone meas­
uring 3 x  2.5 cm was identified in the prox­
imal jejunum (Fig. 4). The stone (Fig. 5) was 
removed through an antimesenteric enterotomy 
proximal to  the site of impaction. No attempt 
was made to visualize the choledochoduodenal 
fistula.
At follow-up examination 8 weeks later the 
patient was symptom-free. Repeat abdominal 
plain films demonstrated the persistence of air 
in the biliary tree (Fig. 6), indicating that the 
fistulous tract was patent. She remains well 
1 year after operation.
Discussion
Review o f the literature revealed only 
a single reported case of small-bowel
FIG. 4— Obstructing stone in small-bowel 
lumen with proximal dilatation and distal col­
lapse.
FIG. 5— Obstructing gallstone measuring 
3 x 2.5 cm.
obstruction due to a gallstone entering the 
bowel through a choledochoduodenal 
fistula. According to the classification 
proposed by Ikeda and Okada,7 our 
patient had a type II fistula caused by a 
relatively large stone arising from the 
extramural portion of the common bile 
duct.
The treatment of gallstone ileus is sur­
gical, aimed at relieving the intestinal 
obstruction. Generally, it is unwise to deal 
with the fistula at the time of enterotomy 
since most o f these patients are elderly 
and poor surgical risks. Surgery directed 
at the fistula in this acute setting is 
difficult and is associated with a high inci­
dence of operative and postoperative 
complications, including common-duct 
injury and duodenal fistula.
Subsequent treatment of the internal 
biliary fistula remains controversial.8 
Most patients have no symptoms due to 
the persistent fistula. The risk of recur­
rent biliary obstruction in patients with 
cholecystoenteric fistula is approximately 
5%.9 In our patient in whom the fistula 
developed in the absence of the gallblad­
der, the risk is small since further stone 
formation is unlikely.
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FIG. 6—Persistence of air in biliary tree 
(arrow) 8 weeks after operation indicates that 
fistula is still patent.
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Traumatic Rupture of the Tracheobronchial Tree
Rupture of the trachea and major bronchi 
usually results from blunt trauma to the 
chest. To define the characteristics of 
the condition, the mechanism of injury, 
presentation and hospital course, the 
authors reviewed seven cases of 
tracheobronchial rupture after blunt 
trauma. Four were injured in a motor 
vehicle accident, two had a crush injury 
and one child had a fall from a 
playground swing. The site of injury was 
the left main bronchus in three, mem­
branous trachea in two and bilateral 
bronchi and bronchus intermedius in one 
patient each. Bronchoplastic repair was 
performed in four patients with salvage 
of lung tissue in three. One patient 
required pulmonary resection. Two 
patients with a laceration of the mem­
branous trachea did not undergo opera­
tion. Two patients died secondary to 
associated head injuries; one patient 
underwent repair of the bronchus inter­
medius and one patient had a lacerated 
membranous trachea.
The possible mechanisms of injury are: 
rapid deceleration with forward swing of 
the trachea, widening of the transverse 
diameter of the chest, exerting traction 
on the carina, and a rapid rise of airway 
pressure on impact. Surgical intervention 
is recommended at an early stage to 
avoid loss of lung tissue.
Les ruptures de la trachee et des grosses 
bronches sont habituellement le fait 
d'une contusion thoracique. Dans le but 
de definir les caractgristiques de cette 
affection, le mecanisme de cette lesion, 
le tableau et revolution cliniques, les 
auteurs etudient sept cas de rupture tra- 
cheobronchiques consecutives a une 
contusion. Quatre avaient ete blesses 
dans des accidents de la route, deux 
avaient ete victimes d'une blessure par
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ecrasement et un enfant avait fait une 
chute d'une balancoire dans un terrain 
de jeu. La localisation anatomique de la 
blessure 6tait la bronche lobaire supe- 
rieure gauche dans trois cas, la trachee 
membraneuse dans deux cas et, dans les 
deux derniers cas, les bronches bilatera- 
les et une bronche moyenne. Chez qua­
tre patients une bronchoplastie a 6te pra- 
tiquee permettant de sauvegarder le tissu 
pulmonaire. Un patient a subi une resec­
tion pulmonaire. Deux patients ayant 
subi une laceration de la trachee mem­
braneuse n'ont pas ete operes. Deux 
patients sont decedes des traumatismes 
craniens subis dans i'accident; un avait 
eu une reparation de la bronche moyenne 
et un patient avait eu une laceration de 
la trachee membraneuse.
Les mecanismes possibles de ces bles- 
sures sont: une deceleration rapide avec 
coup de fouet de la trachee vers I'avant, 
I'elargissement du diametre transverse 
du thorax causant une traction sur I'epe- 
ron tracheal, et une augmentation brutale 
de la pression dans les voies respiratoi- 
res au moment de I'impact. On recom- 
mande une intervention chirurgicale a un 
stade precoce afin d'eviter la perte de 
tissu pulmonaire.
Disruption o f the tracheobronchial tree, 
secondary to blunt chest trauma, is rare 
and sometimes difficult to recognize. Its 
incidence was 2.8% in a review by Ber- 
telsen and Howitz1 of 1178 autopsy 
reports of persons who died after trauma.
In an attempt to define more clearly the 
characteristics of this condition, the 
mechanism o f injury, mode of presenta­
tion and hospital course, we reviewed the 
data of six patients with traumatic injury 
to the trachea and bronchi, seen at the 
Trauma Unit, Health Sciences Centre in 
Winnipeg between January 1982 and 
August 1983. An additional case of a 
young child treated at the Children’s 
Hospital, Winnipeg, in 1981 was included 
in our study.
Patient Population at Risk
Of the 327 patients discharged from the 
Trauma Unit during the study period, 112 
(35%) had sustained blunt chest trauma.
They constitute the group from which our 
cases, excluding the child, were selected.
These multiply injured patients, many 
of whom had abdominal, urologic and 
musculoskeletal injuries, had the follow­
ing incidence o f chest and head injuries; 
fractured ribs 58%, hemopneumothorax 
47% and head injury 16%. The overall 
mortality was 12%; however, there was 
a 50% mortality in the head-injured 
patients. The rate at which tracheobron­
chial disruption occurred in our group of 
blunt chest trauma patients was 5.3%.
Patients
Six patients (four men, two women) 
ranging in age from 19 to 50 years (mean 
38 years) were admitted to the Trauma 
Unit following a motor vehicle accident 
in four and crush industrial accident in 
two. In addition, a 4!4-year-old boy fell 
from a playground swing, suffering no 
demonstrable external injury, and was 
admitted to a local hospital because of 
dyspnea.
Case Reports
Case 1
A 51-year-old construction worker was 
referred for vascular management of a reduced 
shoulder dislocation sustained during a crush 
injury by an earth scraper. On admission, frac­
ture of the left third and fourth ribs with a 
small left anterior flail chest were noted 
together with radiologic signs suggesting left 
lung contusion. The left radial pulse had 
returned spontaneously. Six hours after admis­
sion a repeat chest roentgenogram showed a 
left tension pneumothorax and pneumomedi­
astinum. The pneumothorax cleared following 
insertion of a chest tube. Over the next 8 days 
the course was complicated by fever, hemop­
tysis, collapse of the left lower lobe and per­
sistent left pleural effusion. On the 14th hospi­
tal day, a left bronchial rupture was suspected; 
it was confirmed at bronchoscopy. Three days 
later a thoracotomy was performed. The left 
lung was collapsed and the left main bronchus 
was completely transected proximal to the ori­
gin of the left upper lobe bronchus. The 1-cm 
gap contained abundant granulation tissue and 
peribronchial fibrosis. Distal bronchomalacia 
and extensive suppuration of the lung 
precluded any procedure other than a pneu­
monectomy. The patient recovered and at
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1-year follow-up his pulmonary status 
remained stable with a forced expiratory 
volume in 1 second (FEVi) of 1.5 L.
Case 2
A 4 Vi-year-old boy fell while playing on a 
swing. When admitted to his local hospital a 
left pneumothorax and pneumomediastinum 
were noted. A left tube thoracostomy resulted 
in partial re-expansion of the lung. Twenty - 
four hours later a complete white-out of the 
left lung was noted on the roentgenogram.
On admission to the Children’s Hospital in 
Winnipeg, the chest tube was in place on the 
left, attached to an underwater seal drainage 
system. No air leak was evident but there were 
clinical signs of loss of left lung volume. A 
chest roentgenogram showed an opaque left 
hemithorax with small localized air pockets. 
Bronchoscopy revealed an abrupt termination 
of the left main bronchus 1.5 cm distal to the 
carina. Through a posterolateral thoracotomy 
a circumferentially transected left main bron­
chus was repaired. A 1.5-cm gap between prox­
imal and distal bronchial ends, noted just prox­
imal to the origin of the left upper lobe 
bronchus, was bridged with a peribronchial 
inflammatory reaction. Four months after 
operation, bronchial stenosis at the level of the 
anastomosis required dilatation on two occa­
sions. Two years after operation, the child was 
asymptomatic and had a normal chest roent­
genogram.
FIG. 1—Case 7. Chest film shows left ten­
sion pneumothorax, pneumomediastinum and 
subcutaneous emphysema. Left chest tube is 
in place.
Case 3
A 58-year-old obese, hypertensive, diabetic 
woman was admitted to the Trauma Unit for 
treatment of multiple injuries sustained in a 
motor vehicle accident. Treatment was initially 
directed toward the muskuloskeletal injuries. 
Subsequent chest roentgenograms showed 
pneumomediastinum and interstitial 
emphysema at the base of the neck. Three days 
after admission a repeat chest film disclosed 
a left pneumothorax and pneumomediastinum. 
Bronchoscopy showed complete disruption of 
the left main bronchus, proximal to its bifur­
cation, with partial stenosis and no apparent 
separation of bronchial ends. At thoracotomy, 
after debridement of peribronchial and granu­
lation tissue, the bronchial stumps were 
trimmed and an end-to-end anastomosis was 
performed using interrupted sutures of 4-0 
Vicryl. At follow-up 3 months later, the left 
lung remained expanded without evidence of 
air trapping.
Case 4
A 29-year-old woman was admitted coma­
tose with multiple injuries after being struck 
in a high speed motor vehicle-pedestrian acci­
dent. She was in hypovolemic shock with 
irregular respirations, a dilated left pupil and 
pelvic fractures. She was resuscitated with 
emergency blood transfusion, endotracheal 
intubation and bilateral chest-tube thoracosto­
mies. A computerized axial tomogram of the 
brain showed marked cerebral edema. Sub­
cutaneous emphysema of the neck was noted 
10 hours after admission and a chest roent­
genogram showed pneumomediastinum and 
widespread emphysema of the soft tissues of 
the chest and neck. At bronchoscopy, a lacer­
ation of the membranous trachea, above the 
carina, measuring 2.5 cm was observed. Over 
the ensuing hours, tension subcutaneous 
emphysema and pneumomediastinum deve­
loped, manifested by increasingly high airway 
pressure. Mediastinal decompression through 
a cervical mediastinotomy was considered but 
the condition of the patient precluded opera­
tion. Multiple skin incisions at the base of the 
neck were performed, lowering the airway 
resistances. The neurologic status of the patient 
worsened, causing her death 24 hours after 
admission. Autopsy confirmed the mem­
branous tracheal tear, early mediastinitis, a 
massive retroperitoneal hematoma and severe 
intracerebral hemorrhage.
Case 5
A 33-year-old man was admitted after being 
crushed severely in a motor vehicle accident 
near the hospital. He had no palpable pulse 
despite having had MAST trousers inflated 
enroute to the hospital. Other findings were a 
large right temporoparietal laceration, sub­
cutaneous emphysema of the right hemithorax 
and feeble heart sounds. Initial resuscitation 
included closed cardiac massage, massive trans­
fusion with crystalloid solution and unmatched 
blood, endotracheal intubation and positive- 
pressure ventilation. A portable chest roent­
genogram revealed complete opacification of 
the right hemithorax and multiple rib fractures 
on the right. Emergency right thoracotomy was 
performed. Bleeding from the right pulmonary 
artery was controlled and the vascular lacera­
tion repaired. The bronchus intermedius, 
including the origin of the middle lobe bron­
chus, was lacerated longitudinally. He 
remained acidotic and hypothermic. Refractory 
ventricular fibrillation and electromechanical 
dissociation developed and he died 6 hours 
after admission.
Case 6
In a motor vehicle accident, a 19-year-old 
man suffered midsternal abrasions, subcutane­
ous emphysema in the neck, a pericardial fric­
tion rub and a posterior dislocation of the left 
hip. A chest roentgenogram on admission 
showed a widened mediastinum in the presence 
of pneumomediastinum. The thoracic aorto- 
gram appeared normal. After reduction of the 
hip dislocation, flexible bronchoscopy was per­
formed. It revealed a 7-cm long laceration of 
the membranous trachea extending longitudi­
nally from the midthoracic trachea to just prox­
imal to the carina. There was no airway com­
promise or distal injury. The patient recovered 
fully without repair of the laceration.
Case 7
A 30-year-old heavy equipment operator was 
injured when his tractor overturned. He was 
able to free himself. When admitted to hospi-
Table 1-Data on Patients With Traumatic Rupture of Tracheobronchial Tree
Patient
no.
Age,
y Sex Mechanism of injury Site of injury Associated lesions Repair type
Time to 
repair, d Outcome
1 51 M Crush injury Left main bronchus Shoulder dislocation, 
fractured ribs
Left pneumonectomy 17 Alive
2 4 1/2 M Playground swing fall Left main bronchus — End-to-end
anastomosis
2 Alive
3 58 F Motor vehicle accident Left main bronchus Fractured long bones End-to-endanastomosis
4 Alive
4 29 F Motor vehicle accident Membranous trachea Skull fracture, 
pelvic fracture
— Dead
5 33 M Motor vehicle accident Bronchus intermedius Laceration pulmonary 
artery, skull 
fracture, pelvic 
fracture
Repair Immediate Dead
6 19 M Motor vehicle accident Membranous trachea Hip dislocation — — Alive
7 30 M Crush injury Left main bronchus, 
right main bronchus, 
left upper lobe 
bronchus
Laceration left upper 
lobe and pulmonary 
artery, cardiac 
contusion
End-to-end 
anastomosis, 
left upper 
lobectomy
Immediate Alive
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tal, he was in shock with marked subcutane­
ous emphysema over the anterior chest and 
laboured respirations. Emergency chest-tube 
thoracostomies returned large quantities of 
blood and air bilaterally (Fig. 1). During the 
initial resuscitation, cardiac arrest was success­
fully treated with closed chest massage, venti­
lation through an endotracheal tube and 
volume replacement with unmatched blood. 
Although a chest roentgenogram showed lung 
re-expansion, deteriorating blood-gas status led 
to bronchoscopy, which revealed complete 
right main-stem and partial left main-stem 
bronchial tears. Blood loss from the left chest 
tube continued at a rate of 400 mL/h; bilateral 
thoracotomies were then carried out. A com­
plete transection of the right main bronchus, 
extending to the posterior left main-stem bron­
chus, was repaired by end-to-end anastomo­
sis of the right main bronchus using interrupted 
sutures of 4-0 Prolene. The debrided edges of 
the membranous left main bronchus were 
apposed with horizontal sutures to avoid a cut- 
through effect. A left upper lobectomy was 
performed to control massive air leak and 
blood loss from a completely transected upper 
lobe bronchus and torn segmental pulmonary 
artery.
Postoperatively the patient was treated for 
dysrhythmias related to cardiac contusion, as 
well as for a transient psychosis and possible 
sepsis. He was discharged from hospital 36 
days after admission and at the 2-month 
follow-up his general status was improved.
Summary o f  Cases
Immediately upon admission a pneu­
mothorax was demonstrated in four 
patients. Subcutaneous emphysema and 
pneumomediastinum were noted in five. 
In one, a tension pneumomediastinum 
developed during mechanical volume ven­
tilation. Hemoptysis and hypovolemic 
shock were noted in one patient, who 
underwent immediate thoracotomy for 
massive hemothorax secondary to a lacer­
ation of the lobar pulmonary artery. At 
operation disruption of the bronchus 
intermedius was noted. In six patients 
the suspected clinical diagnosis was 
documented by bronchoscopy. Diagno­
sis was made on the day of admission in 
four patients, 3 days later in two and 14 
days after admission in one.
Bronchoplastic repair was carried out 
in four patients. In two instances of com­
plete circumferential transection of the 
main bronchus, simple debridement of 
the bronchial edges and end-to-end bron­
chial anastomosis with interrupted 4-0 
Vicryl sutures ensured airway continuity. 
The patient with bilateral main bronchial 
injury underwent end-to-end anastomo­
sis of the completely divided right main 
bronchus and repair of a hemicircum- 
ferential laceration of the left main bron­
chus at the level of its membranous por­
tion. Also, this patient required a left 
upper lobectomy for a transected bron­
chus o f the left upper lobe and avulsion 
injury of the apical posterior segmental 
pulmonary artery. Simple closure of a
longitudinal laceration of the bronchus 
intermedius and arterioplasty repair of 
the lobar pulmonary artery were per­
formed in the patient who presented in 
hypovolemic shock.
A patient with complete transection of 
the left main bronchus, in whom severe 
suppuration of the left lung developed, 
required a left pneumonectomy. Two 
patients who had concomitant severe 
head injury died. One had a laceration of 
the lobar pulmonary artery and bronchus 
intermedius and the other a through-and- 
through laceration of the membranous 
trachea.
Results were considered satisfactory in 
the three patients who underwent bron­
choplastic repair of the airway except in 
the child who had bronchial stenosis at 
the level of the anastomosis and required 
transbronchoscopic bronchial dilatation. 
The patient who underwent a left pneu­
monectomy was left with a limited lung 
reserve (FEV! of 1.5 L).
Discussion
It is accepted that the incidence of trau­
matic rupture of the tracheobronchial tree 
has increased at least tenfold over the past 
20 years. Nevertheless, the overall inci­
dence of this lesion remains low in com­
parison with other intrathoracic inju­
ries.2 Our patients represent 5.3% of 
blunt chest trauma victims seen over 20 
months in our Trauma Unit. This figure 
is almost double the incidence of 2.8% 
o f Bertelsen and H ow itz’s study;1 
however, it should be clear that our inci­
dence was calculated from patients admit­
ted to hospital with blunt chest trauma 
and theirs was based on patients dying of 
trauma, not comparable cohorts.
Our experience is similar to that 
reported by Mills and colleagues3 in 
which the spectrum of blunt tracheobron­
chial disruption was illustrated. But it is 
conceivable that our patients suffered a 
more violent form of injury, suggested by 
the case of bilateral bronchial rupture, 
associated vascular injury in two cases 
and severe head injury and pelvic frac­
tures in two other cases (Table I).
According to the time of repair follow­
ing hospital admission, our capacity to 
recognize the problem was less well deve­
loped than that of Mills and colleagues. 
In their reported experience, five of the 
patients were operated upon within 24 
hours of admission. Referral to their insti­
tution was delayed in their other two 
patients, in one by 19 days and the other 
was not referred until destruction of the 
left lower lobe, secondary to bronchial 
stenosis, demanded a lobectomy 4 months 
after injury. Five of our patients under­
went operation, but there was. a delay in 
three Decause of the severity of the chest 
injury and precarious clinical condition
produced by blood loss. In these three 
patients, operation was not done until the 
diagnosis of bronchial disruption was 
confirmed, a day after admission in the 
young child and 4 and 17 days later in the 
remaining two. The two patients operated 
upon immediately had associated pulmo­
nary artery injury and hypovolemic 
shock. Delay in diagnosis proved to be 
too costly in one patient; severe pulmo­
nary sepsis developed with early septice­
mia and a left pneumonectomy was 
required. Even though we do not advo­
cate nonoperative management of tra­
cheobronchial injuries, two of our 
patients who had a laceration of the mem­
branous trachea were not operated upon. 
In one, a precarious neurologic state from 
a severe head injury precluded surgical
FIG. 2—During rapid deceleration, shear­
ing forces (middle arrow) act predominantly 
where airway is fixed — cricoid and carinal 
areas (upper and lower arrows).
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intervention. In the other, absence of 
signs and symptoms of mediastinitis or 
airway compromise led to successful con­
servative management. This patient was 
assessed while in hospital, clinically and 
radiologically, on a daily basis, and 
before discharge, bronchoscopy with a 
flexible scope showed a patent trachea 
and healing of the posterior longitudinal 
laceration.
Our patients exemplify the recognized 
mechanisms of injury. The young child 
illustrates the well-known phenomenon of 
blunt chest trauma exerting forces insuffi­
cient to fracture the thoracic skeleton, 
especially in a young, compliant chest 
cage, but producing a tracheobronchial 
rupture. In this instance, rapid decelera­
tion results in shearing forces where the 
tracheobronchial tree is fixed, particularly
FIG. 3—Increase of transverse diameter of 
chest (bottom) secondary to anteroposterior 
compression pulls lungs apart and exerts trac­
tion on carina.
*
FIG. 4—Disruption of membranous trachea 
may result from rapid rise of airway pressure 
at time of impact when glottis is closed.
in the cricoid and carinal areas, relative 
to the main-stem bronchi (Fig. 2). This 
mechanism may have been responsible for 
the cricoid and carinal lesions seen in 6 
of 13 cases of tracheobronchial disruption 
reported by Jones and colleagues.4 The 
patient with bilateral main bronchial rup­
ture represents the effects of sudden 
forceful compression of the thoracic cage, 
decreasing the anteroposterior diameter 
of the thorax and increasing the trans­
verse diameter. This lateral motion pulls 
the lungs apart producing traction on the 
trachea and carina and disruption of the 
main-stem bronchus when tissue elastic­
ity is exceeded (Fig. 3). Longitudinal 
laceration of the membranous trachea 
occurred in two of our patients, proba­
bly secondary to crushing o f the 
tracheobronchial tree between sternum 
and vertebral column with the glottis 
closed at the moment of impact. As 
intrabronchial pressure increases rapidly, 
a vertical laceration may occur in the 
weakest portion of the membranous 
trachea (Fig. 4).
Conclusions
Disruption of the tracheobronchial tree 
should always be considered in patients 
sustaining blunt chest trauma even though 
it may not appear to be severe, as shown 
by our youngest patient. Bronchoscopy 
is the most reliable way of establishing the 
site, nature and extent of tracheobron­
chial disruption and it should be per­
formed when the diagnosis is suspected. 
A victim of blunt chest trauma in whom 
pneumomediastinum, refractory pneu­
mothorax or a large air leak develops 
needs early bronchoscopy to evaluate the 
airway.
Thoracotomy should be performed as 
soon as the patient’s condition allows, in 
an attempt to repair the bronchus without 
delay, avoiding loss of lung tissue.5’6 Our 
case 1 illustrates the unsalutary effect of 
delay in diagnosis and treatment. Unfor­
tunately, associated injuries, especially of 
the head, may preclude early surgical 
intervention and play a major role in 
determining final outcome, as illustrated 
by our two deaths.
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Fingertip Amputation: Review of 100 Digits
Evaluation of the functional results and 
complications of 100 fingertip amputa­
tions revealed no difference between the 
two most commonly used repairs; 52 
injuries were treated by primary closure 
with residual viable skin flaps and 27 by 
split-thickness skin grafting. No decline 
in unfavourable functional results was 
found when patients evaluated 6 weeks 
after injury were compared to patients 
evaluated 42 weeks after injury, sug­
gesting that delaying the patient's return 
to full activity by prolonging rehabilita­
tion is unlikely to yield much 
improvement.
Shortening the nerves in proximal 
amputations closed by residual flaps did 
not decrease nerve irritation. Resection 
of bone produced a mobile amputation- 
stump tip. While the mean time off work 
or return to full activity following skin 
grafting was 6 days less than it was 
after primary closure, the difference was 
not significant.
L'evaluation du fonction et des complica­
tions du traitement de 100 amputations 
des bouts des doigts n'a montre aucune 
difference entre les deux moyens de trai­
tement le plus souvent utilises: fermeture 
par premiere intention avec lambeaux 
cutanes viables (n=52) et greffon 
cutane semi-epais (n = 27). Aucune dimi­
nution de mauvais resultats n'a ete mon­
tre chez les patients evalues 6 semaines 
apres accident en comparaison avec les 
cas evalues 42 semaines apres accident, 
ce qui suggere que c'est peu probable
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qu'on produise une amelioration signifi­
cative si Ton retarde le retour a une vie 
active par la participation dans un pro­
gramme prolonge de rehabilitation.
Le raccourcissement des nerfs dans les 
amputations proximales fermees avec 
lambeaux cutanes n'a pas diminue I'irri- 
tation des fibres nerveuses. La resection 
de I'os a produit un moignon d'amputa- 
tion avec un bout mobile.
La duree moyenne avant le recommen­
cement de travail ou de vie active apres 
('application du greffon cutane etait 6 
jours moins longue que dans les cas trai- 
tes par fermeture h premiere intention; 
cette difference n'etait pas significative.
Fingertip amputations at or distal to the 
distal interphalangeal joint may be con­
sidered minor injuries, but they can cause 
much disability and result in a consider­
able loss of time from work or until 
return to full activity.
We evaluated 100 digits treated by 
several methods of repair, depending on 
the attending physician’s choice. Com­
parable groups of digits were compared 
statistically to determine any significant 
differences between the two most com­
mon methods of repair—primary closure 
with residual skin flaps and split thick­
ness skin grafting—with respect to per­
sisting disability, complications and loss 
of time from work or until return to full 
activity.
Patients
Our study population consisted of 
patients with fingertip amputation 
presenting for treatment at the Emergency 
Department of Vancouver General 
Hospital between June and September in 
1980 and 1982 and followed up at the 
Hand Clinic.
The levels of amputation were grouped 
as (a) distal to the nail lunula and (b) at 
or proximal to the nail lunula. The injury 
was classified according to the angle of 
amputation surface in relation to the hand 
(i.e., transverse, volar oblique or dorsal 
oblique). Amputations were also classi­
fied as guillotine or crush. Associated
injuries of the amputated digit and other 
digits were noted, including fractures and 
lacerations of tendon and nerve. To deter­
mine time off work or until return to full 
activity for those patients injured in non­
work activity, only those patients whose 
injury was a single amputated fingertip 
without associated injury were compared; 
patients with multiple-digit amputations 
or associated injuries of the amputated 
digit were excluded.
The patients were followed up until 
rehabilitation was complete. Complica­
tions were noted at each visit. Final evalu­
ation was done either at the time the 
patient was ready to return to work or up 
to 1 year later, for patients who were lost 
to immediate follow-up. This afforded an 
opportunity to compare those assessed 
soon after injury with those assessed later. 
Subjective complaints included rest pain, 
cold hypersensitivity and paresthesia 
(shock-like radiating pain with activity). 
Objective tests were done at the final 
evaluation. Light touch was assessed by 
touching the treated area with Kleenex tis­
sue. Percussion hypersensitivity was 
present if tapping the amputation stump 
on a table top with moderate force was 
painful. Hypersensitivity to rough sur­
faces was present if rubbing the stump 
with an operating-room scrub brush was 
painful. Two-point discrimination was 
tested by reducing the separation of 
caliper points 1 mm at a time and ran­
domly applying one or two points. The 
separation at which three consecutively 
incorrect responses occurred was 1 mm 
less than the measurement recorded. 
Values of 10 mm or more were not 
included in the calculation of the mean 
since many healed skin grafts were not 
this large at the time of final assessment.
Analysis of Data
Mean ± standard deviations were com­
pared by the Student’s t-test; a value of 
p < 0.05 was considered significant. The 
absolute frequency of observations was 
compared using the Pearson x2 test (two 
tail) for large groups. When the total 
number of observations was less than 22, 
or 1 or more cells of the 2 x 2 table was
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less than 6, Fisher’s exact probability test 
(one tail) was used.
Epidemiology
One hundred fingertip amputations 
were evaluated in 92 patients. Of these, 
63 sustained a single fingertip amputa­
tion; 6 had multiple amputations and 23 
had a single fingertip amputation with 
additional injuries.
Job inexperience was not an important 
factor since over half of the 56 patients 
injured at work had been at the same 
occupation for more than 2 years. 
However, more (23%) were injured dur­
ing the first hour on the job than during 
any subsequent hour of the working day.
Functional Results
Comparison o f Primary Closure 
and Split-Thickness Skin Grafting
Since primary closure with a residual 
flap and split-thickness skin grafting were 
the two most common types of repair 
employed, comparisons of function were 
limited to these two methods (Table I). 
With primary closure a similar number of 
digits were assessed early (5.8 weeks) and 
later (42 weeks) after injury (Table II). 
The incidence of subjective complaints 
and objective findings was similar in the 
two groups. There was no difference in 
two-point discrimination between digits 
assessed early and those assessed later.
No significant difference between the
early and the late group was found in 
digits managed by split-thickness skin 
grafting (Table II).
When all of the patients who under­
went primary closure were compared with 
all those receiving split-thickness skin 
grafts (Table I), the only significant 
difference (p = 0.04) was that failure of 
split-thickness skin grafts to survive 
occurred more frequently than flap 
failure (necrosis).
Influence o f Bone and Nerve Treatment
Of the 32 amputations at or proximal 
to the nail lunula treated by primary 
closure, 15 required resection of nerves. 
There were no significant differences 
between the groups with regard to sensa­
tion or other nerve-related phenomena. 
Cold hypersensitivity was more frequent 
when the nerves were not shortened. 
However, hypersensitivity to rough sur­
faces was more frequent when the nerve 
was shortened (Table III).
In 20 distal amputations treated by 
primary closure, bone was shortened in 
12 (Table IV). Half of these 12 had poor 
adherence of the amputation closure site 
to underlying bone with a tendency to 
slippage of the tip, whereas, none of those 
in which the bone was not shortened had 
mobile tips. No other significant differ­
ences were detected in these two groups.
Effect o f Mode o f Injury
Seventy-nine digits were assessed to 
compare the effect of mode of injury. 
Fifty-two digits were treated by primary 
closure and 27 by split-thickness skin 
grafting. Forty-five had a guillotine 
amputation and 34 had a crush amputa­
tion (Table V). Digits that were crushed 
yielded a higher incidence of rest pain (p
Table 1-Comparison of Functional Result and Complications 
Between Digits Managed by Primary Closure and 
Split-Thickness Skin Grafting
Complication/function
Primary closure, 
no. of digits 
(n -  52)
Split-thickness 
skin-grafting, 
no. of digits 
(n -  27) p value
Rest pain 11 2 0 .10*
Cold hypersensitivity 22 9 0.44+
Paresthesia 18 6 0.26+
Absent light touch 4 2 0 .67 *
Percussion hypersensitivity 18 9 0 .9 1 1
Rough-surface
hypersensitivity 13 8 0.66+
Ulceration 1 1 0 .57*
Nonadherence of tip 13 6 0.78+
Absent subcutaneous bulk 8 7 0.26+
Flap or graft failure 1 4 0 .04*
Two-point discrimination
in digits with < 1 0  mm separation, 4.9 ±  1.8 5.5 ±  1.9 0.26+
mm (mean ±  SD) (n = 39) (n -  19)
'Fisher's exact probability test. 
+X2 test (Yates).
+Student's 7-test.
Table II—Functional Result and Complications Assessed Early and Late
Primary closure, no. of digits
Split-thickness skin grafting, 
no. of digits
Complication/function
5.8 ±  0.5 wk* 42 ±  6 wk*
(n -  24) (n -  28) p value
6.4 ±  6 wk* 42 ±  7 wk* 
(n -  12) (n = 15) p value
Rest pain
Cold hypersensitivity 
Paresthesia 
Absent light touch 
Percussion hypersensitivity 
Rough-surface hypersensitivity 
Ulceration
Nonadherence of tip 
Absent subcutaneous bulk 
Two-point discrimination in 
digits with < 1 0  mm separation, 
mm (mean ±  SD) 4.9 ±  2.0* 
(n -  18)
8
14
9
0
12
6
0
7
5
4.9 ±  1.5* 
In -  21)
0 .1 4 t  
0.35+  
0.91 + 
0.39 + 
0.29+ 
0.75+  
0 .4 6 t  
1.0+ 
0 .8 8 t
0 .9 5 # 6.1 :
(n
1. 8 *
9)
5.0
(n
1.9*
10 )
'Mean standard deviation. 
tFisher's exact probability test. 
+XZ test (Yates).
^Student's f-test.
0.34+
0.44+
0.7 +
0.34+
0.52+
0.56+
0.56+
0.36+
0 .2#
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= 0.08). No other differences were 
found.
Time o f f  Work
Patients with single-digit injuries whose 
wounds were closed with local tissue or 
skin grafts were off work for a shorter 
period than those whose wounds were 
closed with distant flaps (Table VI). 
Patients whose digits healed by secondary 
intention were off work for a similar num­
ber of days to those with a skin graft or 
primary closure with residual flaps.
Patients treated by primary closure 
were off 1 week longer than those treated 
by split-thickness skin grafting regardless 
of Workers’ Compensation Board (WCB) 
coverage (Table VII). Irrespective of the 
method of closure, those with WCB 
coverage were off work for a longer time. 
The differences were not significant.
Right-hand-dominant patients who had 
single-digit injuries managed by either 
primary closure or a split-thickness skin 
graft were selected. Time off work for 
those with injury to the left hand (32 ± 
23 days) was almost identical to that for 
patients with right-hand injuries (34 ± 28 
days). There was no substantial difference 
in time taken off work or for return to 
full activity when the two most-frequently 
injured digits were compared (left index 
32 ± 19 days, n = 13 and left thumb 30 
± 22 days, n = 9).
Discussion
Selection o f  Procedure
All types of closure were used for the 
transverse amputation. A dorsal oblique 
amputation, with exposed bone constitut­
ing a major part of the raw surface of the 
total amputation was most often closed 
primarily (15 of 23), and usually required 
bone shortening. Split-thickness skin 
grafting was more often selected for volar 
oblique amputations (12 of 20), because 
more raw pulp and relatively less bone 
constituted the raw surface. With distal 
injuries, all types of closure were 
employed, but primary closure was used 
more frequently for amputations prox­
imal to the nail lunula where additional 
bone resection was not a major concern. 
With proximal injuries, identification and 
resection of a nerve was performed in 
about half the cases. This resulted in a 
lower incidence of cold hypersensitivity, 
but no other sensory differences that 
might be expected following shortening 
of the nerve. Half of the distal amputa­
tions in which the bone was shortened and 
closed primarily had mobility of the tip 
skin. All distal amputations without 
shortening of bone had adherent tips. A 
closure that was a little tight at the time 
of treatment might eventually provide 
better grasp.
Table III—Effect of Nerve Resection Following Amputation Through 
_______ Proximal Half of Digit Treated by Primary Closure
Complication/function
Nerve shortened, 
no. of digits 
(n = 15)
Nerve not shortened, 
no. of digits 
(n = 17) p value
Rest pain 4 4 0.57*
Cold hypersensitivity 5 11 0.08*
Paresthesia 7 5 0.26*
Absent light touch 1 1 0 .7 2 '
Percussion hypersensitivity 8 6 0.25t
Rough-surface hypersensitivity 6 2 0 .0 8 '
Two-point discrimination in
digits with < 1 0  mm separation,
mm (mean ±  SD) 5.7 ±  2.1 5.2 ±  1.6 0.554
(n -  10) (n = 13)
'Fisher's exact probability test. 
t x 2 test (Yates],
4-Student's t-test.
Table IV—Effect of Bone Resection Following Amputation Through 
Distal Half of Digit Treated by Primary Closure
Complication
Bone shortened, 
no. of digits 
(n -  12)
Bone not shortened, 
no. of digits 
(n = 8) p value
Rest pain 3 0 0.19*
Cold hypersensitivity 5 1 0 .1 9 '
Ulceration 0 0
1Absent subcutaneous bulk 
Nonadherence of tip to
1 0 .6 5 '
underlying bone 6 0 0.02*
'Fisher’s exact probability test.
Table V - Effect of Mechanism of Injury in Primary Closure 
and Split-Thickness Grafting Combined
Complication
Mechanism of injury 
Guillotine, Crush, 
no. of digits no. of digits 
(n -  45) |n = 34) p value
Rest pain 4 9 0 0 8 '
Cold hypersensitivity 17 14 0.764
Paresthesia 14 10 n 871
Absent light touch 4 2 0.94*
Percussion hypersensitivity 16 11 0.774
Rough-surface hypersensitivity 13 8 0.594
'Fisher's exact probability test. 
t y 2test (Yates).
Table Vl-Treatment of Digits and Time off Work or Until 
Return to Full Activity for Single-Digit Amputations
Method of closure
Total no. of 
digits
Single-digit*
Amputations
Time off work, d 
(mean ±  SD)
Primary closure 
Split-thickness skin
52 27 37 ±  26
grafting
Healing by secondary
27 19 31 ±  22
intention
Full-thickness skin
10 8 34 ±  21
grafting 3 3 37 +  41
Kleinert flap 4 2 52 •+• 14
Cross-finger flap 3 3 82 ■+■ 32
Thenar flap 1 1 156
'Injury to one digit on the injured hand with no other associated injury proximal to the level of am­
putation.
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Distant flaps were seldom used. They 
were selected for volar or dorsal oblique 
defects with extensive exposure of bone 
that would have required a substantial 
length of bone shortening if primary 
closure or split-thickness skin grafting had 
been selected. Because rehabilitation is 
prolonged, distant flaps should only be 
used when no other method of closure 
will suffice.
Subjective and Objective Evaluation
Some patients had their final evalua­
tion when they resumed full activity or 
were sent back to work, while others were 
examined later. With both primary 
closure and split-thickness skin grafting, 
the incidence of unfavourable findings in 
digits assessed early was no greater than 
that in digits assessed later. The condition 
6 weeks after injury seems to be an indi­
cation of the long-term result, suggesting 
that continued time off work for rehabili­
tation may not yield much improvement.
Two-point discrimination of 5 mm was 
similar in both the early and late groups 
of patients whose stumps were closed 
primarily. Four years after repair, Stur- 
man and Duran1 observed a mean two- 
point discrimination of 3 mm in 66 digits 
closed primarily. In patients assessed 3 
years after injury they observed two-point 
discrimination of 5 mm in 53 digits 
managed by split-thickness skin grafting, 
the same findings as in our study at 46 
weeks after injury. In our study two-point 
discrimination was 1 mm less (not signifi­
cant) in the digits managed by split­
thickness skin grafting and assessed later.
Cold sensitivity was the most prevalent 
complaint following both primary closure 
(42%) and skin grafting (34%). It was 
common in reports originating from 
colder cities (Brody and colleagues2 from 
Montreal, PQ and Sturman and Duran1 
from Columbus, Ohio), with an incidence 
of up to 50%. Holm and Zachariae3 
from Denmark reported cold hypersen­
sitivity in 39% of digits that were allowed 
to heal by secondary intention in contrast 
to 60% of digits in which primary closure 
followed bone resection.
The incidence of percussion hypersen­
sitivity of the stump was similar in digits
treated by either primary closure or split­
thickness skin grafting. Tenderness was 
more frequent with the latter. This is 
comparable to the results in the series 
reported by Sturman and Duran1 (70% 
vs. 51%) and Clifford4 (75% vs. 18%). 
In contrast, Brody and associates2 
reported tenderness more frequently with 
primary closure (33% vs. 24%).
When digits treated by primary closure 
(n = 52) and skin grafting (n = 27) were 
combined (Table V) rest pain was found 
to be more frequent in crush than in 
clean-cut guillotine amputations (p = 
0.08). In both types of closure, signs and 
symptoms did not differ in 25 injured 
digits of the dominant right hand from 
those in 45 of the non-dominant left 
hand.
From a practical standpoint the choice 
between primary closure with a residual 
flap and split-thickness skin grafting is 
determined by the type of injury, includ­
ing the angle of amputation, the amount 
of bone exposed and, to a lesser extent, 
the level of amputation. The final result 
with each method is similar. Provided 
that bone does not protrude from the 
amputation stump, split-thickness skin 
grafting may preserve a few millimetres 
of additional length, without producing 
an inferior final result. In some cases, the 
secondary contraction of a graft may 
produce a tip in which the final graft is 
a fraction of its original size.
Time o ff Work
Patients who had a single-digit ampu­
tation were off work a shorter time (33 
days) than those with multiple-digit inju­
ries (68 days). Metcalf and Whalen5 
reported 25 lost days for single-digit inju­
ries and 35 for multiple-digit injuries.
Patients treated by skin grafting were 
off work for a shorter time than those 
treated by primary closure but the differ­
ence was not significant. This difference 
was also reported by Sturman and 
Duran,1 Brody and colleagues2 and Bar­
clay,6 with a wide range of time off work 
following skin grafting ranging from a 
low of 10 days reported by Sturman and 
Duran,1 to a high of 63 days reported by 
Barclay.6 In contrast, Clifford4 found
Table VII—Time off Work or Until Return to Full 
Activity. Single-Digit Injury. Primary Closure Versus Split- 
Thickness Skin Grafting______ _______
Primary closure Split-skin grafting
WCB No. Time off (d ±  SD) No. Time off (d ±  SD)
Yes 14 43 ±  26a 10 35 ±  27b
No 13 31 ±  26c 9 26 ±  18"
Totals/means 27 37 ±  26E 19 31 ±  22f
WCB = Workers' Compensation Board coverage.
p value (Student's f-test): a vs. b -  0.46, c vs. d -  0.64, e vs. f -  0.39, a vs. c -  0.23, b vs. d -  
0.4.
that patients treated by split-thickness 
skin grafting were off work longer than 
those treated by primary closure.
We found that patients with distal 
amputations, whose digits were allowed 
to heal by secondary intention without 
operative treatment, were off work the 
same amount time as those treated with 
by either skin grafting or primary closure. 
Holm and Zachariae3 reported that 81% 
of patients whose wounds were allowed 
to heal by secondary intention returned 
to work in 28 days compared with 56% 
of patients whose digits were closed with 
residual flaps after bone shortening.
Patients covered by the Workers’ Com­
pensation Board were off slightly longer 
than those who were injured at home, 
irrespective of closure method. Brody and 
colleagues2 reported that patients with 
WCB coverage were off 11 days longer, 
a difference similar to that of our series.
We thank Drs. A .D . Courtemanche, P.T. 
Gropper, B. Foley, D.A. Kester and D.G. Fitz­
patrick whose patients were studied; Mrs. E. 
Germann who prepared the computer pro­
gram; Dr. R. Rickards for translation and Ms. 
V. Mah and Mrs. G. U thoff for preparing 
the manuscript.
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NOTICES
continued from page 10
General Surgical Symposium
The Division of General Surgery of the 
University of Ottawa School of Medicine 
will hold its annual General Surgical Sym­
posium on Feb. 15 and 16, 1985 at the 
Westin Hotel in Ottawa, Ont. It will deal 
with management of a variety of com­
monly encountered surgical problems. In 
addition to local faculty, guests will 
include Dr. Andrew Warshaw, Associate 
Professor of Surgery at Harvard Medi­
cal School and Dr. Zane Cohen, Assis­
tant Professor of Surgery at the Univer­
sity of Toronto.
For further information contact Dr. 
J.L. Wellington, Chairman, Program 
Committee, General Surgical Sympo­
sium, Department of Surgery, Ottawa 
General Hospital, 501 Smyth Rd., 
Ottawa, Ont. K1H 8L6.
continued on page 83
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Recent Research Suggests...
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Head Injuries: a Prospective, Computerized Study
A prospective study of 3000 consecu­
tive patients with head injury admitted to 
hospital showed a marked seasonal, 
daily and hourly variation and an overall 
male-to-female ratio of 2.19:1. The 
majority of patients were in the second, 
third and fourth decades of life with a 
peak in the early part of the second 
decade. The incidence was highest in 
unemployed and welfare recipients. 
Traffic accidents were the leading cause 
followed by fights and falls. Drug or 
alcohol use, or both, was evident in 
45.6%  of cases. The number of head 
injuries caused by intoxicated individuals 
is not known. Most patients had a con­
cussion only. There was no evidence 
that the patients with concussion who 
returned to full activity immediately had 
any more adverse effects than those 
advised to "take it easy" for about 1 
week.
Une etude prospective de 3000 admis­
sions consecutives pour traumatisme cra- 
nien d^montre des variations saisonnifc- 
res, journalises et d'heure en heure 
marquees. Le rapport male/femelle etait 
de 2.19:1. La majority des accidents se 
trouvent dans les deuxteme, troisieme, et 
quatrieme dScenies avec un sommet 
dans la jeune vingtaine. Leur nombre 
etait plus eleve chez les sans-emplois et 
les assistes sociaux. Les accidents de la 
route en sont la cause principale, suivis 
de pres par les bagarres et les chutes. 
L'usage de I'alcool ou de drogues, ou les 
deux, etait evidente dans 45.6%  des 
cas. Le nombre des blessures craniennes 
causees par des individus intoxiques est 
inconnu. La grande majorite a ete identi- 
fiee comme souffrant de commotion
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cerebrale. II n y a aucune preuve que les 
patients ayant subi une commotion cere­
brate et qui ont ete remis en pleine acti- 
vite immediatement, ont plus souffert 
que ceux qui ont ete avises de "faire 
attention" pendant environ 1 semaine.
Of the numerous head injury studies 
reported, some are composite,1 some 
prospective2-5 and some retrospective,6'9 
while others address a specific varia­
ble,1013 such as alcohol,1416 vehicle 
type,17’18 traffic  accidents19'21 and 
specific degree of severity.22'26 If the 
enormous number of human, socioeco­
nomic and environmental variables were 
all included, the cell size would become 
so small as to be statistically insignificant 
even if all the series were pooled. In addi­
tion, beyond the few measurables such as 
age, sex, time, occupation, temperature 
and place, there are no uniformly accept­
able yardsticks for these many variables 
or even agreement as to their identity. 
Yet, if variables are excluded, results 
become illusory and conclusions open to 
challenge. Even items that are common 
knowledge to some workers in the field, 
such as the causative association of alco­
hol and drugs, the greater incidence of 
head injury in the unemployed and the 
extent of functional loss secondary to 
minor head injury, are backed by evi­
dence that comes closer to meeting popu­
lar rather than rigid scientific criteria such 
as Koch’s postulates. Yet, legislative bod­
ies must provide regulations and controls, 
while judiciary bodies (the courts, com­
pensation boards, insurance companies) 
are asked to set precise monetary values 
on imprecise diagnoses such as concussion 
and contusion. The agencies must relay 
on opinions and the available weight of 
evidence, both best obtained by compar­
ing similarities and variables from all 
available series. The reliability of these 
opinions and weight of evidence can only 
be improved by larger numbers of 
patients.
Our prospective computerized study 
reported here was arbitrarily terminated 
at the 3000th patient, making it the lar­
gest reported series. It included as many
variables as deemed practicable and was 
undertaken in order to add to the avail­
able opinions and weight o f evidence.
Epidemiologic Background
The catchment area is 90% urban from 
Winnipeg, the administrative, financial, 
cultural, educational and transportation 
centre of a prairie province with a salt­
water seaport and industries ranging from 
mining, smelting, steel milling and fish­
ing to the needle trades, and with temper­
ature extremes of 40.5°C and -45°C . 
The population, which has remained rela­
tively constant over the past 35 years, has 
a cosmopolitan ethnic spread with a prob­
able Anglo-Saxon plurality, but with large 
native Indian, Metis, Scandinavian, 
Icelandic, French, Ukranian, German 
and Jewish communities, with many 
being unable to speak English, and sub­
stantial minorities of black, Chinese, 
Japanese, Filipino, Asian, Italian and 
Portuguese.
Methods
A prospective study was carried out of 
3000 consecutive patients with head inju­
ries admitted to the Health Sciences 
Centre, Winnipeg, during the 40 months 
preceding Aug. 31, 1981, with an 
18-month follow-up of selected groups. 
Injuries considered too minor for admis­
sion, pure scalp injuries and those that 
caused death during transportation were 
not included. No patient who died while 
being transported had a lucid interval so 
probably few, if any, could have been 
saved by earlier arrival. Other series have 
reported that 50% to 65% of all head- 
injury deaths occurred before or during 
transportation. During the study period 
there were no seatbelt or helmet laws, and 
the legal drinking age was 18 years. There 
are several other municipal and rural 
hospitals in the area, but only one other 
neurosurgical centre in the city and no 
others in the province. For head injuries, 
the Health Sciences Centre catchment 
population is estimated at 330 000, 
approximately 10% being rural.
In cooperation with the Medical
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Records Department and the University 
of Manitoba Computer Sciences Depart­
ment, a protocol was drawn up and then 
submitted to two other neurosurgical 
centres; their recommendations were 
incorporated. The protocol eventually 
contained 220 items programmed for 
computer storage so that any item could 
be retrieved, evaluated and correlated 
with all others. The data were transferred 
from the patients’ charts to a protocol by 
medical secretaries, who conferred with 
the authors whenever interpretation was 
necessary and obtained additional infor­
mation when needed from nurses, interns, 
residents, police or ambulance attendants. 
If further information or follow-up was 
required, physicians and patients were 
assured of the statistical nature of the 
project and its anonymity. When ready 
for storage into the computer, 40 of the 
220 possible items at the most would be 
applicable to any one patient.6’10-24
Results
Incidence
The 3000 separate episodes of head 
injury involved 2850 patients (2719 
treated for single episodes, 131 treated for 
repeated head injuries, ranging from two 
to five injuries per patient). The Mayo 
Clinic workers correctly pointed out that 
this small repeating group statistically 
represents a very high-risk population.9 
For the 40-month period of our study, the 
annual incidence was 2.2/1000 for the 
catchment population. Other studies 
show an incidence ranging from 1,79 to 
6/1000.3,25
Our study shows a marked seasonal 
variation with a peak in the spring months 
decreasing to a low in the winter. The day 
of the week was an important factor, with 
a slow increase from Mondays to a peak 
on Saturdays. The time of day was also 
important, most injuries occurring from 
15:00 to 03:00 and fewest from 06:00 to 
08:00. These seasonal, daily and hourly 
changes were noted to a greater or lesser 
degree in other series.n ’15’17’24’27’28
Sex and Age
While the provincial male-to-female 
ratio is 1.02:1, the overall head-injury 
ratio is 2.19:1 with an increased dis­
crepancy in the middle decades. When 
corrected for distribution by age, patients 
in the second, third and fourth decades 
combined accounted for 61.8% of the 
head injuries. Subdivision to 3-year inter­
vals produced a peak at ages 18 to 20 
years, and another at 70 years. These 
findings are similar to those of other large 
studies.6'9,10,17,20,24
Occupation
Thirteen broadly defined categories
were used, 12 of which were specific. The 
remaining category, “ other occupational 
status” , consisted primarily of those 
younger than 19 years and older than 70 
years who were assumed to be students 
and retired people (unemployable 
patients). If people in this category are 
excluded, the “ employable” population 
accounted for 70.7% (2120) of the 3000 
head injuries. The largest subgroup of 
employable patients with head injuries 
were welfare recipients constituting 
29.2%, yet they constituted only 1% of 
the catchment population.29 The next 
largest category was “ unemployed” with 
18.3% while the average provincial unem­
ployment rate during this period was 
approximately 10%.30 The third largest 
category was unskilled workers (11.7%). 
The other groups were as follows: skilled 
workers 6.9%, labourers 6.8%, house- 
wives/husbands 6.4%, clerical 3.8%, self- 
employed 2.8%, professionals 1.7%, 
semiskilled workers 1.6%, farmers 1.1%, 
and managers 0.7%. The remaining 9% 
had no documentation as to type of 
employment.
It is notable that of the employable 
population, welfare recipients and the 
unemployed together account for 47.5% 
of the cases, and yet account for no more 
than 11% of the population served. To 
some extent, this preponderance in the 
lower income group has been noted in 
other series.16,17
If the occupation is charted by decreas­
ing frequency of head injury, an inverse 
relationship to earning capacity is noted. 
Is it the ability to earn more that progres­
sively removes an individual from head 
injury situations or some other coincident 
factor that makes for more prudence?
Causes
Head injuries were incurred in traffic 
accidents, fights, falls in sports, at work, 
from gunshot wounds and accidents on 
the farm (Table I).
Traffic Accidents
Automobile, pedestrian, motorcycle 
and snowmobile accidents accounted for
988 injuries, 32.9% of the total, similar 
to other series,9,28 although Bakay and 
Glasauer31 reported 75% in their study. 
The male-to-female ratio decreased to 
1.78:1 from the overall ratio of 2.19:1.
Head injuries due to traffic accidents 
were further examined as to the role of 
the victim. Of these, the victim was the 
driver in 31.7% (314 injuries) and the pas­
senger in 25.8% (255 injuries), while 
pedestrians were victims in 20% (198 inju­
ries).20 Of the remainder, bicyclists were 
victims in 7.7% (76 injuries) (in another 
series,18 47% of the bicyclists interviewed 
thought they were at fault), motorcyclists 
in 7.6% (75), snowmobilers in 1.6% 
(16)32,33 and the traffic accident cause 
was miscellaneous in 5.5% (54) of head 
injuries. These proportions are roughly 
the same as those reported by Hart and 
associates19,20 and Simpson and associ­
ates.34 There were 28 times as many 
registered passenger vehicles, including 
trucks, as registered motorcycles in the 
province.32 Despite this, there was one 
accident per 233 motorcycles as opposed 
to one accident per 990 passenger vehi­
cles — 4.3 times more accidents per 
motorcycle.
Sex.—Head-injured men exceeded 
women as operators of snowmobiles in a 
ratio of 3.8:1, of motorcycles in a ratio 
of 3.15:1, bicycles 1.43:1 and automobiles 
1.71:1; on the other hand, women 
exceeded men as passengers in a ratio of 
1.93:1, and as pedestrians, 1.16:1.
Age.—Forty-four percent of the 
automobile drivers and 60% of the 
motorcyclists were between the ages of 20 
and 29 years, 60% of the passengers were 
between the ages of 10 and 20 years, 
47.5% of the pedestrians were under the 
age of 19 years as were 82.9% of the bicy­
clists, similar to findings in other 
reports.11,12,24 In children younger than 9 
years and adults older than 70 years, 
traffic accidents were the most common 
cause of head injury, 54.2% and 52.4% 
respectively.
Occupation.—The proportions of the 
occupational categories within the traffic 
accident group were similar to the over­
all proportions: 23.8% welfare, 19.3%
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unemployed and 15.8% unskilled 
labourers. These rates were similar to 
those of others.16’19
Fights
Head injuries resulting from fights and 
assaults accounted for 29.2% of injuries. 
Of these 876 cases, the majority (76.1 %) 
occurred in people between the ages of 20 
and 49 years with a peak in the 20 to 
29-year age group.
Fights were the single most frequent 
cause of head injury in both the fourth 
and fifth decades with a male-to-female 
ratio of 2.36:1.
Combined welfare recipients and 
unemployed accounted for 498 (56.8%) 
of the 876 head injuries due to fights or 
assaults, with a male-to-female ratio of 
1.17:1 (p < 0.05).
Falls
As in two other large series,9’35 falls 
accounted for 29.1% of the head injuries 
in our series. The ratio of men to women 
in this group was 2.16:1. Falls were the 
single most frequent cause of head injury 
in patients under 10 years and over 50 
years of age, together accounting for 
56.7% of the 873 injuries due to falls, and 
this was reflected in the type of employ­
ment of patients in this group. It fell most 
frequently into the “other occupational 
status” category.
Sports Injuries
One hundred and twenty-four injuries 
(4.1% of the total) occurred during 
sports. None were from boxing, although 
there is an active amateur and profes­
sional boxing program in the province.
Work-Related Injuries
These injuries accounted for only 111 
(3.7%) cases.
Gunshot Wounds
These accounted for 13 (0.4%) of all 
head injuries.
Farm Accidents
In this group were 9 (0.3%) head 
injuries.
Miscellaneous Circumstances
Four percent of all head injuries were 
in this group.
Drug and Alcohol Abuse and Smoking
The figures for head injuries resulting 
from drug and alcohol abuse will always 
be understated. First, there is an obvious 
reluctance to record use of these agents 
on the charts of prominent citizens and, 
second, even when drug or alcohol abuse
is strongly suspected, neither will be 
recorded unless the patient or friends 
admit to it. Beyond this, blood and urine 
samples are examined only rarely because 
of concern as to whether the altered level 
of consciousness is secondary to the head 
injury or intoxication; hence the 45.6% 
drug or alcohol use in our series is a mini­
mum and yet it is similar to that recorded 
by others.12’14’22’23,34
Of the 1368 drug- or alcohol-related 
head injuries, the male-to-female ratio 
was 2.72:1, a significant difference over 
the 2.19:1 ratio for the entire study (p < 
0.05).
Drug or alcohol use was most frequent 
in the third decade, being associated with 
31.7% of head injuries, followed by 
21.6% in the fourth decade, after which 
the usage progressively decreased.
The number of head injuries in nonin- 
toxicated individuals caused by those 
under the influence of drugs or alcohol 
is not known but is suspected to be very 
high.
The combined categories of welfare 
and unemployed constitute something less 
than 11% of the total population, yet 
account for 79.6% of all the recorded 
cases involving drugs or alcohol.
Arranging the occupations by decreas­
ing frequency of alcohol or drug involve­
ment indicates, in general, an inverse rela­
tionship to earning capacity. The 
significance of such a relationship is 
speculative.16’19,22
There was drug or alcohol involvement 
in 76% of the head injuries due to fights, 
39.4% of those due to sports injuries and 
4.6% of those due to work-related inju­
ries. The association of occupational sta­
tus with drug use is significant (p < 
0.001); the combined categories of wel­
fare and unemployed accounted for 
74.9% of the interaction effect in fights 
and falls. Of the welfare and unemployed 
group with drug or alcohol involvement, 
63.6% of head injuries were the result of 
a fight or an assault. Furthermore, wel­
fare recipients and the unemployed who 
had head injuries resulting from fights 
accounted for 31.7% of all the drug and 
alcohol cases.
Early in the series, one passenger in a 
traffic accident volunteered that the acci­
dent had occurred as the driver was light­
ing a cigarette and one other stated it had 
occurred as a cloud of smoke was 
exhaled. No others in the series volun­
teered or acknowledged that smoking was 
a factor.
Diagnosis
The most common primary diagnosis 
in our study was concussion in 2574 inju­
ries (85.8%), proportionately distributed 
among all age groups, occupations and 
circumstances. Of the remaining 426 
(14.2%) head injuries, contusion was
diagnosed in 88 instances (20.6%), 
cerebral laceration in 30 (7.4%), subdural 
clot in 81 (19.0%), intracerebral clot in 
19 (4.4%), extradural clot in 24 (5.6%) 
and in 81 instances (19.0%) combinations 
of these. The remaining 103 were catego­
rized as miscellaneous injuries. The vari­
ous categories of fracture — linear, 
depressed and basilar, with or without 
spinal fluid leaks — were almost without 
exception associated with one of the 
primary diagnoses.
During the study, angiography was 
largely replaced by computerized tomog­
raphy. There is some concern that 
because of this trend the occasional trau­
matic aneurysm may have been missed.36 
The use of echography was discontinued 
early as a diagnostic procedure, having 
been proven worthless in our centre.
Severe Injury
Cerebral damage more extensive than 
concussion included all cases in which a 
cranial surgical procedure was required 
(other than for simple depressed frac­
ture), and those associated with coma (no 
vocal response to pain),37’39 those in 
which a cerebral neurologic deficit per­
sisted for more than 4 hours and those 
with evidence of intracerebral hemor­
rhage on scanning. There were 426 such 
cases. Spinal fluid fistulas or skull frac­
tures alone were not considered indicative 
of more than concussion. Cerebral neu­
rologic deficit persisting more than 4 
hours included 150 cases of extremity 
paresis, 123 of pupillary irregularities, 92 
of convulsions, 74 cases associated with 
respiratory irregularities and 155 cases 
associated with temperature, blood pres­
sure or pulse deviations. Of these, 44.6% 
(190 patients) had more than one such 
sign.
The male-to-female ratio and age 
spread were essentially the same as for the 
whole study, except that most cases of 
convulsions were in children (13.0% 
under 2 years of age).11 There were 135 
cases of spinal fluid fistula, most com­
monly in patients between the ages of 15 
and 23 years.40 Drugs or alcohol were 
involved in 40.7% of the 426 injuries in 
which the patient was considered to have 
more than concussion.
Associated Injuries
Of the 3000 head injuries, 1831 (61%) 
were associated with additional injuries, 
most frequently as the result of traffic 
accidents (59%, p < 0.001). Of these, 
1450 (79.2%) had a single additional 
injury, the most frequent being to the 
face, in 684 instances, followed by 
extremity soft-tissue injury in 239 
instances, extremity fractures in 100, chest 
in 93, neck and soft-tissue in 44, cervical 
spine in 42, pelvic in 36, abdominal in 13,
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inner ear injuries in 5 and miscellaneous 
in 194 instances. Multiple associated inju­
ries were found in 381 patients (20.8%). 
Each category of additional injury was 
most frequently the result of a traffic acci­
dent, with the exception of neck and 
facial injuries which occurred more fre­
quently as the result of a fight or a fall. 
Alcohol or drugs, or both, were involved 
in 50.7% of those with associated inju­
ries, with a male-to-female ratio of 
1.16:1.
Treatment
Those eventually discharged with a 
diagnosis of concussion (2538 patients) 
were observed only. This was by far the 
most common procedure. However, there 
was a marked difference in the discharge 
advice given by the two staff services. One 
service advised all concussion patients to 
return immediately to full activities with 
the assurance that, “ nothing will come 
apart or go wrong inside your head” . The 
other service advised all to, “ take it easy 
for a week or two” . As the services rotate 
each month, there was an effective age, 
sex, occupation and situation randomiza­
tion of these two groups over the 
40-month period of the study.
Suturing was the next most frequent 
treatment listed (739 cases), followed by 
burr-hole drilling (83), craniectomy (48), 
craniotomy (48), tracheostomy (40) and 
shunting (2). There were 37 miscellane­
ous treatments.
Because of the rotation between the 
two services each month, there was also 
randomization in the handling of the 
severe head injuries. On one service, all 
patients were treated intensively with 
intracranial pressure monitoring, paral­
ysis, ventilation and barbiturates. On the 
other service, treatment consisted of 
maintaining an airway and giving man­
nitol, based on clinical indications.
The differences in management had lit­
tle or no effect on mortality, as reported 
by Jennett and associates5 who found 
that intracranial pressure monitoring did 
not affect the mortality and that, as a 
whole, patients treated more intensively 
(i.e., paralysed, ventilated and given bar­
biturates) did less well as a group than 
might have been expected.21 Becker and 
associates41 and Bowers and Marshall3 
did not agree.
Deaths
The m ortality  was 4.36% (124 
patients). The male-to-female ratio was 
2.74:1, increased from the ratio of 2.19:1 
for the study as a whole. (The overall 
provincial accident fatality male-to- 
female ratio including poisoning is 
2:1,42) For men, most deaths occurred in 
the third decade followed by the fifth and 
then the second, while most deaths in
women occurred in the eighth followed 
by the fourth and the third. Thus, men 
are not only more likely to receive a head 
injury, but even more so to receive a 
severe head injury, at an earlier age.
Traffic accidents and falls accounted 
for 42.8% and 41.2% of the deaths 
respectively. In the third decade, the most 
frequent cause of death was a traffic acci­
dent (20 of 27, 74.1%). After the age of 
70 years, the most frequent cause was a 
fall, accounting for 27 of the 32 fatalities 
(84.4%). Forty-eight percent of the 
motor-vehicle-accident deaths involved 
motorcycles, yet motorcycles account for 
only 3.6% of the registered vehicles in the 
province. Thus, there are 4.3 times as 
many head injuries per vehicle and 12.3 
times as many deaths per vehicle for 
m otorcycles. Although H art and 
associates19 stated that most motorcycle 
accidents are not the fault of the cyclist, 
50% of the motorcycle fatalities occurred 
between 24:00 and 02:00 hours when the 
streets have only 2% of the total daily 
traffic. There were no deaths from bicy­
cle accidents. Alcohol or drugs, or both, 
were involved in 35.1% of all the fatali­
ties, in 45.7% of those from falls, in 
34.8% of those from traffic accidents, in 
15.2% of those from fights, in 2.2% of 
those from gunshot wounds and in 2.1% 
of those from unknown circumstances. It 
should be emphasized that the additional 
number of head injuries in sober persons 
caused by individuals under the influence 
of drugs or alcohol is unknown.
Outcome
Of the 2850 patients, 1449 (50.8%) 
were detained for 24 hours or less; 941 
remained up to 7 days, another 192 up to 
14 days, 61 up to 21 days and 206 patients 
over 3 weeks. One patient who had a 
placement problem remained in hospital 
for 687 days. A relatively small percen­
tage were permanently disabled from 
head injury alone (45 patients, 1.6%). 
This included blindness in one eye (6), 
hemiparesis (3), aphasia (2), anosmia (1) 
and 22 other disabilities including demen­
tia of varying degrees; 11 patients had 
more than one of these disabilities. We 
agree with Jane and Rimel35 that these 
patients rarely, if ever, return to their 
original place in society. The age, sex and 
substance use patterns of these patients 
were similar to the overall trend of this 
study. Twenty-six (57.8%) of those with 
permanent disability were injured in 
traffic accidents, 8 (17.8%) in fights and 
5 (11.1%) in falls. A similar distribution 
was noted by Rutherford.23
When we compared the two groups of 
concussion patients (those advised to 
return to work immediately and those 
advised to “ take it easy for a while’ ’), we 
found that the only patient-initiated 
return visits and inquiries from the first
group (those advised to return immedi­
ately to full activities) came from those 
with third-party liability involvement. 
From the second group, there were many 
calls and return visits (in some instances, 
advised by the discharging physician) con­
cerning the ability to return to full activi­
ties. To this extent, those who returned 
immediately to their full activities 
appeared to fare better.
Comparison of the third-party liability 
group with the group without third-party 
liability revealed no statistically signifi­
cant difference in the time away from 
work, but the subsequent duration of 
complaints and days lost from work, 
regardless of the two categories of dis­
charge advice, indicated that motivation 
was important.43
Discussion
The profile of a person most at risk is 
a 19-year-old, unemployed, male driver 
with a past history of head injury, a sus­
pended licence, with a female passenger, 
both under the influence of drugs or alco­
hol, or both, at 02:00 hours on Sunday 
morning. The number of others injured 
by this person is unknown, but doubtless 
very high. The profile of the safest 
individual is a middle-aged woman walk­
ing to work or to the market, sober, at 
09:00 hours on Monday morning. The 
unemployed welfare recipient late in the 
second or third decade under the 
influence of drugs or alcohol, or both, 
costs the community a considerable and 
disproportionate sum in caring for head 
injuries and the injuries caused to others. 
With the present per diem cost of 
$361.35, the average yearly hospital cost 
of head injuries for our catchment area 
would be $3 252 150. ($10 per capita). 
This sum would be dwarfed by the medi­
cal fees, ambulance costs and long-term 
care costs, and eclipsed by the cost of 
work days lost, legal fees and claim set­
tlements.
The very small number (about 2%) 
requiring intensive care and the additional 
6% requiring definitive surgery constitute 
a very small proportion. Those with head 
injuries only who died before admission 
and are not included in this study had no 
history of a lucid interval, so were 
unlikely to have been saved had they 
arrived in hospital earlier. While we 
recognize that patients with other injuries 
are saved because of earlier care,44-46 we 
agree with Marshall and associates47 that 
with head injuries alone, mortality and 
morbidity are probably not significantly 
modified by efforts to reduce transpor­
tation time. In other words, additional 
money spent on sophisticated transpor­
tation and intensive care would apply to 
a very small percentage of the head inju­
ries and would be unlikely to bring a sig­
nificant change in outcome.
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The figures on accidental injury are 
appalling in the most advanced countries 
today, ranking fourth as a cause o f death 
behind ischemic heart disease, cancer and 
cerebrovascular accident.24 Obviously, 
head-injury prevention would provide 
great savings and overall advantage to 
society, but to date, there is no agreement 
as to how this might be done. The 
problem has frustrated those with the best 
intentions for decades. Our government 
advocates mandatory drug and alcohol 
tests while at the same time our 
newspapers report that 75% o f convicted 
drivers have immediate, partial or com­
plete restoration o f their suspended driv­
ing privileges.
Physician and public education must 
continue to improve.48 Trauma results in 
more years o f lost life than cancer and 
heart disease combined and probably 
many times the years o f productivity. Yet, 
the money spent on research for all 
trauma in only about 0.7% o f  that spent 
on cancer and heart disease.45 Attention 
must be focussed on the time lost from 
work and the progressively larger settle­
ments awarded to those with nothing 
more than concussion, whose injuries 
constitute 85.8% o f head injuries in 
patients admitted to hospital. As long as 
it is accepted that anyone with concussion 
is to some extent permanently disabled 
and can be expected to have symptoms 
for many months, the review boards, 
judges and juries have little more than an 
emotional basis for evaluating the 
patient’s statements and determining set­
tlement. Until the medical profession pro­
vides more definitive answers concerning 
the boundaries and reversibility o f con­
cussion, these settlements will continue as 
an escalating economic drain on the tax­
payer.
It is evident from looking at all the cost 
factors: prevention, transportation, treat­
ment, long-term care, lost productivity 
and settlement, that the latter two are the 
variables most amenable to modification. 
Money spent for research on concussion 
offers a great potential yield in the medi­
cal socioeconomic problems o f head 
injuries.
We acknowledge with thanks the help of C. 
Kostelnuk, D. Wong and M. Marko; P. Moo- 
die from the Computer Programming Depart­
ment, University of Manitoba; statisticians, B. 
Ten Have and M. Krenn; and L. Richardson, 
graphic artist, Instructional Media Centre, 
University of Manitoba.
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A  symposium on maxillofacial trauma 
will be held M ar. 3-6, 1985 at the Hyatt 
Lake Tahoe, Lake Tahoe, Nevada. Spon­
sored by the Department o f Otolaryn­
gology-Head and Neck Surgery and 
Extended Programs in Medical Education 
o f the University o f California School o f 
Medicine at San Francisco, this program 
is intended to update treatment principles 
o f  practising otolaryngologists, plastic 
surgeons, oral surgeons, emergency medi­
cine physicians and critical care nurses in 
the area of maxillofacial injuries.
The program faculty will bring together 
a group o f experienced surgeons and 
allied professionals who focus on problem 
areas and new developments in the treat­
ment o f the injured patient. The guest lec­
turer will be Robert Kellman o f Southern 
University o f  New York, Syracuse. 
University faculty will include Ronald M. 
Barton, Roger L. Crumley, Herbert H. 
Dedo, Jack Koumdjian, Guy Trengove- 
Jones, Donald D. Trunkey and Thomas 
O. Wildes. It will meet the criteria for 16 
hours o f AM A/C M A/AC C M E  category 
1 credit.
For further information contact: 
Extended Programs in Medical Educa­
tion, University o f California School o f 
Medicine, Rm. 569-U, San Francisco, C A  
94143; (415) 666-4251.
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NOTICES
continued from  page 75
Maxillofacial Trauma
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Postoperative Abdominal Wall Hematomas Have a Distinctive
Appearance on Ultrasonography
In six patients a large abdominal wall 
hematoma developed 1 1/2 to 6 months 
after operation. In each case, differentia­
tion of incisional hernia from hematoma 
was difficult, but the distinctive appear­
ance on ultrasonography of an ovoid 
mass with thick straight internal septae, 
characteristic of hematoma, was noted 
in all. Ultrasonography also showed the 
multilocular nature of the lesion which 
made percutaneous aspiration difficult.
Un gros hematome de la paroi abdomi- 
nale est apparue chez six patients de 
1 1/2 mois a 6 mois apres une interven­
tion chirurgicale. Dans tous les cas, il fut 
difficile de differencier I'hematome d'une 
hernie incisionnelle. Neanmoins il fut 
chaque fois possible d’observer a I'echo- 
graphie I'apparence distinctive d'une 
masse ovoide avec une dpaisse cloison 
droite interne. L'echographie montrait 
egalement ('aspect multiloculaire de la 
lesion, ce qui en compliqua I'aspiration 
percutanee.
When abdominal wall masses appear 
after repair o f large incisional hernias it 
may be difficult to differentiate between 
a hematoma and recurrent hernia, espe­
cially in obese patients. Ultrasonography 
may be helpful in such cases. We report 
six patients in whom hematomas deve­
loped 1 'h to 6 months after hernial 
repair. The distinctive ultrasonographic 
appearance may aid the surgeon and radi­
ologist faced with a similar diagnostic 
dilemma to diagnose the hematoma.
Patients
In the six patients (four women, two
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men), who ranged in age from 41 to 68 
years, a mass developed after repair of a 
large hernia. No patient was taking 
anticoagulants and none showed evidence 
of sepsis. In several patients the mass 
appeared suddenly. It did not vary with 
posture and suggested an incarcerated 
hernia. Family doctors were convinced 
that the hernias had recurred.
All patients were examined with either 
a static B scanner (Picker 80L; Picker 
Nuclear, Chicago, 111.), or an abdominal 
real-time B-scan unit (ADR [Advanced 
Technology Laboratories, Bellevue, 
Wash.] or Diasonics [Diasonics Inc., Mil­
pitas, Calif.] wide-view scanner).
Case Reports
Case 1
A markedly obese 55-year-old woman under­
went surgical repair of a large recurrent inci­
sional hernia. Her postoperative course was 
uncomplicated until she presented 3 months 
later with a tender swelling (9 x 12 cm) 
beneath her lower abdominal incision. She was 
afebrile. Ultrasonography was requested to 
exclude recurrent hernia. It showed a well- 
defined septate mass measuring 7 x 12 cm 
(Fig. 1) near the midline in the lower abdomen. 
The septae were thick and linear. Percutane­
ous aspiration yielded only a small quantity of 
sterile fluid. The mass gradually resolved over 
a period of months.
Case 2
This 56-year-old man with a history of heavy 
smoking and chronic obstructive pulmonary 
disease underwent repair of an incarcerated, 
recurrent, umbilical, incisional hernia. His 
postoperative course was unremarkable; in par­
ticular, he was afebrile. At the time of 
ultrasonography, 5 months later, he com­
plained of recurrent swelling at the incision.
On ultrasonography there was a mass meas­
uring 10.5 x 4.5 cm just deep to the anterior 
abdominal wall (Fig. 2). It demonstrated thick 
internal septae that were linear in configura­
tion. After 110 mL of bloody fluid was aspi­
rated percutaneously the mass resolved.
Case 3
This 41:year-old woman presented 4Vi
months after repair of a recurrent, umbilical, 
incisional hernia with tenderness and swelling 
deep to her transverse incision. Her postoper­
ative course had been smooth.
Ultrasonography (Fig. 3) showed thick linear 
septae in a moderately well-defined mass 8 cm 
long. Percutaneous aspiration of the mass was 
unsuccessful. She underwent surgical removal 
of the hematoma the day after ultrasonogra­
phy. A cyst filled with old blood clot, fibrin 
and serum was completely removed.
FIG. 1—Case 1. Longitudinal scan, 2 cm to 
right of midline, shows spherical, sharply 
delimited mass just beneath anterior abdomi­
nal wall with multiple, thick, linear septae.
FIG. 2—Case 2. Transverse scan, 3 cm 
above the level of the symphysis pubis, shows 
ovoid mass with broad linear septae just 
beneath anterior abdominal wall.
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The rather thick, angular septae found 
in our patients were likely due to frag­
mentation of the clot and clot retraction. 
It should be emphasized that on the basis 
of ultrasonography alone, an abscess 
could not be excluded. However, we have 
not seen abscesses with such an abun­
dance of thick angular septae in our insti­
tution. The multiple septae explain the 
difficulty encountered in aspirating the 
hematoma in two of our patients, and this 
finding suggests that therapeutic aspira­
tion will often be impossible, due to the 
multilocular nature of the hematoma.
The appearance of these incisional 
hematomas was so similar and distinctive 
as to allow a firm diagnosis of hematoma 
to be made after the initial case. Recur­
rent hernia could be excluded with con­
fidence. Such hematomas are more prone 
to occur when hernias are large and 
patients obese. These patients are partic­
ularly difficult to examine when postoper­
ative masses appear. Careful hemostasis 
and long-term use of closed suction 
catheters may help to decrease the fre­
quency of this complication.
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Case 4
This 68-year-old man had a cholecystectomy 
and repair of a left inguinal hernia. Some bruis­
ing in the left lower quadrant and scrotum were 
noted immediately postoperatively, but his 
recovery was smooth. Seven weeks postoper­
atively a firm, nontender, mobile swelling 
related to the lower end of the groin incision 
was noted.
Ultrasonography was requested to differen­
tiate between a recurrent hernia and hema­
toma. It showed a 3-cm ovoid mass crossed by 
thick linear septae (Fig. 4). The mass resolved 
with no clinical evidence of recurrent hernia.
Case 5
A 51-year-old woman, who weighed 146 kg, 
had a gastroplasty for morbid obesity. Twenty 
months later she underwent repair of a large 
incisional hernia. Her weight at that time was 
110 kg. Two months later she noticed a mass 
at the site of the incisional hernia repair.
On physical examination an area of fullness 
14 cm in diameter was noted beneath her mid­
line abdominal incision. The swelling did not 
change with position. The area was dull to per-
F1G. 3—Case 3. Longitudinal scan, 3 cm to 
left of midline, shows spherical mass contain­
ing multiple thick septae in radial configu­
ration.
FIG. 4—Case 4. Longitudinal scan in left 
groin showing ovoid mass with multiple thick 
septae.
cussion and only mildly tender. There was no 
clinical or laboratory evidence of infection. The 
clinical diagnosis was hematoma but recurrent 
and incarcerated hernia could not be excluded, 
so she was referred for ultrasonography.
Ultrasonography showed a mass in the upper 
abdomen 14 cm long, 12 cm wide and 8 cm in 
anteroposterior diameter. It was complex, con­
taining both cystic and solid regions. The sep­
tae within it were very thick and angular. The 
ultrasonographic appearance was that of a 
hematoma. The mass persisted unchanged but 
she continued to gain weight to 127 kg. One 
year after hernia repair her gastroplasty was 
revised and a 12-cm cystic hematoma was 
excised from the abdominal wall at the same 
time.
Case 6
This 43-year-old woman, weighing 162 kg, 
underwent a gastroplasty for morbid obesity. 
A large incisional hernia from previous 
cholecystectomy was repaired at the same time. 
Six months later a large abdominal mass deve­
loped at the site of her incision. It increased 
slightly in size over the next 2 months but 
caused her only mild discomfort.
Physical examination showed a nonreduci­
ble, nontender fixed mass 10 x 15 cm in 
dimension beneath her upper midline incision. 
The mass was not tender and could not be 
reduced. She was afebrile and there were no 
signs of inflammation.
Ultrasonography showed a mass 14 cm wide 
and 9 cm in anteroposterior diameter. It was 
cystic with a single thick septum located eccen­
trically within the mass. Because of persistent 
obesity and lack of symptoms, treatment was 
postponed. Two years later the persistent mass 
caused more discomfort. A 15-cm encapsulated 
hematoma was removed without complication. 
There was no hernia.
Discussion
In all six patients ultrasonography cor­
rectly distinguished the hematoma from 
recurrent hernia at the site of incisional 
swelling. The information was useful in 
the management of this group of obese 
patients. In several cases operation was 
avoided and in others aspiration sug­
gested. The patients’ family doctors and 
surgeons were reassured by the findings. 
Elective excision could be planned for 
persistent hematomas.
The ultrasonographic features of hema­
tomas of differing ages have been well 
described.1’2 With the criteria of Wicks 
and associates,2 the hematomas in our 
patients would fall into the early (1 to 7 
days) or middle (8 to 30 days) groups, 
even though they presented months after 
operation.
The ultrasonographic features differ 
from those described for rectus sheath 
hematoma, which is usually elliptical in 
shape and sonolucent, without internal 
septae.3 Septae have, however, been 
described in hematomas at other sites4’5 
and occasionally in rectus sheath 
hematoma.6
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Medical Writing for Publication
Professional Services, in cooperation with 
the C.V. Mosby Company Ltd., will pre­
sent an intensive seminar on medical wri­
ting for publication on Feb. 15, 1985 at 
the Sutton Place Hotel, Toronto, Ont. 
This seminar will cover general publishing 
requirements, guidelines for manuscript 
preparation, organizing skills and ele­
ments of clear, effective writing. The 
resource leaders are K. Berger, a senior 
acquisitions editor in the Medical Division 
of C.V. Mosby Company, and A.P. 
Sheen, a freelance writer and editor. The 
fee of $165 includes program materials, 
textbook, lunch and refreshments.
For more information write Professio­
nal Services, 205 Humber College Blvd., 
Rexdale, Ont. M9W 5L7; or call (416) 
675-5077.
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Right Hepatic Lobectomy for Primary and Metastatic Tumour: 
Experience in a Community Teaching Hospital
The first eight patients who required 
either a total or extended hepatic lobec­
tomy for malignant tumour at a commu­
nity teaching hospital are reviewed. Two 
patients had primary liver tumours and 
six had metastatic adenocarcinomas, five 
from colorectal and one from an 
unknown primary tumour. There were no 
deaths perioperatively, morbidity was 
minimal and survival was encouraging. 
Three patients died of disseminated dis­
ease 9, 16 and 18 months respectively 
after hepatic resection. However, five 
patients were free of disease 19, 27,
52, 63 and 80 months after operation. 
The authors' initial experience compares 
favourably with that of others and 
demonstrates that major hepatic resec­
tion can be done safely and can offer 
prolonged survival of good quality to a 
selected group of patients, even when 
the tumour load is large.
On 6tudie les huit premiers patients qui 
ont subi une lobectomie hepatique totale 
ou etendue pour tumeur maligne dans un 
hopital universitaire. Deux patients 
avaient des tumeurs hepatiques primiti­
ves alors que six etaient porteurs de 
metastases, cinq d'origine colorectaie et 
une d'une tumeur primitive non identi- 
fiee. Aucun deces peroperatoire n'a 6te 
enregistre, la morbidite a ete minimale et 
la survie encourageante. Trois patients 
sont morts de cancer generalise 9, 16 et 
18 mois respectivement apres la resec­
tion hepatique. Cependant, cinq patients 
sont exempts de maladie 19, 27, 52, 63 
et 80 mois apres I’operation. Inexpe­
rience initiale des auteurs se compare 
favorablement a celle des autres et 
demontre qu'une resection hepatique
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importante peut etre pratiquee en toute 
securite et offrir une survie prolongee de 
bonne quaiite a un groupe choisi de 
patients, meme quand la tumeur est 
grosse.
Surgeons can expect to be confronted 
with potentially resectable malignant liver 
tumours, requiring more than just a 
wedge resection or left lateral segmentec- 
tomy to obtain adequate clearance. These 
lesions may be either primary in the liver 
or, much more frequently in North 
America, synchronous or metachronous 
metastatic lesions from a primary colorec­
tal tumour.
Despite advances in both diagnosis and 
therapy, less than 40% of all colorectal 
carcinomas are localized1 and there has 
been little improvement in survival over 
the past three decades.2 The liver is the 
most common site of distant metastatic 
disease, the right lobe being most fre­
quently involved,3 and it is estimated 
that over half of all colorectal cancer 
patients who die, do so with or because 
of liver metastases.4
Approximately 7% of primary malig­
nant liver tumours are resectable.5 Some 
reports estimate that nearly 10% of 
patients with colorectal cancer, the second 
most frequent neoplasm in the western 
world,2 will present with, or eventually 
suffer from, clinically apparent meta­
stases confined to a resectable portion of 
the liver.68 The reported median sur­
vival, even for this select group, varies 
between 3 and 19 months and the longest 
survival time between 20 and 36 
months.811
There has been less debate concerning 
the management of solitary primary 
hepatic cancer in the noncirrhotic liver 
than that of a localized embolic liver 
metastasis from a distant colorectal 
primary tumour. Whereas major hepatic 
resection, considered a local treatment, 
seemed justified in the former,5'7 other 
forms of therapy appeared to be more 
rational and appealing for the latter. 
There is no evidence that either single or 
combination systemic chemotherapy has 
benefited patients with colorectal
metastases and the reported side effects 
of such therapy seem to outweigh the 
limited response.12
Intra-arterial hepatic perfusion, which 
involves additional expense and expertise 
and is often impractical because of ana­
tomic anomalies,13 has so far failed to 
produce substantial improvement over 
intravenous chemotherapy14 despite 
recent encouraging response rates of more 
than 80%.15
There is no evidence that these modal­
ities have a role to play, even in the adju­
vant setting, in selected patients with 
resectable primary or metastatic liver 
tumours.16'17 On the other hand, Foster 
and Berman7 and Foster1819 reported, 
between 1970 and 1978, that a 5-year sur­
vival rate of 25% could be anticipated for 
selected patients who underwent surgical 
resection of primary liver tumours and 
certain types of liver metastases.
Our interdisciplinary oncology unit 
adopted a policy of considering all local­
ized liver tumours, either primary or 
metastatic from the colorectum, as poten­
tially resectable unless proved otherwise. 
This report summarizes our initial 
experience with this policy as it pertains 
to patients in whom the hepatic tumour 
load was sufficiently large to require a 
major hepatic resection.
Patients
Eight patients (four men, four women, 
constituting the personal experience of 
J.R.) who underwent a major hepatic 
resection for primary or metastatic cancer 
at St. Mary’s Hospital in Montreal 
between 1978 and 1983 form the basis of 
this report (Table I). Seven patients had 
a total right hepatic lobectomy and one 
had an extended right hepatic lobectomy 
(right trisegmentectomy). The mean age 
was 56.2 years. Two patients had primary 
liver tumours (one hepatoma and one 
cholangiocarcinom a) and six had 
metastatic adenocarcinomas (five from a 
colorrectal primary tumour and one 
unknown). Of the five patients with 
proven colorectal primary tumours, three 
underwent synchronous liver resection
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(less than 3 months after the colorectal 
prim ary resection) and two had 
metachronous lobectomy 32 and 42 
months after removal of the primary 
colonic tumour. Three patients had two 
adjacent but separate tumour masses 
within the excised specimen. The mean 
diameter of the hepatic tumour load was 
15.9 cm (Fig. 1).
Mode of Detection
Physical examination was indicative of 
a liver tumour in only three of the eight 
patients. Two presented with tender liver 
masses and the third had hepatomegaly, 
which developed 33 months after colonic 
resection. Results of liver function studies 
were normal in three patients; however, 
the carcinoembryonic antigen level was 
elevated in four of the five patients with 
metastatic colorectal liver tumours. 
Ultrasonography was diagnostic for a 
mass within the liver in all cases. Neither 
computerized tomography nor angiogra­
phy added essential information to the 
preoperative evaluation of these patients.
Operative Notes
Half of the patients, particularly dur­
ing our initial experience, required a 
thoracic extension of the basic bilateral 
subcostal incision. The mean duration of 
the operation was 6.3 hours and the mean 
blood replacement was 7.8 units. Two 
intraoperative complications were recog­
nized: a major tear in the retrohepatic 
inferior vena cava in the only case in 
which preliminary dissection and ligation 
of the right hepatic vein was attempted 
and a severed common hepatic duct, mis­
taken for the right hepatic duct, that 
healed well after primary repair over a T- 
tube stent. There were no operative 
deaths. Morbidity in the first seven 
patients was limited to atelectasis alone 
in three patients and atelectasis with a uri­
nary tract infection in another. The mean 
postresection hospital stay for those seven 
patients was 10 days. However, ascites, 
cholangitis and a biliary fistula developed 
following a right trisegmentectomy in one 
patient, complications that required sup­
portive therapy during a 30-day hospital
stay. On the basis of sequential postoper­
ative ultrasonography, hepatic regenera­
tion was judged complete by the fourth 
postoperative month (Fig. 2) by which 
time the elevated carcinoembryonic anti­
gen level in our present survivors had 
dropped below 2.5 ng/mg.
Survival
Survival with so few patients is difficult 
to evaluate. Life-table analysis predicted 
a 5-year survival of 55% (Fig. 3). Three 
patients, all with metastatic adenocarci­
noma (two with single lesions), died at 9, 
16 and 18 months after resection, all of 
hepatic recurrent and disseminated dis­
ease. But, the remaining five patients were 
alive and free of disease as of their last 
restaging, 19, 27, 52, 63 and 80 months 
after hepatic resection. In an attempt to 
assess the quality of life of our five sur­
vivors, Spitzer’s QL-index was used.20 
Four of the patients are fully active in 
their respective occupations and obtained 
the maximum score of 10. The fifth sur­
vivor, the patient who underwent triseg-
Tahle 1—Clinical Data
Lab data before
Site and 
type of 
primary 
lesion
Interval hepatic resection
Patient Age, 
no. vr Sex
Primary
procedure
primary
colon/hepatic
resections
Liver
function
studies
CEA,
ng/mg
Ultrasono­
graphy
Postop
survival,
mo
Present
status Comments
i 27 F Rectosigmoid 
Dukes' C
Anterior
resection
2 wk ALK, LDH 
elevated
< 2 .5 + 9 DWW Metastatic adenocarcinoma 
24 x  26 cm, disease-free 8 mo
2 43 F Rectal 
Dukes' C
Abdominoperineal
resection
2 wk LDH
elevated
20 + 80 AFD 12-cm mass with 3-cm adjacent 
lesion. Well-differentiated 
adenocarcinoma extending to 
resection margin
3 55 F Liver,
cholangio-
carcinoma
— — ALK, LDH 
elevated
7 + 63 AFD Well-differentiated mass, 
30 x  27 cm
4 75 M Synchronous 
colonic 
lesions, 
Dukes' C
Right hemi­
colectomy/ 
sigmoid 
resection
21/2 wk WNL 20 + 16 DWD 2 adjacent, poorly differentiated 
metastatic adenocarcinomas, 
disease-free 11 mo
5 67 M Unknown ALK, LDH 
elevated
< 2 .5 + 18 DWD Moderately well-differentiated 
mucus-secreting adenocar­
cinoma 10 x 9 cm. Unsus­
pected pleural metastasis, 
found when closing thoraco­
tomy incision, was also 
resected
6 39 M Rectal, 
Dukes' B
Anterior
resection
42 mo WNL 4.5 + 52 AFD 42 mo postlobectomy CEA rose 
from negative (<  2.5) to 18 
ng/mg. Anastomotic recur 
rence, Dukes' A. Ab­
dominoperineal resection. No 
other disease. CEA negative 
again
7 75 F Sigmoid, 
Dukes' A
Left
hemicolec-
32 mo ALK
elevated
12 + 27 AFD Well-differentiated, metastatic 
adenocarcinoma, 10 cm
8 69 M Liver
hepatoma
tomy
- WNL < 2 .5 + 19 AFD Poorly differentiated, medial 
segment, left lobe, 10 cm. 
Mild cirrhosis
ALK -  alkaline phosphatase, LDH = lactic dehydrogenase, WNL -  within normal limits, CEA = carcinoembryonic antigen, DWD -  dead with disease, AFD -  
alive free of disease, + = positive.
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mentectomy, still has not regained his 
preoperative activity level and obtained 
a score o f 7.
Discussion
Previous reports have suggested that 
the extent of the liver tumour load is an 
important determinant in survival of 
untreated patients and those who have
FIG. 1—Case 2. Sagittal section of right lobe 
of liver.
undergone resection.6'7’9’10’21 However, 
there are data proposing that patients who 
require major hepatic resection for com­
plete removal of a large primary or 
metastatic tumour can aspire to the same 
enhanced survival as those whose tumour 
was controlled by wedge resection 
alone.22’23 There is justified concern,
¥
FIG. 2—Ultrasonography 2 ‘/2  months after 
right hepatic lobectomy. Liver regeneration is 
nearly complete.
mostly on behalf of medical oncologists, 
that the potential benefit o f major liver 
resection could be negated by an increase 
in perioperative morbidity and mortality, 
particularly since few centres have 
acquired extensive experience with this 
procedure.
In their 1974 liver tumour study, Foster 
and Berman7 visited 98 hospitals in 48 
cities to collect 621 cases of various types 
of liver resection for solid liver tumours. 
They noted that only 12 centres could
YEARS
FIG. 3—Life-table analysis of survival of 
patients after major hepatic resection.
Table II—Reported Series of Liver Resection
Type of resection
Authors, yr
Review
period
No. of 
cases
Total
lobectomy
Trisegment-
ectomy
Segmentectomy 
or wedge
Mortality,
% Comments
Wilson and 
Adson,24 1 9 7 6
1 9 4 9 -7 2 60 11 - 49 1.6 2 8 %  5-yr survival
Wanebo and 
a sso cia te s,11 1 9 7 8
1 9 5 1 -7 7 27 4 - 23 7 28%  5-yr survival*
Fortner and 
asso cia te s,23 1 9 7 8  
Inouye and 
W helan,5 1979 
Adson and
Van Heerden,22 1 9 8 0
1 9 7 0 -7 8
1 9 6 0 -7 5
1 9 7 3 -7 9
108
15
34
57
19
27
Not stated 
3
24
12
9
33
5.8
72%  3-yr survival primary,* 
88%  colorectal metastases 
3 of 15 resected patients 
survived 3 yr 
4 1 %  3-yr survival*
Hanks and 
asso cia te s,25 1 9 8 0
1 9 4 7 -7 9 32 17 4 11 4 -
Adson and 
W eiland,26 1981
- 1 9 8 0 60 30 12 18 5 3 6%  5-yr survival*
Logan and 
asso cia te s,6 1 982
1 9 7 1 -8 0 19 8 5 9 5.3 6 3%  2-yr survivalt
Morrow and
asso cia te s,27 1 9 8 2
1 9 6 1 -7 8 75 16 2 57 20 34%  5-yr survival
Ryan and
asso cia te s,28 1 9 8 2
1 9 7 1 -8 1 52 33 19 - 8 -
Rajpal and
asso cia te s,30 1 9 8 2
Thompson and 
asso cia te s,29 1 9 8 3 
Iw atsuki and 
asso cia te s,31 1 9 8 3  
Taylor and 
asso cia te s,32 1 9 8 3
1 9 7 2 -8 1
1 9 5 5 -8 0
1 9 6 4 -8 2
- 1 9 8 3
3 4
138
150
22
19
63
44
10
4
13
68
3
11
62
38
9
11.8
10.9
6
0
5 0%  of patients disease free 
at mean follow-up of 23 mo 
(range from 5 to 53 mol 
3 8 %  5-yr survival primary, 
3 1%  colorectal metastases 
5 7%  5-yr survival primary, t 
4 8 %  colorectal metastases 
5 6 .4%  5-yr survivalt
Lim and
M cPherson,33 1 9 8 3
- 1 9 8 3 7 7 - - 0 Mean survival 4 0  mo
Kortz and
asso cia te s,34 1 9 8 4  
Nim s,35 1 9 8 4
1 9 7 4 -8 2
1 9 7 9 -8 0
21
10
14
2
1
3
6
5
5
0
3 4 %  7-yr survivalt
3 patients disease free 
between 27 and 4 3  mo
Operative deaths excluded, 
tA ctu aria l survival.
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contribute more than 10 cases while 36 
others added between 5 and 10 cases. In 
only 59% of these cases did the operative 
report describe anything more than a sim­
ple wedge resection or a left lateral seg- 
mentectomy. They reported an operative 
mortality (death at any postoperative 
interval related to the operation) of 22% 
for those who underwent a total or 
extended lobectomy. This rate fell to 
7.6% for a lesser procedure. In 1978, 
Foster19 reported an 11 % mortality for 
all patients who underwent liver resection 
for colorectal metastasis.
In a more recent sampling of 17 publi­
cations from the North American centres 
(Table II),5’6*11’22-35 9 reported data based 
on more than 15 cases of total or extended 
lobectomies. On the other hand, an 
increasing number of centres,32-35 have 
reported their initial, limited experience 
with major hepatic resection. Their 
acceptable morbidity, 0% to 5% mortal­
ity and encouraging survival reflect the 
accumulated published experience now 
available to community hospitals that 
wish to develop a particular involvement 
with liver resection. They may be partially 
motivated by the possible increase in the 
frequency of hepatic resection now that 
the follow-up of most colorectal cancer 
patients is better coordinated in interdis­
ciplinary oncology units. More emphasis 
is put on the early detection of liver 
metastasis using reliable indicators such 
as serial ultrasonographic and carcinoem- 
bryonic antigen determinations.36
To minimize morbidity, careful selec­
tion of patients is essential. Although cir­
rhotics with primary liver tumours can 
tolerate limited resection,37 major resec­
tion should be limited to those with ade­
quate hepatic reserve and regenerative 
potential. The only patient in our series 
whose postoperative morbidity resulted in 
a prolonged hospital stay had normal 
results of liver function studies but early 
nutritional cirrhosis and fatty change in 
the resected specimen related to alcohol 
abuse some time in the past. Only patients 
with liver metastasis whose primary is 
Wilms’ tumour, colorectal tumour or car­
cinoid are considered for major hepatic 
resection. Thorough screening of candi­
dates with apparently resectable tumours 
should minimize unsuspected metastatic 
disease (as in our case 5). Screening proce­
dures should include full lung tomogra­
phy, double air contrast and endoscopic 
gastrointestinal studies, bone and possi­
bly brain scanning.
Liver function studies, ultrasonography 
and radionuclide scanning constitute the 
bases of our preoperative evaluation of 
the liver; computerized tomography and 
angiography are considered optional. 
None of these studies, except in the most 
obvious cases, replace exploratory 
laparotomy, the ultimate staging proce­
dure, in a patient whose tumour load 
appears confined to the liver.
The technical aspects of major hepatic 
resection have been well described by 
others,738-40 and are based on sound ana­
tomical knowledge as defined by Suzuki 
and associates,13 Mclndoe and Coun­
seller,41 Healey42 and Michels.43 Meticu­
lous inspection and palpation of the entire 
liver must be carried out to avoid miss­
ing an often ill-defined contralateral 
deposit. As proposed by others,28 a 
thoracic extension of the bilateral sub­
costal incision should be used only if 
visualization of the retrohepatic inferior 
vena cava is inadequate. Except for 
lesions easily amenable to wedge resection 
or left lateral segmentectomy, controlled 
anatomic lobectomy had proven to be a 
safe procedure, affording adequate mar­
gins, and should be performed when in 
doubt. We prefer to do preliminary hilar 
dissection and transection before ligating 
the hepatic vein, which is best left for 
when the liver parenchyma has been 
divided along the lobar planes and there 
is optimal exposure of this critical area.
Once the tumour is resected, survival 
appears to be independent of whether the 
resected liver contains a primary tumour 
or colorectal metastasis,29,31 the regional 
nodal status of the colorectal primary,7,29
the interval between the resections of the 
primary and metastatic tumours32 or the 
number of metastatic deposits in the 
resected specimen.27 As reported by 
others,11,26 patients who died following 
hepatic resection did so with both local 
liver recurrence and w idespread 
metastases.
The encouraging data suggesting that 
ad juvant portal vein in fusion  of 
5-fluorouracil and heparin will decrease 
the incidence of metachronous hepatic 
metastasis44 is now being tested in a mul­
ticentre North American trial under the 
auspices of the National Surgical Adju­
vant Breast Project (NSABP). Additional 
trials are in progress to define better the 
role and optimal mode of delivery of 
intra-arterial chemotherapy and arterial 
occlusion for established nonresectable 
primary tumours or hepatic metastases.45 
A selected group of patients, however, 
will have their tumour load confined to 
the portion of the liver that can be 
removed by either a total or extended 
lobectomy. Major hepatic resection, when 
performed with minimal morbidity and 
mortality, can offer patients a 5-year sur­
vival of good quality that may be as high 
as 50% when the outlook is otherwise 
hopeless.
The establishment of a national regis-
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try for surgery of hepatic metastases46 is 
an important step in defining better the 
indications and benefits o f  this kind of 
therapy.
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SESAP IV Critique
ITEM 8
Though the success of digital replantation reaches 85% and higher under ideal 
circumstances, a number of indications and contraindications have become ap­
parent. This operation is long and tedious, and should be attempted only by 
the experienced surgeon. Single-digit replantation, even of a dominant index 
finger, is seldom worthwhile except for the thumb, which is useful in pinch 
and grasp even if part is lost and even without intrinsic motion. Properly refriger­
ated amputated digits (sterile moist container in water and ice) can be success­
fully replanted 12 to 14 hours after amputation. Crush injuries and avulsion 
injuries preclude a good result, however. Ring avulsions usually cause such 
damage. One indication of avulsion damage along a digital artery is a telltale 
“ Chinese red line,” indicating bleeding at multiple sites of avulsion along the 
volar digital vessels.
E
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ZOVIRAX
(ACYCLOVIR SODIUM)
LV INFUSION
Now, the first effective anti-herpes therapy is 
available in an I.V. infusion form: Indicated for immuno­
compromised adults and children with initial or recur­
rent mucosal or cutaneous herpes simplex infections 
...and for normal patients with severe initial episodes 
of herpes simplex infections.
ZOVIRAX
(ACYCLOVIR SODIUM)
LV. INFUSION
ACTIONS
ZOVIRAX (acyclovir), an acyclic nucleoside analog, is a substrate specific for herpesvirus- 
specified thymidine kinase. It inhibits replication of these viruses. Normal cellular thymidine 
kinase does not effectively utilize acyclovir as a substrate. Herpesvirus-specified thymidine 
kinase transforms acyclovir to its monophosphate which is then transformed by cellular 
enzymes to acyclovir diphosphate and acyclovir triphosphate. Acyclovir triphosphate is both 
an inhibitor of, and a substrate for, herpesvirus-specified DNA polymerase. Although the cellular 
oc-DNA polymerase in infected cells may also be inhibited by acyclovir triphosphate, this occurs 
only at concentrations of acyclovir triphosphate which are higher than those which inhibit the 
herpesvirus-specified DNA polymerase. Acyclovir is preferentially taken up and selectively 
converted to its active form by herpesvirus-infected cells. Thus, acyclovir has a very much lower 
toxic potential for normal uninfected cells because: 1) less is taken up; 2) less is converted to 
the active form; 3) cellular oc-DNA polymerase has a lower affinity for the active form of the drug. 
INDICATIONS AND CONICAL USE
ZOVIRAX Sterile Powder is indicated for treatment of initial and recurrent mucosal and 
cutaneous herpes simplex infections in immunocompromised adults and children. It is also 
indicated for severe initial episodes of herpes simplex infections in patients who may not be 
immunocompromised. It is not recommended for use in herpes encephalitis or other herpes 
group infections all of which are still the subject of ongoing investigations.
The indications are based on the results of a number of double-blind, placebo-controlled 
studies which examined changes in virus excretion, total healing of lesions, and relief of pain. 
Because of the wide biological variations inherent in herpes simplex infections, the following 
summary is presented merely to illustrate the spectrum of responses observed to date. As in 
the treatment of any infectious disease, the best response may be expected when the therapy 
is begun at the earliest possible moment.
In patients experiencing initial episodes of herpes genitalis, virus excretion had ceased 
in 100% of initial lesions within 3 days after the start of a 5-day course of intravenous ZOVIRAX 
therapy. Only 20% of placebo recipients were virus-free at this time, as well as when therapy 
was discontinued. ZOVIRAX therapy arrested virus excretion in over 90% of immunocompromised 
patients with mucocutaneous disease at the end of 7 days of therapy, while only 26% of placebo- 
treated patients were virus negative at the same time.
Because complete re-epithelialization of herpes-disrupted integument necessitates recruit­
ment of several complex repair mechanisms, the physician should be aware that the dis­
appearance of visible lesions is somewhat variable and will occur later than the cessation of 
virus excretion. In spite of these limitations, 100% of ZOVIRAX-treated patients with initial 
episodes of herpes genitalis healed within 15 days after initiation of treatment. Only 50% of 
placebo recipients were healed at this same interval. The lesions of 61% of immunocompromised 
patients who received ZOVIRAX were healed within 15 days after the initiation of a 7-day course 
of therapy; only 38% of placebo patients had healed their lesions at that point.
Pain associated with herpes infections is highly variable in frequency and intensity. These 
clinical studies, however, demonstrated that ZOVIRAX therapy plays a significant role in reduc­
tion of pain in cutaneous herpes infections in immunocompromised patients. For example, 
61% of ZOVIRAX-treated immunocompromised patients were pain-free by day 10, whereas 
44% of placebo-treated patients were pain-free in the same period of time.
Whereas cutaneous lesions associated with herpes simplex infections are often pathogno­
monic, Tzanck smears prepared from lesion exudate or scrapings may assist in diagnosis. 
Positive cultures for herpes simplex virus offer the only absolute m eans for confirmation of 
the diagnosis.
CONTRAINDICATIONS
ZOVIRAX Sterile Powder is contraindicated for patients who develop hypersensitivity to 
the drug.
WARNINGS
ZOVIRAX Sterile Powder should not be administered by any route [i.e. topically (skin or 
eye), intramuscularly, orally or subcutaneously] other than by intravenous infusion. 
PRECAUTIONS
Precipitation of ZOVIRAX crystals in renal tubules can occur if maximum solubility (1.3 mg/mL 
in water) is exceeded. This phenomenon is reflected by a rise in serum creatinine and blood 
urea nitrogen and a decrease in creatinine clearance. With sufficient renal tubular compromise, 
urine output decreases
Acute increases in serum creatinine and decreased creatinine clearance have been observed 
in humans receiving ZOVIRAX and: (1) who were poorly hydrated; (2) who were receiving 
concomitant nephrotoxic drugs (e.g., amphotericin B, and aminoglycoside antibiotics); (3) who 
had pre-existing renal compromise or damage; and (4) in whom the dose was administered 
by rapid intravenous injection (less than 10 minutes). Observed alterations in renal function 
have been transient, in some instances resolving spontaneously without change in ZOVIRAX
dosing regimen. In other instances, renal function improved following increased hydration, 
dosage adjustment, or discontinuation of ZOVIRAX therapy.
When dosage adjustments are required they should be based on estimated creatinine 
clearance (See DOSAGE AND ADMINISTRATION).
It is not known whether acyclovir is excreted in human milk. Because many drugs are 
excreted in human milk, caution should be exercised when ZOVIRAX is administered to a 
nursing mother.
All animal studies carried out to date on reproduction and teratology have been negative. 
However, since animal reproduction studies are not always predictive of human response, 
ZOVIRAX should be used during pregnancy only if the physician feels the benefit will outweigh 
the possible harm to the fetus.
There exists no data, at this time, which demonstrates that the use of ZOVIRAX will 
prevent transmission of herpes simplex infection to other persons.
Consideration should be given to an alternative treatment regimen if after 5 days of treat­
ment there is no expected clinical improvement in the signs and symptoms of the infection.
Strains of herpes simplex virus which are less susceptible to ZOVIRAX have been isolated 
from herpes lesions and have also emerged during intravenous treatment with ZOVIRAX. 
ADVERSE REACTIONS
The most frequent adverse reactions reported during controlled clinical trials of acyclovir 
were inflammation or phlebitis (14%) at the injection site following infiltration of the I.V. fluid, 
and rash or hives (4.7%). Of the patients receiving placebo, 4.8% experienced the sam e reactions 
(inflammation/phlebitis, rash or itching).
Less frequent adverse reactions were diaphoresis, hematuria, hypotension, headache and 
nausea, each of which occurred in 1.6% of the patients. Hematuria and nausea were experienced 
by placebo recipients at the same frequency. These reactions were observed in severely 
immunocompromised patients who often have multisystem diseases unrelated to herpes 
infections and, therefore, it is difficult to state conclusively that these reactions were caused 
by ZOVIRAX therapy.
Additional adverse reactions were reported in uncontrolled trials. The most frequent 
adverse reaction was elevated serum creatinine. This occurred in 9.8% of patients, usually 
but not always following rapid (less than 10 minutes) intravenous infusion. It is not known 
whether this phenomenon is drug related but in view of the fact that the drug is known to 
crystallize in urine there exists a possibility that this occurred due to inadequate hydration of 
the patients. Less frequent adverse experiences were thrombocytosis (0.4%) and jitters (0.4%). 
SYMPTOMS AND TREATMENT OF OVERDOSAGE
No acute massive overdosage of the intravenous form has been reported.
Doses administered to humans have been as high as 1200 m g/m 2 (28 mg/kg) three 
times daily for up to two weeks. Peak plasma concentrations have reached 80 \ig/mL. Possible 
evidence of central nervous system (CNS) toxicity (coarse tremors, confusion and agitation) 
and/or bone marrow toxicity were seen in four patients at 2100 and 2700 m g/m 2/day. The 
CNS side effects resolved upon lowering the dosage or discontinuing ZOVIRAX therapy Pre­
cipitation of acyclovir in renal tubules may occur when the solubility (1.3 mg/mL) in the intra­
tubular fluid is exceeded. Precipitation may be avoided or overcome by adequate hydration of 
the patient. Acyclovir is dialyzable. In the event of acute renal failure and anuria, hemodialysis 
should be initiated until renal function is restored.
DOSAGE AND ADMINISTRATION
CAUTION -  RAPID OR BOLUS INTRAVENOUS AND INTRAMUSCULAR OR SUBCUTANEOUS 
INJECTION ARE TO BE AVOIDED.
Therapy is recommended for at least 5 days for immunocompetent patients and for at 
least 7 days for immunocompromised patients.
Adults: 5 mg/kg infused at a constant rate over a 1-hour period, every 8 hours (15 mg/kg/day)
in patients with normal renal function.
Children Under 12 Years: In children under 12 years of age, more accurate dosing can be 
attained by administering 250 mg/m 2 infused at a constant rate over a 1-hour period, every 
8 hours (750 m g/m 2/day).
Patients with Acute or Chronic Renal Impairment: Use the recommended doses and 
methods of administration-, and adjust the dosing interval as indicated in the following table. 
Creatinine Clearance Dose Dosing Interval
(mL/min/1.73m2) (mg/kg) (hours)
>50 5 8
25-50 5 12
10-25t 5 24
0-10+ 2.5 24-48
t  Hemodialysis: For patients who require hemodialysis, the mean plasma half-life of 
acyclovir during dialysis is approximately 5 hours, which results in a 60% decrease in plasma 
concentrations following a 6-hour dialysis period. Recommended doses should be administered 
every 24-48 hours, and after hemodialysis.
PHARMACEUTICAL INFORMATION
Reconstitute as follows:
Vial Size 
500 mg
Volume to be 
Added to Vial 
10 mL
Solutions for Reconstitution
Sterile Water for Injection 
Reconstitution Table
Approximate Available 
Volume______
Approximate Average 
Concentration 
50 mg/mL10 mL
SHAKE WELL UNTIL DISSOLVED. ASSURE COMPLETE DISSOLUTION BEFORE MEASURING 
AND TRANSFERRING EACH INDIVIDUAL DOSE.
Intravenous Infusion: The calculated dose of the reconstituted solution should be removed 
and added to an appropriate intravenous solution listed below at a volume selected for ad­
ministration during each 1-hour infusion. Infusion concentrations exceeding 10 mg/mL are 
not recommended. Since the vials do not contain any preservatives any unused portion of 
the reconstituted solution should be discarded.
Solutions for I.V. Infusion
5% Dextrose Injection Ringer's Injection
5% Dextrose and 0.9% Sodium Chloride Injection Normal Saline Injection
5% Dextrose and 0.2% Sodium Chloride Injection Lactated Ringer’s Injection
Stability of Solution
Storage: Reconstituted solutions at a concentration of 50 mg/mL should be used within 
12 hours if kept at room temperature. Refrigeration may result in the formation of a precipitate 
which will redissolve at room temperature.
Once diluted, the admixtures are to be administered within 24 hours of the preparation. 
The admixtures are not to be refrigerated.
Incompatibility: ZOVIRAX should not be added to biologic or colloidal fluids (e.g. blood 
products, protein hydrolysates or amino acids, fat emulsions, etc.).
DOSAGE FORMS
Availability: ZOVIRAX is available as sterile powder in 10 mL vials, each containing acyclovir 
sodium equivalent to 500 mg of acyclovir.
Storage: ZOVIRAX should be stored at 15°-30°C.
Product Monograph available on request.
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1.1. M a y b a , m d , f r c s c *
Winnipeg Orthopaedic Society, a Short History
Orthopedics as a specialty has been prac­
tised in Winnipeg since Dr. H.P.H. Gal­
loway arrived there in 1905. He had 
received his MD degree in 1887. He 
worked as a general practitioner in 
Toronto for several years and later did 
postgraduate surgical training in Boston, 
New York, Liverpool and London, 
England. In association with Dr. B.E. 
McKenzie, he founded the Toronto 
Orthopaedic Hospital in 1895. Dr. Gal­
loway was a lecturer in orthopedic sur­
gery at the Manitoba Medical College in 
1907. He was President of the American 
Orthopaedic Association in 1919. He 
advocated open reduction for congenital 
dislocation of the hip as early as 1920.
Subsequently, others, such as Drs. 
A .P. MacKinnon, J.E. Lehmann, A. 
Gibson, A.A. Murray, W.A. Gardner 
and F.L. McKinnon, came to Winnipeg 
to practise orthopedics. The Winnipeg 
General Hospital, St. Boniface General 
Hospital and the Winnipeg Children’s 
Hospital were the main institutions where 
they practised their specialty, although, 
later, in 1925, a ward at the Children’s 
Hospital was set aside for the unit of the 
Shriners Hospital for Crippled Children. 
This unit was headed by Dr. A.A. Mur­
ray. Murray, a native of Nova Scotia, 
gained his MD from the Manitoba Med­
ical College in 1913 and in 1919 he trained 
in orthopedics under Dr. Galloway.
Formal discussions regarding ortho­
pedics took place at hospital ward rounds 
and at scientific presentations of the Min- 
Da-Man Orthopaedic Society, so named 
because its members were drawn from 
Minnesota, North and South Dakota and 
Manitoba. The Min-Da-Man meetings 
were rotated to various centres in the 
province and the three states.
More recently, orthopedic practices
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were established in Winnipeg by Drs.
G . H. Ryan, A.E. Deacon, K.C. McGib- 
bon, P. Berbrayer, C. Hollenberg, F.R. 
Tucker, W.B. MacKinnon, E.S. James,
H. Funk, D.M. Bruser and L.D. Croll.
The orthopedists participated at scien­
tific meetings of the Canadian Ortho­
paedic Association and the American 
Orthopaedic Association and informally 
at gatherings in the surgeons’ homes.
After World War II, orthopedic meet­
ings were held in the clubrooms of the 
Medical Arts Building in Winnipeg. These 
consisted of informal discussions on 
problems in the practice and science of 
orthopedics, and discussions on medical 
fees. This was followed by a social 
evening.
Two of the founding members of the 
Winnipeg Orthopaedic Society were Drs. 
D.A. Gibson and W.A. Gardner. Dr. 
Gibson, born in Scotland in 1883, 
attended the University of Edinburgh and 
graduated with first-class honours. He 
was awarded medals in medicine, surgery 
and mid-wifery. He came to Winnipeg in 
1913 and served as Chairman of the 
Department of Anatomy at the Manitoba 
Medical College until 1918. Thereafter he 
was an associate professor of surgery and
FIG. 1—Crest of Winnipeg Orthopaedic 
Society.
was in charge of orthopedic surgery at the 
Manitoba Medical College. He practised 
orthopedics at the Galloway/Gibson 
Clinic in Winnipeg. Dr. Gardner was 
born in Huntingdon, Quebec, in 1877. 
After receiving his MD degree from 
McGill University, he studied surgery in 
New York and London, England. He 
became a lecturer in clinical surgery at the 
Manitoba Medical College in 1919. He 
was attending orthopedic surgeon at the 
Winnipeg Shriners Hospital for Crippled 
Children and the Winnipeg Misericordia 
General Hospital. In 1922 he became 
chief medical officer for Canadian 
National Railways. He also served as 
President of the Min-Da-Man Ortho­
paedic Society. In his youth he was a 
bugler and was a member medical officer 
of the Queen’s Own Cameron High­
landers.
On Feb. 23, 1948, in a letter to Dr. Gib­
son, Dr. Gardner expressed a desire to 
form a formal orthopedic society in the 
city. This resulted in the founding of the 
Winnipeg Orthopaedic Society that year, 
with Dr. Gibson being the first president. 
Meetings were held monthly at the Med­
ical Arts clubrooms until 1960 and then 
at the new Manitoba Rehabilitation 
Hospital until 1973. During 1973 and 
1974, the Society met for its meetings at 
the Manitoba Clinic, then in 1975, the 
locale was changed to the Winnipeg 
Squash Racquet Club and continues there 
to the present.
In 1960, the Society organized a sym­
posium on rehabilitation of orthopedic 
disabilities under the chairmanship of Dr. 
C. Hollenberg; the topics were scoliosis 
and pediatric disorders. This was the first 
of what has become an annual sympo­
sium. Guest speakers at that first sympo­
sium were John Cobb of New York, 
George Garceau of Indianapolis, Earl 
McBride and Claude Lambert of North­
western University in Chicago, William 
Littler of New York and Harold Sofield 
of Chicago. Scientific and clinical papers 
were presented and discussed, and this 
format has continued to the present. The 
symposium provides ongoing education
92 VOLUME 28, NO. 1, JAN U ARY 1985 /  THE CANADIAN JOURNAL OF SURGERY
for the orthopedic and medical commu­
nity. Subsequent organizers for the sym­
posium have been Drs. W.R. Welply, 
P.N. Porritt, G.E. Johnson, D. Lyttle 
and R. Monson.
In 1967, members of the Society par­
ticipated in the orthopedic care of athletes 
during the Pan-American Games in Win­
nipeg. A 25th anniversary dinner, at 
which the older orthopedists were 
honoured, was held in Winnipeg at the 
North Star Inn in 1973.
Society members have also been active 
in the Canadian Orthopaedic Association. 
Several have served as President of that 
body. They are Dr. A. Gibson — 1950, 
Dr. W.B. MacKinnon — 1960 and Dr. 
F.R. Tucker — 1968. Others served as 
chairman of the local arrangements com­
mittee for the Association’s annual meet­
ing: Dr. W.B. MacKinnon — 1962, Dr. 
D.R. Bigelow — 1973, Dr. R. Macoomb
— 1964. Dr. A. Gibson designed the crest 
of the Canadian Orthopaedic Association
— a maple leaf with fleur-de-lis.
During the chairmanship of Dr. W.B.
MacKinnon, a committee was struck, on 
Nov. 6, 1962, to draft a constitution for 
the Winnipeg Orthopaedic Society. The 
committee comprised the following mem­
bers: Dr. D.M. Bruser, Dr. P.H. Decter,
Dr. T.J. Mills and Dr. P.N. Porritt, 
Secretary. The draft constitution was rati­
fied by the membership the same year. 
The Society has the following aims and 
objectives:
• To improve the standards of ortho­
pedic practice in Manitoba.
• To further the education of the med­
ical profession, paramedical personnel 
and the public in orthopedic matters.
• To improve the condition of practice 
of orthopedic surgeons in this area.
• To act as liaison between the medi­
cal profession and other agencies in mat­
ters that concern the practice of ortho­
pedic surgery.
Categories of membership in the Soci­
ety were to be honorary, emeritus, active, 
associate and nonresident.
Annually in the spring, a banquet is 
held in honour of the students training in 
orthopedics at the University of Man­
itoba’s teaching hospitals (St. Boniface 
and Winnipeg general hospitals, The 
Children’s Hospital of Winnipeg, Deer 
Lodge and Manitoba Rehabilitation 
hospitals and the Rehabilitation Centre 
for Children [formerly Shriners 
Hospital]).
In 1983, under the presidency of Dr. 
1.1. Mayba, a design for a crest of the 
Winnipeg Orthopaedic Society was 
approved (Fig. 1). It consists of the tree 
of Nicolas Andry de Boisregards, and has 
five different colours on the leaves, sig­
nifying the various cultures; the prairie 
crocus, (Anemone patens), the floral 
emblem of Manitoba, and the sugar 
maple (Aceraceae saccharuin) are also 
represented. The crest was designed by 
Mr. Don Belamy and Dr. 1.1. Mayba and 
executed by Mr. Don Belamy.
In 1984, Winnipeg was the host city for 
the annual meeting of the Canadian 
O rthopaedic A ssociation. Dr. R. 
Macoomb, the organizing chairman of 
the local arrrangements committee, was 
helped by many Society members and 
their wives to ensure a successful scien­
tific and social meeting. The crest of the 
Winnipeg Orthopaedic Society and the 
armorial bearings of the University of 
Manitoba, Faculty of Medicine, were dis­
played at the meeting in the Winnipeg 
Convention Centre.
The Winnipeg Orthopaedic Society 
looks to the future to continue the fellow­
ship of orthopedic surgeons and to foster 
the best practices in orthopedic care 
through continuing education.
Reviewers 1984
The Editors, on behalf of the Editorial Advisory Board of the Journal, acknowledge with thanks the services 
of the following reviewers of manuscripts for the past year.
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H.W. Beattie R.M. Filler N.S. Mitchell
P. Belliveau R.A. Forse J.E. Morin
G. Bertrand G.S. Fox D.S. Mulder
G.S. Cameron D.M. Giron J.E . Mullens
S.E. Carroll F.M. Guttman M .J. Phillips
R.C-J. Chiu R.O. Heimbecker I. Prieto
W.B. Chung J. Heppell W .R.J. Rennie
W.P. Cockshott H.S. Himal H. Richardson
F.M. Cole E.J. Hinchey R.S. Roberts
C.M. Couves F.G. Inglis F. Shamji
R.K. Daniel R.G. Keith H.M. Shizgal
J. De Maria l.H. Koven L.A. Stein
J.E. Devitt J.A. Lamont G.W. Stevenson
A.R.C. Dobell B. Langer J.F. Symes
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A.C.H. Duranceau A. Loutfi H.B. Williams
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BOOK REVIEW S
ARTHROSCOPY: Diagnostic and Surgical 
Practice. S. Ward Casscells. 192 pp. Illust. 
Lea & Febiger, Philadelphia, 1984. $50 
(US). ISBN 0-8121-0888-4.
Arthroscopy is a diagnostic aid and surgical 
tool that is used extensively around the world. 
It has expanded to this level in little more than 
10 years, after the introduction of the first com­
mercially available arthroscopes. From its 
beginnings as a device used to augment clini­
cal diagnosis, it has burgeoned into a fully 
fledged surgical technique that has considera­
bly reduced morbidity, rehabilitation time and 
costs in a wide variety of intra-articular dis­
orders.
This small book is a condensation of a great 
deal of experience amassed by a number of pre­
eminent orthopedic surgeons. The editor’s 
hope to help establish arthroscopy in its proper 
place has been fulfilled. Even the still- 
suspicious die-hards should be convinced by 
the diversity of conditions amenable to diag­
nosis and treatment by arthroscopy, from 
meniscal tears and articular defects to plicae 
and osteochondritis dissecans.
The book is well organized and is divided 
into two sections: diagnostic and surgical 
aspects. Procedures are described in detail 
along with some background and evaluation 
of results. The quality of the line drawings and 
many arthroscopic photographs is excellent, 
marred only by a few reversed pictures that do 
not match their legends. Since some experience 
is needed to recognize structures within the 
limited visual field of an arthroscopic photo­
graph, the book would benefit from more line 
drawings alongside the photographs, with the 
structures specifically marked. This would 
greatly expand the book’s usefulness to novice 
arthroscopists and orthopedic residents.
This publication is the first to cover the 
whole range of arthroscopy and its applica­
tions. There is something in it even for the 
experienced arthroscopist, but it is particularly 
valuable for those somewhere between their 1st 
and 500th case.
Bob Jackson, sometimes known as the 
“ father of Canadian arthroscopy” , states in 
the foreword that “ it truly is a state-of-the-art 
publication” . This statement is quite valid, 
both for the book and for his own outstanding 
chapter on injuries to the anterior cruciate liga­
ment. The collection of experience in this book 
provides an excellent opportunity for those 
interested in the field to bring themselves up 
to date and to broaden their arthroscopic hori­
zons. I recommend it.
O liv er  T . P o rtn er , m d , c m , frcsc
1081 Carling Ave.,
Ottawa, Ont.
K1Y 4G2
ATLAS OF HEART DISEASE. J.H. Holz- 
ner and P. Mathes. English edition by 
W.A. Baxley. 348 pp. Illust. Butterworth 
Scientific, London; Butterworth & Co. 
(Canada) Ltd., Toronto, 1983. Price not 
stated. ISBN 0-407-00264-2.
This is a superb atlas of heart disease. It was 
written not as a textbook of cardiac diseases 
but rather as a well-illustrated atlas, showing 
the link between clinical findings and 
anatomopathologic alterations in cardiac dis­
ease. In addition, it was designed to show, with 
a series of magnificent illustrations, what can 
be achieved by a multitude of special exami­
nations. The contents flow so beautifully that 
it can be read as a fascinating novel.
There are a multitude of atlases of this kind 
available but because of its simple and direct 
approach and its outstanding illustrations, I 
consider it to be a unique contribution to the 
medical literature.
All cardiologists and cardiovascular surgeons 
will find this atlas useful and it would make 
a fine reference for radiology technicians and 
those performing electrocardiography and 
echocardiography. It would also be helpful for 
medical students when studying the anatomy 
and physiology of the heart.
This atlas is a special work of art and I 
recommend it without reservation.
C ec il  M. C ouves, m d , fr csc , facs
3104 Cox Rd.,
Kelowna, BC 
VIZ 2B4
THE BREAST: an Atlas of Reconstruction. 
Wallace H.J. Chang and Judith J. Petry. 
434 pp. Illust. Williams & Wilkins, Balti­
more, 1984. Price not stated. ISBN 
0-683-01668-7.
All aspects of breast reconstruction are covered 
in this book. The two authors have selected safe 
techniques that represent the current state of 
the art; they are illustrated step by step by Lois 
Liebman-Fischman. Nineteen guest contribu­
tors, many of whom have breast procedures 
bearing their names, have participated in a 
manner reminiscent of a panel discussion 
among experts at an international meeting.
The book deals extensively with augmenta­
tion and reduction mammoplasty, mastopexy, 
subcutaneous mastectomy and reconstruction 
following simple, radical and prophylactic sub­
cutaneous mastectomy. It also addresses the 
treatment of congenital breast and nipple 
deformities and gynecomastia. Sections deal­
ing with post-traumatic (post-burn) deformi­
ties, reconstruction of the nipple-areolar com­
plex following mastectomy and surgical 
correction of capsular contracture round out 
the contents.
The anatomy relevant to the performance of 
intercostal, field and cervicothoracic epidural 
blocks is illustrated and concisely described. 
Techniques, including drug dosage, along with 
their merits are clearly stated and the consider­
ations for general anesthesia are presented. The 
text emphasizes anesthetic techniques appropri­
ate for surgery in an outpatient setting, 
minimizing postoperative discomfort and 
speeding recovery. Anatomic diagrams in 
colour of the breast, upper trunk, abdominal 
musculature, axilla and thoracolumbar region 
by Katherine C. Powell open the text. A bib­
liography of references relevant to each proce­
dure completes the book, although reference 
numbers do not appear in the text.
In each chapter, a series of large, uncluttered 
diagrams details each technical step. Captions 
for many are brief and technical diagrams 
might benefit by a few additional details, even 
though many of the points are brought up later 
in the text. The illustrations are followed by 
pre- and postoperative photographs of patients 
treated by the techniques. Following this, a 
panel of up to five experts discusses a series 
of questions dealing with procedure selection, 
technical points at various steps and follow­
up care. Candid answers and opinions are con­
cisely stated. The authors complete each chap­
ter with comments on their personal choice and 
opinions.
Reduction mammoplasty is particularly well 
covered, with guest contributors Regnault, 
Pitanguy, McKissock, Strombeck and Dufour- 
mentel, whose own named procedures typify 
the basic anatomic and philosophical 
approaches to the reduction procedures that 
have been performed by several different 
methods and variations. Their preference for 
their own procedures and their experience with 
each other’s procedures offer great insight to 
a surgeon who is searching for new ideas for 
a common problem.
Regnault and Perras, in the chapter on 
mastopexy, assess 10 different procedures in 
tabular form, including advantages, disadvan­
tages and personal comments; this is followed 
by selected cases and line drawings illustrating 
a number of the methods. Constable has col­
laborated on a comprehensive and concise 
chapter on reconstruction of breasts with post­
burn deformities.
Breast reconstruction following radical 
mastectomy, using the latissimus dorsi flap, is 
covered in detail; however, the variety of 
myocutaneous flaps based on the rectus 
abdominis muscle receives only a single page 
of diagrams and three paragraphs of editorial
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o f the Journal, should be submitted separate from the text, one to a page.
References should be cited by number in the text, in order o f  occurrence, and listed 
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An abstract in English, and in French i f  possible, about 125 words long, should 
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Authors wilt receive a copy o f  the edited manuscript for approval before publica­
tion but will not receive galley proofs.
comment. The comments of an advocate of the 
rectus abdominis techniques would have 
strengthened this section by allowing the reader 
to compare the two approaches.
The chapters dealing with reconstruction fol­
lowing simple and radical mastectomy and 
prophylactic subcutaneous mastectomy address 
pathologic considerations, timing, pre-existing 
scars and radiotherapy. The topics are 
approached after the decision to perform sur­
gery has been made, concentrating mainly on 
the technical points without discussing in depth 
the multitude o f considerations necessary to 
decide whether reconstruction is indicated.
This text covers all aspects of reconstruction 
and is enhanced by the contributions o f well- 
respected breast surgeons. It will be of value 
to residents in plastic surgery and to practis­
ing surgeons who perform a relatively small 
volume of breast reconstructions and wish to 
refresh their knowledge or look at alternatives 
relevant to a particular patient. The more 
experienced surgeons who have already deve­
loped their own techniques and personal 
modifications may benefit from the panel dis­
cussions in which procedures and experiences 
are assessed and dissected.
Charles F.T. Snelling, md, frcsc
Laurel Medical Centre,
306-888 West 8th Avenue,Vancouver, BC 
V5Z 3Y1
Directives aux collaborateurs
Toute communication initiale doit etre adressee aux coredacteurs, Le journal cana- 
dien de chirurgie, CP 8650, Ottawa, Ont. KIG 0G8.
Les textes originaux des articles et des autres communications y  compris un nom- 
bre limite de rapports sur des cas speciaux doivent etre rediges en triplicata, en fran- 
gais ou en anglais, et accompagnes d ’une lettre demandant leur publication dans le 
Journal. Les auteurs doivent egalement inclure une declaration afin de nous confir­
mer que le manuscrit n ’est pas sous consideration par un autre journal et qu ’il ne 
fu t pas publie auparavant. Veuillez les dactylographier sur une seule face d ’une feuille 
non reglee avec double interligne et grandes marges. Les unites de mesure doivent 
etre exprimees selon le Systeme international d’unites.
Les illustrations telles que des photographies d ’appareils cliniques, des radiogram­
mes, des photomicrographies, des graphiques et des diagrammes, en triplicata, doi­
vent etrefournies sous la forme d ’epreuves sur papier glace sans montage, les bordu- 
res intactes, d ’un format ne depassant pas 20 X 25 cm. Chaque illustration doit etre 
munie d ’une legende dactylographiee sur une page separee du texte de Particle. S ’il 
s ’agit de radiogramme, envoyez une copie et non l ’original. S ’il s ’agit d ’unephoto- 
micrographie, indiquez le contrast utilise et Pechelle de Pagrandissement. Les lettres 
qui servent a identifier les elements d ’une illustration doivent etre d ’une dimension 
suffisante afin de demeurer visibles lorsque les necessity de Pimpression imposent 
une reduction de l'image fournie. II ne faut pas qu’on puisse identifier un patient 
grace a une illustration a moins qu’il n ’y  ait expressement consentipar ecrit; faute  
de permission les traits de sa physionomie doivent etre obliteres. Les illustrations en 
couleur ne seront publiees qu ’aux frais de Pauteur. Si Pillustration provient d ’une 
autre source, il convient d ’obtenir tant de Pauteur que de Pediteur de Pouvrage dont 
elle est tiree, Pautorisation de s ’en servir aux fins de la publication.
Il faut que les tableaux soient conformes au format rectangulaire du Journal et 
rediges sur des feuilles separees du texte, un tableau par feuille.
Les references doivent etre citees dans le texte au moyen d ’un chiffre et groupes 
dans Pordre a la fin  de Particle selon la maniere de faire adoptee par ce Journal.
Un resume, en frangais et aussi en anglais, qui ne doit pas depasser 125 mots doit 
accompagner chaque article sur une feuille separee.
A titre d ’approbation, un exemplaire du manuscrit redige sera envoye a Pauteur 
mais non les epreuves.
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As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept suitable classified 
advertisements. The deadline is 1 month before issue date. Regular classified rates (for each insertion): $37.00 
for the first 40 words or less, additional words 40C each (additional $14.00 for frame). Special Display under 
75 words, 2 1/4" x 2", $90.00. $5.00 charge (first insertion only) for CJS box numbers. Display rates availa­
ble on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
ACADEMIC APPOINTMENT: ON -  Applica­
tions are invited for the position of Division Head of 
General Surgery at the Wellesley Hospital, Toronto. 
Fu ll-tim e  appo in tm ent at Associate Pro­
fessor/Professor level, University of Toronto with 
salary and benefits commensurate with qualifica­
tions and experience. The successful applicant 
would be expected to develop an Oncology Service 
that would display excellence in clinical cancer 
surgery, clinical trials and basic cancer research. 
Prospective applicants should have demonstrated 
evidence of superior skills in at least two of these 
fields. In addition, if the qualifications prove ap­
propriate the successful applicant may also be in­
vited to direct the University of Toronto, Program in 
Surgical Oncology. Closing date for receipt of ap­
plications if February 14, 1985. Contact: Dr. J.L. 
Provan, Surgeon-in-Chief, Wellesley Hospital, 
160 Wellesley St. E., Toronto, ON M4Y 1J3. In 
accordance with Canadian Immigration re­
quirements, this advertisement is directed to Cana­
dian citizens and permanent residents. — S85-01
GENERAL SURGEON: BC -  Wanted to join 
another surgeon, serving Cariboo Chilcotin in large 
clinic and well equipped 84-bed hospital. Contact: 
Dr. P.A. Cullum, Yorston Medical Clinic, 
e203-143 4th Ave. S., Williams Lake, BC V2G 
1J8, (604) 398-6757. -S84-031
ACADEMIC APPOINTMENT: NS -  The Depart­
ment of Surgery, Dalhousie requires a senior clinical 
investigator to lead a research team investigating 
the role of the immune system in host defense in 
surgical disease. The specific area of emphasis is the 
role of the complement system in patients with 
trauma, infection and multi-system organ failure. 
The candidate must have an FRCSC or equivalent 
laboratory research as an independent investigator. 
Preference will be given to individuals with a PhD in 
a relevant field. University rank as an associate or 
full professor will be combined with an equivalent 
hospital appointment. Remuneration will be accor­
ding to qualifications and experience. Dalhousie 
University is an equal opportunity employer, but in 
accordance w ith  Canadian Immigration re­
quirements, this advertisement is directed to Cana­
dian citizens and permanent residents. Applications 
should be sent to: Dr. Bernard Perey, Professor 
and Head, Department of Surgery, Victoria 
General Hospital, Halifax, NS B3H 2Y9.
— S85-02
GENERAL SURGEON : ON — Required in August 
1985 to replace retiring surgeon in southwestern On­
tario town. Practice by referral only. Hospital 200 
beds. Must have FRCS(C) or be completing the 
FRCS(C) degree in the fall of 1985. Sports and 
recreational facilities available. Please write with 
curriculum vitae to : Box S105, CJS. — S84-041
LOCUM OBSTETRICIAN/GYNECOLOGIST -
FRCS(C) required for female gynecologist's prac­
tice, 2 hours from Toronto, for February 1985. 
Possibility of regular locums or practice-sharing. 
Reply: Box S106, CJS. -S84-042
Canhealth Systems Limited
Due to  expansion — to ta lly  equipped 
Medical O ffices fo r rent on a sessional 
basis in prestig ious central dow ntow n 
To ron to  location. Fully serviced Medical 
Centre support available to  suit re­
qu irem ents.
You w ill be associated w ith  a group 
p re se n tly  d e live rin g  se rv ices on a 
regional, national and international scale. 
Write stating requirements to: 
Canhealth Systems Limited 
Box 33, 150 York Street 
Toronto, Ontario 
M5H 3S5 (416) 364-3008 
_______________________________ -S 8 5 -0 3
C LIN IC AL FELLOWSHIPS
Ewart Angus Intensive Care Unit 
Wellesley Hospital 
Toronto
Two positions available July 1, 1985 for a 
period of 1 year in a Medical-Surgical Unit with 
on-site computer support facilities. Duties com­
prise clinical research in a strong academic and 
teaching unit. Present research includes nutri­
tional studies in critical illness, sepsis and non- 
invasive respiratory monitoring and respiratory 
muscle function.
Reply to: Dr. D.P. Jones, Director
EAICU, Suite 219, E.K. Jones Bldg., 160 
Wellesley St. E., Toronto, ON M4Y 1J3, 
(416)966-6656. -S84-024
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Foothills H ospital
CHIEF,
DIVISION OF 
CARDIAC SURGERY
The Chief o f Cardiac Surgery w ill be responsible fo r the develop­
m ent o f the Cardiac Surgery Service, w h ich  w ill exem plify ex­
cellence in clinical cardiac surgery, clinical and basic research, 
undergraduate and postgraduate tra in ing. This position is a jo in t 
appo in tm en t w ith  The U niversity o f Calgary and Foothills 
H ospita l.
The successful candidate w ill be a Fellow o f the Royal College of 
Physicians and Surgeons o f Canada w ith  additiona l tra ining in 
Cardiac Surgery, be eligible fo r licensure in A lberta  and possess 
experience in adm inistra tion, teaching and research, The suc­
cessful applicant w ill have professional and academ ic qualifica­
tions fo r the rank of Professor or Associate Professor.
Footh ills Hospital is southern A lberta 's  main teaching and refer­
ral health care centre.
Salary w ill be in accordance w ith  qualifica tions and experience. 
Interested applicants are invited to apply by sub m itting  a com ­
plete resume by March 14, 1985 to:
Peter Cruse 
Professor and Head 
Department of Surgery 
Foothills Hospital 
1403 -  29 Street N.W.
Calgary, Alberta T2N 2T9 
Canada
A ll qualified individuals are encouraged to apply, but preference 
will be given to Canadian citizens and permanent residents.
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